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ABSTRACT 
Wendy Renee Miller 
EPILEPSY SELF-MANAGEMENT IN OLDER ADULTS: A QUALITATIVE STUDY 
Epilepsy is the most common chronic neurological condition in the United States, 
and it is incurable. Those who suffer from it must engage in both collaborative and 
independent management of their condition for the remainder of their lives. The 
treatment and care of those with epilepsy must therefore include not only medical 
interventions, which alone cannot cure the disorder or prevent the disability associated 
with it, but must also prepare persons for and facilitate their independent  
management—self-management—of the disorder. Self-management is a process that 
affects important outcomes including resource utilization, mortality, and quality of life. In 
the United States, those age 60 years and older have the highest incidence of new-onset 
epilepsy. Despite the high incidence of epilepsy in this population, coupled with the 
knowledge that self-management affects important outcomes, a thorough search of the 
literature suggests that self-management experiences of older adults diagnosed with 
epilepsy late in life have not been investigated.  
The purpose of the study was to examine, using a qualitative descriptive design, 
the self-management experiences of older adults diagnosed with epilepsy at or after age 
60. Semi-structured interviews were used to generate data. A total of 20 older adults 
participated. Major findings indicate that older adults in the sample, and particularly the 
women, experienced a delay in receiving an epilepsy diagnosis. These older adults 
experienced multiple problems and life changes since diagnosis—some of which are 
viii 
unique to this population and many of which are amenable to intervention. These older 
adults devise and execute a variety of management strategies, within a system, that are 
classified as disease/treatment-focused and problem/life changes-focused. These 
strategies further are categorized as proactive or reactive, with proactive strategies being 
pre-planned and effective, and reactive strategies being unplanned and less effective. 
Knowledge generated from this study reveals the problems experienced by older adults 
with epilepsy, as well as their management needs. These findings will inform future 
studies, the aim of which will be to investigate more thoroughly these problems and 
needs and, ultimately, to inform interventions aimed at resolving this population’s 
problems and concerns while also improving outcomes. 
 Janice M. Buelow, PhD, RN, FAAN, Chair 
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CHAPTER I 
INTRODUCTION AND NATURE OF THE STUDY 
Background and Description of Problem 
Epilepsy, the most common chronic neurological disease in the United States, 
currently affects over 3 million people in this country, and 200,000 Americans are  
newly diagnosed with the condition each year. In 2008, epilepsy resulted in 400,000 
hospitalizations, 2 million emergency room visits, and 9,000 deaths in the United States 
(Centers for Disease Control and Prevention, 2009). Epilepsy is “a medical condition 
characterized by the occurrence of more than one unprovoked seizure” (Epilepsy 
Foundation, 2009, p. 1). Like all chronic diseases and conditions, epilepsy is incurable. 
Thus, those who suffer from it are required to engage in both collaborative and 
independent management of their condition, often for the remainder of their lives. The 
treatment and care of those with epilepsy therefore must include not only medical 
interventions, which by themselves cannot cure the disorder or prevent the disability and 
other negative effects associated with it (Bodenheimer, Lorig, Holman, & Grumbach, 
2002), but also must prepare persons for and facilitate their independent  
management—self-management—of the disorder. 
The requisite self-management accompanying an epilepsy diagnosis often is 
complex, as those with the condition are faced with the constant need to perform 
behaviors to ensure medication adherence, to manage symptoms and medication side 
effects, to monitor for exacerbations, to ensure safety, and to lessen the overall effect of 
the disease and its treatment on daily life (Buelow & Johnson, 2000; Kobau & DiIorio, 
2003; Unger & Buelow, 2009). In addition, unique to epilepsy is the potential for a great 
loss of independence upon diagnosis—those with epilepsy often cannot drive a motor 
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vehicle and have numerous other lifestyle and activity restrictions that interfere with their 
ability to fulfill daily roles (Gilliam et al., 1997; Krumholz, 2009). 
While epilepsy affects people of all ages, those age 60 years and older have the 
highest incidence of new onset epilepsy. In fact, in the United States, 27% of new 
epilepsy diagnoses each year involve those age 60 years and older (Hesdorffer et al., 
2011). While limited literature surrounding the epilepsy self-management of younger 
adults—including of what it is comprised and what affects and influences it, as well as 
the effectiveness of some interventions to improve it and its associated outcomes—exists, 
researchers have not yet investigated the epilepsy self-management of older  
adults—those age 60 years and older (Epilepsy Foundation, 2009; Martin, Vogtle, 
Gilliam, & Faught, 2003)—who have been diagnosed with epilepsy in older adulthood. 
Researchers who have published research done with older adults with epilepsy have 
focused on investigating those older adults’ concerns about having epilepsy (Martin, 
Vogtle, Gilliam, & Faught, 2005) and their quality of life (Laccheo et al., 2008), but no 
published literature pertaining to their actual epilepsy self-management experiences can 
be found. Further, no studies in which older adults diagnosed with epilepsy in older 
adulthood comprised the sample can be found in the literature. 
Researchers’ lack of attention to older adults’ experiences with epilepsy  
self-management persists despite knowledge that this portion of the population is 
profoundly affected by new-onset epilepsy and that epilepsy self-management affects 
important outcomes such as quality of life, disease severity, mortality, and healthcare 
resource utilization (Centers for Disease Control and Prevention, 2009). The knowledge 
that exists regarding the epilepsy self-management of younger adults may not be wholly 
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applicable to older adults given the uniqueness of this population in terms of  
age-associated physiologic changes, the existence of multiple comorbidities, 
polypharmacy, and the common existence of a family member—spouse, adult child, or 
significant other—who is involved intricately in managing the older adult’s epilepsy 
(Rowan & Ramsay, 1997). Moreover, older adults suffer disproportionately from the 
negative sequelae of epilepsy (i.e., falls, medication toxicity) than do younger adults with 
the disorder (Brodie & Kwan, 2005). Therefore, existing interventions that are intended 
to improve epilepsy self-management and outcomes, which have been based on research 
findings with younger adults with epilepsy, may not be as effective for older adults given 
that they are not tailored for this population. 
Thousands of older adults begin self-managing epilepsy on a yearly basis 
(Hesdorffer et al., 2011). Since older adults are the fastest growing portion of the 
population and the life expectancy in this country continues to rise (Centers for Disease 
Control and Prevention, 2010a; Rowan & Ramsay, 1997; United States Census Bureau, 
2009), a growing number of older adults will be required to begin management of 
epilepsy in the coming years (Hesdorffer et al., 2011). Thus, in order to generate 
knowledge that will guide the development of self-management outcome-enhancing 
interventions for older adults diagnosed with epilepsy later in life, the epilepsy  
self-management experiences of this population must be explored. 
The remainder of this chapter includes a discussion of the purpose of a study 
aimed at addressing the previously described problems, the specific aims of and research 
questions that guided the study, definitions of key terms, the significance and 
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contribution of the study, and the assumptions and philosophical perspective upon which 
the study was based. 
Study Purpose 
While researchers have begun investigating the self-management experiences of 
young and middle-aged adults with epilepsy, no studies examining the self-management 
experiences of older adults diagnosed with epilepsy at or after age 60 can be found in the 
literature. Understanding the impact of epilepsy on the lives of older adults and the 
problems they face in managing this disorder is necessary to develop effective 
interventions to improve self-management outcomes for the population of older adults 
diagnosed with epilepsy at or after age 60. Thus, the purpose of this study was, via 
qualitative inquiry, to explore the epilepsy self-management of older adults diagnosed 
with epilepsy at or after age 60. 
Specific Aim and Research Questions 
The specific aim of the study was to describe the epilepsy self-management 
experiences of older adults diagnosed with epilepsy at or after age 60 from the 
perspective of those older adults. 
Because very little is known about the phenomenon of interest, a qualitative 
descriptive research design was employed to fulfill the study’s purpose (Sandelowski, 
2000). Sandelowski (1995a) espouses the use of research questions to guide a qualitative 
descriptive study as such questions help to ensure that specific aspects of the 
phenomenon of interest are well explored. The questions that follow in this section 
guided the study, though it is acknowledged that other aspects of the phenomenon not 
included in the research questions emerged during the course of data generation and 
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analysis as important in describing the phenomenon of interest (Sandelowski, 1995a; see  
Chapter III). 
Research Question One: What are older adults’ experiences with the process of 
being diagnosed with epilepsy? 
Research Question Two: What problems are experienced by older adults while  
self-managing epilepsy? 
Research Question Three: How do older adults perceive that their lives have 
changed since being diagnosed with epilepsy? 
Research Question Four: What strategies do older adults utilize in self-managing 
epilepsy? 
Research Question Five: What outcomes do older adults hope to achieve in  
self-managing their epilepsy? 
Definitions of Key Terms 
Epilepsy: A medical condition characterized by the occurrence of more than one 
unprovoked seizure. 
Older adult: A person age 60 years or older who, in this situation, has been 
diagnosed with epilepsy at or after age 60 (Epilepsy Foundation, 2009; Hesdorffer et al., 
2011). 
Self-management: In reference to general chronic disease—a dynamic,  
self-directed, action-oriented, ever-changing behavioral and cognitive process in which 
those with chronic diseases engage, within a family or other system, in order to manage 
various aspects of their disease and its effect on their lives in multiple domains (Barlow, 
Wright, Sheasby, Turner, & Hainsworth, 2002; Clark, 2003; Holman & Lorig, 2004; 
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Lorig, Feigenbaum, Regan, Ung, & Holman, 1986; Lorig & Holman, 2003; Ryan & 
Sawin, 2009). 
Epilepsy self-management: An interactive, fluid phenomenon in which persons 
with epilepsy continually evaluate their perceived health status (comprised of how they 
feel emotionally/physically and how they are able to function on a daily basis) and 
implement a variety of behaviors to manage their medications/treatments, seizures, 
safety, physical and emotional comfort, functional status, and other factors depending on 
their current perceived health (Unger & Buelow, 2009). 
Significance and Contribution 
Chronic disease is the central health issue in the United States, accounting for 
more than 70% of healthcare expenditures each year (Partnership for Solutions, 2002). 
Self-management has been recognized by many researchers, including nurse researchers 
(Barlow et al., 2002; Lorig, 2003; Lorig & Holman, 2003; Marks, Allegrante, & Lorig, 
2005a, 2005b), as highly influential to outcomes associated with chronic diseases, 
including epilepsy. Because self-management plays an integral role in influencing 
important outcomes associated with epilepsy (e.g., quality of life, healthcare resource 
utilization, and disease/seizure severity), knowledge of what epilepsy self-management is 
comprised must be generated in order to inform the design of self-management 
interventions that ultimately could improve outcomes. Unfortunately, there are no 
published results of investigations pertaining to the epilepsy self-management 
experiences of the hundreds of thousands of older adults—a unique population in terms 
of their experiences with chronic diseases—in the United States who have been 
diagnosed with epilepsy at or after age 60. Such research is necessary to ensure that older 
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adults who have been diagnosed with epilepsy later in life are able to receive tailored  
self-management interventions that ultimately will lead to improvement in their 
outcomes. Moreover, investigation into older adults’ epilepsy self-management 
experiences is important given that the incidence of epilepsy in the older adult population 
is expected to increase in the United States in the coming years as the life expectancy in 
this country continues to rise (United States Census Bureau, 2009). This study addressed 
the afore-mentioned gaps in the literature by generating knowledge, in the form of rich 
description, regarding older adults’ experiences with epilepsy self-management. The 
results of this study will serve as a base upon which more explanatory and interpretive 
qualitative research—which can ultimately inform quantitative inquiry and intervention 
development for this population—can be designed. Results rendered from this study also 
will directly and immediately inform intervention development for the population of 
older adults diagnosed with epilepsy at or after age 60. 
Assumptions and Philosophical Perspective 
The study was based on the following assumptions: 
1. Epilepsy self-management is a process that is experienced subjectively. 
2. Epilepsy self-management can be investigated systematically. 
3. Narratives of individuals’ experiences of epilepsy self-management are 
sufficient sources of data to explore and describe the components of 
epilepsy self-management, which was the primary purpose of the study. 
The study was executed via a qualitative descriptive design. Qualitative 
description shares the core philosophical underpinning—the use of a realist  
perspective—that underlies all qualitative methods. A realist perspective is characterized 
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by the belief that reality is context-dependent and individually constructed. Such a 
perspective denies the existence of a single, true reality. The goal of qualitative research, 
then, is not to discover the one true depiction of reality but to produce idiographic 
knowledge in the pursuit of ascertaining how the social world is interpreted, understood, 
experienced, produced, or constituted (Mason, 2002). The idiographic knowledge 
produced from qualitative inquiry can form the foundation of a program of research 
(Sandelowski, 1995a) and ultimately inform quantitative studies aimed at model testing 
and intervention development and testing (Miller, 2010). 
Summary 
In this chapter, the need to investigate the epilepsy self-management experiences 
of older adults diagnosed with the condition in older adulthood was identified. While it is 
known that epilepsy self-management affects important outcomes such as healthcare 
resource utilization, seizure severity and frequency, and quality of life in younger adults, 
and epilepsy self-management targeted interventions have been developed for that age 
group, very little is known about the epilepsy self-management experiences of older 
adults and particularly those diagnosed with epilepsy later in life. Knowledge of what 
these older adults’ epilepsy self-management experiences are comprised is necessary in 
order to develop self-management interventions specific to this population, the members 
of which are physiologically, developmentally, and socially distinct from younger adults 
(Rowan & Ramsay, 1997). The purpose of the study was to investigate the  
self-management experiences of older adults diagnosed with epilepsy at or after age 60 
from those older adults’ perspectives. The results of the study will (a) help clarify the 
concept of epilepsy self-management as it pertains to older adults diagnosed with 
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epilepsy late in life; (b) provide guidance for future, more explanatory and interpretive 
qualitative studies; and (c) provide guidance for future quantitative studies, thereby 
ultimately influencing the development of epilepsy self-management interventions 
targeted for older adults diagnosed with epilepsy at or after age 60, as well as the 
measurement of outcomes associated with the epilepsy self-management of older adults. 
Qualitative description was chosen as the most appropriate method for the study. 
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CHAPTER II 
REVIEW OF LITERATURE 
Introduction 
When executing a qualitative descriptive study, the researcher conducts a review 
of the literature in order to familiarize himself or herself with the current state of 
knowledge surrounding the phenomenon of interest (Corbin & Strauss, 2008; 
Sandelowski, 2000). Such a review makes the researcher aware of what is known about 
the phenomenon of interest, as well as what knowledge about the phenomenon is still 
lacking or incomplete, thereby informing the study’s purpose and research questions. In 
comparison to those reviews of the literature appropriate for quantitative studies, as well 
as those seen in other types of more theory-driven qualitative studies, the review of 
literature in a qualitative descriptive study is somewhat broad and is meant to give the 
researcher an overall sense of what is known and is not known about the phenomenon of 
interest and to justify the need for the study. The review should not focus intently on 
concepts chosen a priori other than the phenomenon of interest (Corbin & Strauss, 2008; 
Sandelowski, 2000). Thus, an appropriate review of the literature for the current study 
should include a description of the state of the science of epilepsy self-management and 
particularly that in older adults diagnosed with the disorder at or after age 60. However, 
the epilepsy self-management literature is quite small and that for older adults is 
extremely limited. Thus, in this chapter, both the state of the science of epilepsy  
self-management, including that for older adults, as well as the state of the science of 
general chronic disease self-management, which is pertinent to epilepsy self-management 
and for which there is a much more well-developed literature, are described. The 
researcher completed the review via the use of Medline, CINAHL, PubMed, Cochrane, 
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and PsychLit databases, as well as via review of pertinent textbooks. The following 
search terms were utilized: chronic disease, chronic illness, self-management, self-care, 
adherence, compliance, interventions, older adults, elderly, epilepsy, and seizures. These 
terms were combined in a variety of ways. For example, when searching for literature 
pertaining to the effectiveness of chronic disease self-management interventions, the 
terms chronic disease, interventions, and self-management were combined. The search 
was limited to articles published in the English language between the years of 1990 and 
2011. Studies involving pediatric participants (those age 17 years and younger) were 
excluded. 
The initial portion of this chapter includes a description of the degree to which 
older adults in this country are affected by chronic diseases, including epilepsy, and the 
costs associated with older adults’ chronic diseases. The remainder of the discussion 
includes a depiction of the current state of the science regarding chronic disease  
self-management and epilepsy self-management, including that for older adults, in terms 
of the ways in which self-management has been conceptually and operationally defined, 
the outcomes of self-management, what variables affect and influence self-management, 
and the effectiveness of self-management interventions in affecting outcomes. As well, 
an explanation of the ways in which age-related physical and physiologic changes can 
affect epilepsy self-management is provided. The results of a pilot study that was 
conducted to evaluate the feasibility of the data generation and analysis methods of the 
current study briefly are reviewed. Finally, a critique of the literature is offered, and gaps 
in the literature are summarized. Appendix A provides a summary of the state of the 
science of both sets of literature reviewed. 
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What is the Impact of Chronic Disease in Older Adults? 
Chronic Disease Burden in Older Adults 
Staggeringly, more than 80% of North American older adults live with one 
chronic disease, and 50% live with two or more chronic diseases concurrently. Further, 
the number of older adults suffering from at least one chronic disease is expected to triple 
in the next 40 years in the United States (Centers for Disease Control and Prevention, 
2010a). The costs associated with chronic diseases in older adults is high ($30 billion 
annually) and continues to rise (Crystal, Johnson, & Harmon, 2000; Joyce, Emmett, 
Keeler, & Goldman, 2005; Naughton, Bennet, & Feely, 2006). 
The best way to reduce chronic disease-associated costs is via chronic disease 
prevention (Boult, Altmann, & Gilbertson, 1996). However, in the United States, there 
are millions of older adults suffering from chronic diseases for whom prevention is not 
applicable. Diminishing the costs associated with chronic disease in older adults must be 
accomplished via effective long-term disease management in terms of improving  
disease-related outcomes such as mortality and healthcare resource utilization. Research 
evidence suggests that effective, long-term management of chronic diseases has the 
potential to drastically reduce chronic disease-related costs in the United States. Joyce 
and colleagues (2005) investigated the costs and life expectancy associated with six 
major chronic diseases afflicting older adults in the United States—diabetes, 
cardiovascular disease, hypertension, cancer, neurological conditions (including 
epilepsy), chronic obstructive pulmonary disease, and myocardial infarction—and the 
potential reduction in costs and mortality achieved via long-term disease management. 
The researchers examined a sample of 24,842 older adults using a microsimulation model 
 13 
to project costs and mortality associated with the various diseases from persons age 65 
years to death, determining that an older adult with a chronic disease accounts for $2,000 
more in healthcare spending per year per chronic disease. Disease-associated costs were 
recalculated given successful management, defined in terms of the number of 
hospitalizations and utilization of healthcare resources, of the diseases, and the results 
projected a 70% decline in costs per disease per person and a lengthening of life 
expectancy up to six years (Joyce et al., 2005). Lorig (2003) and Holman and Lorig 
(2004) noted that an integral part of successful disease management is the  
self-management in which persons with chronic disease engage on a daily basis. It is thus 
vital that older adults with chronic diseases, in conjunction with their healthcare 
providers, be prepared adequately in order to effectively manage their chronic diseases 
over time. 
Community-Dwelling Older Adults and Chronic Disease 
Of the North American older adults suffering from chronic disease, five million 
live at home. Although these older adults maintain a degree of independence and remain 
in their homes, 75% of them have difficulty performing activities such as shopping and 
preparing meals, and most live with a family member or significant other who assists 
them, to some degree, with disease management (Centers for Disease Control and 
Prevention, 2010a). 
Older adults with chronic disease(s) living in the community face unique 
challenges, are at increased risk for injury, and experience decrements in mood and 
quality of life (Anderson, Freedland, Clouse, & Lustman, 2001; Lawlor, Patel, & 
Ebrahim, 2003; Yohannes, Roomi, Baldwin, & Connolly, 1998). For example, in a 
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community-based sample of 4,060 older women, the number of chronic diseases helped 
predict the number of at-home falls (Lawlor et al., 2003). Others have found that older 
adults with diabetes had a three-fold increase in depression when compared with older 
adults without the disease (Anderson et al., 2001). In addition, older adults with chronic 
obstructive pulmonary disease living at home had a higher incidence of depression and a 
lower quality of life when compared to older adults without the disease (Yohannes et al., 
1998). Older adults with chronic diseases have been shown to lack knowledge about their 
disease(s). Investigators found that community-dwelling older adults with diabetes lacked 
knowledge about the condition in terms of its causes, treatment, and consequences, and 
lack of knowledge was associated with poor outcomes (Whitley, Fermo, Ragucci, & 
Chumney, 2006). 
Epilepsy and Older Adults 
One chronic disease, epilepsy, is far-reaching in its effect on older adults. More 
than 300,000 North American older adults currently suffer from epilepsy, and the 
incidence of new-onset epilepsy is highest in those age 60 years and older (Centers for 
Disease Control and Prevention, 2010b; Epilepsy Foundation, 2009; Faught, 1999). 
Causes of new-onset epilepsy in older adults vary, but it is estimated that nearly half are 
related to cerebrovascular accidents or atherosclerosis (Epilepsy Foundation, 2009; 
Paradowski & Zagrajek, 2005; Rowan et al., 2005; Rowan & Ramsay, 1997). In more 
than 50% of cases of new-onset epilepsy in older adults, however, the cause is unknown 
(Rowan et al., 2005; Rowan & Ramsay, 1997). Unlike in younger adults with epilepsy, 
for whom the most common type of epilepsy is complex partial arising from the temporal 
lobes, the most common type of epilepsy in older adults diagnosed with the disorder late 
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in life is complex partial arising from the frontal lobes (Ramsay, Rowan, & Pryor, 2004). 
The clinical presentation of epilepsy in older adults is atypical, and they are often 
misdiagnosed with syncope, altered mental status, or dementia (Ramsay et al., 2004; 
Waterhouse & Towne, 2005). Treatment of epilepsy in older adults often consists of one 
or more anti-epileptic drugs and is accompanied by lifestyle modifications and 
restrictions, such as inability to drive and avoidance of seizure triggers (Leppik, 2001; 
Rowan & Ramsay, 1997). Less commonly, epilepsy in older adults is treated surgically 
(Gallo, 2006). 
Older adults with epilepsy experience a variety of symptoms and complications, 
including: seizures; post-ictal fatigue and confusion; medication side effects such as 
nausea, somnolence, and cognitive effects; falls and fractures; hospitalizations; and 
institutionalization in an extended care facility due to epilepsy (Brodie & Kwan, 2005; 
Rowan & Ramsay, 1997). In addition, older adults with epilepsy have been shown to 
have a significantly poorer quality of life than older adults without the disorder (Laccheo 
et al., 2008). 
Both the Epilepsy Foundation (2009) and the Centers for Disease Control and 
Prevention (2010b) recognize the need to increase understanding of how epilepsy affects 
older adults and have called for research in this area. In addition, in a recently published 
survey conducted by the Centers for Disease Control and Prevention-associated Center 
for Managing Chronic Disease (Center for Managing Chronic Disease, 2010), epilepsy 
self-management researchers and epilepsy clinicians noted that one population in great 
need of self-management research is older adults and especially those newly diagnosed 
and those managing co-morbidities. 
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How Has Self-Management Been Conceptually Defined in the Literature? 
General Chronic Disease Self-Management 
As pointed out by Lorig and Holman (2003) in their comprehensive review of the 
history and use of the term self-management as it pertains to those with chronic diseases, 
self-management has been conceptualized in a variety of ways over the past four decades. 
However, in the nursing literature, chronic disease self-management has been and 
continues to be represented primarily as a verb and refers to the behaviors that persons 
with chronic diseases execute in managing their diseases and associated effects. That is, 
what people do constitutes their self-management (Lorig & Holman, 2003). These actions 
may be in the form of direct, observable behaviors or cognitive strategies or decisions 
(Lorig & Holman, 2003). An example of an observable self-management behavior is a 
person setting an alarm to remember to take medications on time; a person with diabetes 
planning meals to ensure the ability to enjoy dessert at an important social occasion is an 
example of a cognitive self-management strategy. Similarly, in a more recent review of 
the chronic disease self-management literature, Unger and Buelow (2009) found that the 
way in which general chronic disease self-management, over the past decade, has been 
conceptualized in the nursing and medical literature can best be described as actions 
taken by persons with chronic disease concerning medication and treatment compliance, 
safety, event management, and lifestyle management. 
Researchers have conducted investigations to specify and further explicate the 
self-management behaviors used by those with chronic diseases. Corbin and Strauss 
(1988), for example, based on a large-scale qualitative study with people living with a 
variety of chronic diseases, found that self-management behaviors occur within three 
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realms: medical management, adopting new behaviors or life roles, and dealing with 
associated emotions. Later, Lorig and her colleagues, in a Center for the Advancement of 
Health project (2002), based on 25 years of research with persons self-managing chronic 
diseases, a review of the literature, and a Robert Wood Johnson meeting on the topic of 
chronic disease self-management, identified five core self-management behaviors that 
occur as part of the self-management of most chronic diseases: problem-solving, 
decision-making, resource utilization, forming of a relationship with a provider, and 
taking action. These five core behaviors are executed in the three realms outlined by 
Corbin and Strauss (1988). Problem-solving is important in self-management given that 
self-management is problem-based (Lorig & Holman, 2003) and refers to identification 
of problems, generation of possible solutions, implementation of solutions, and 
evaluation (Center for the Advancement of Health, 2002). Decision-making refers to 
decisions made by those with chronic diseases during the problem-solving process as 
well as those day-to-day decisions they make in response to changes in their condition. 
Resource utilization refers to the use of a variety of resources (people, toll-free telephone 
numbers, and the Internet, for example) to find information to help them manage their 
diseases and associated effects. Forming of a relationship with a provider refers to 
persons with chronic diseases forming a long-term, ongoing partnership with care 
providers in managing their disease over time. This partnership is distinct from that in 
acute disease in which the care provider independently directs the diseased or injured 
person’s treatment. Taking action refers to persons with chronic diseases devising action 
plans regarding a variety of disease-related decisions and issues then carrying out and 
evaluating those plans (Center for the Advancement of Health, 2002). Lorig and Holman 
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(2003) also noted that an additional core behavior of self-management is self-tailoring, 
which refers to persons with chronic disease using the afore-mentioned core behaviors 
based on personal evaluation of their own needs and not necessarily their healthcare 
providers’ evaluation of their needs. 
Three other key features of self-management, as it is conceptualized currently in 
the nursing literature, include that (a) it is a multi-faceted process, not an outcome;  
(b) self-management is not synonymous with compliance to a provider’s instructions; and 
(c) self-management includes both family (biological or not) and the individual.  
Self-management researchers, though they recognize that the core of self-management is 
the behaviors and strategies executed by persons with a chronic disease in order to 
manage their disease and its effects, have noted that self-management is a fluid process 
based on many factors such as stage of disease, disease severity, and changes in personal 
circumstances including a decrease or increase in financial resources (Clark, 2003; Grey, 
Knafl, & McCorkle, 2006; Holman & Lorig, 2004; Lorig & Holman, 2003; Moore, 2009; 
Ryan & Sawin, 2009). Self-management, then, is not stagnant but dynamic and changing 
as the context in which the person managing the disease changes. Self-management is 
also neither an endpoint nor an outcome but a process that affects and leads to outcomes 
(Holman & Lorig, 2004; Osborne, Wilson, Lorig, & McColl, 2007). As articulated by 
Clark (2003), changing people’s self-management behaviors is useless if those behaviors 
do not improve outcomes such as quality of life or health status. Ryan and Sawin (2009), 
too, noted that self-management is a process that affects important outcomes but that it is 
not an outcome. Self-management, then, is a portion of the means to an end—but not the 
end (Holman & Lorig, 2004). 
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Self-management researchers also agree that self-management does not, or should 
not, refer strictly to patient compliance or adherence to a provider’s instructions such as 
taking medications as prescribed (Ruggiero, Glasgow, & Dryfoos, 1997). To 
conceptualize self-management in this way would be, according to Holman and Lorig 
(2004), a disservice to those with chronic disease. Grey et al. (2006), based on a 
comprehensive review of the self-management literature, differentiate self-management 
from treatment compliance by stating that self-management “is a dynamic means of 
maximizing health rather than the submission to prescribed orders implied by the term 
compliance” (p. 279). 
Nurse researchers have been at the forefront of distinguishing self-management 
from patient compliance or adherence. Qualitative studies involving patients diagnosed 
with a variety of chronic diseases, including human immunodeficiency virus 
(Swendeman, Ingram, & Rotheram-Borus, 2009; Webel & Holzemer, 2009), diabetes 
(Morrow, Haidet, Skinner, & Naik, 2008), heart failure (Thornhill, Lyons, Nouwen, & 
Lip, 2008), epilepsy (Buelow, 2001; Schneider & Conrad, 1983; Unger & Buelow, 2009), 
and asthma (George, Campbell, & Rand, 2009; Martin, Beebe, & Lopez, 2010) have 
revealed that treatment compliance is only one facet, and often not the most important 
facet, of self-management for persons living with chronic disease. Rather, persons with 
chronic disease engage in self-management in order to live as normally as possible within 
the context of having a chronic disease. That is, persons with chronic disease engage in 
behaviors to ensure that their normal, everyday lives can coexist with their chronic 
diseases (Grey et al., 2006). 
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Further distinguishing chronic disease self-management from treatment 
compliance, Clark (2003), in her comprehensive review and synthesis of the  
self-management literature, notes that all persons with chronic disease, regardless of 
outcomes, are practicing self-management. All persons with chronic disease use  
self-management strategies—effective or ineffective, congruent or incongruent with 
provider instructions—to manage their diseases. For example, just as a person with 
asthma who monitors his or her symptoms and avoids triggers in order to prevent 
symptoms is practicing self-management, so is another person with asthma who overuses 
bronchodilators in order to alleviate symptoms. Thus, self-management refers to all the 
strategies used by persons in managing all aspects of their diseases. Self-management 
strategies often are personally derived, influenced by the person’s context in the form of 
work, family, and friends, and strategies often are not related directly to or in line with 
provider instructions (Clark, 2003; Holman & Lorig, 2004). 
More recently, investigators have addressed self-management from the family 
perspective. In a review of the self-management literature, Grey and colleagues (2006) 
found that chronic disease self-management involves and affects the entire family of the 
person with the chronic disease. Changes in the family, such as the addition or 
subtraction of members, changes in family priorities, and fluctuations in family income, 
cause changes in a person’s self-management behaviors. As well, changes in a person’s 
chronic disease, such as increased or decreased severity, affect the ways in which the 
family is involved in disease management (Grey et al., 2006). The family in which 
disease management occurs can consist of those not biologically related to the person 
with the chronic disease—such as friends, co-workers, or others to whom the person feels 
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close and responsible. It also is not necessary that the person with the chronic disease live 
with the family members assisting him or her with disease management (Grey et al., 
2006; Ryan & Sawin, 2009). Ryan and Sawin (2009) and Clark (2003) reported findings 
similar to those of Grey and colleagues (2006) in their reviews of the self-management 
literature and accordingly have added a family dimension to their self-management 
models. Other researchers have designed self-management interventions for adults based 
on the family aspect of management. Moore (2009), in her ongoing research with cardiac 
rehabilitation patients, has found that these persons’ self-management as it relates to 
weekly exercise is influenced greatly by the family, or system as it is referred to by 
Moore (2009), in which those persons live and exist. Accordingly, Moore and her 
colleagues (2009), as part of a National Institutes of Health-funded study  
(P30 NR010676), are in the process of devising and testing a self-management 
intervention that involves the entire family, or system, in which persons in  
post-myocardial infarction cardiac rehabilitation exist. Participants will design their own 
self-management action plans with others in their family or system, and action plans are 
devised with the needs and desires of the entire family or system in mind (Moore, 2009). 
Moore (2009) reports that the preliminary findings of the ongoing study are promising in 
terms of those participants undergoing the system-oriented self-management intervention 
exercising more often and more consistently than those receiving the individual 
intervention. With the emergence of self-management models and interventions that 
specifically consider the family aspect of self-management, it is clear that  
self-management is no longer being seen as an individual process but as one embedded 
within a system. 
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As this discussion of the conceptualization of chronic disease self-management 
has revealed, while key features of the concept appear in the literature, there is no single 
definition concisely answering the question, “what is chronic disease  
self-management?” The lack of such a precise definition is likely because  
self-management researchers themselves continue to grapple with defining this concept in 
a manner that does justice to its multi-faceted, complex, and process-like nature (Lorig & 
Holman, 2003). However, a definition of the concept as it is currently represented in the 
literature, and which depicts the key aspects of it (that it is action-oriented, an  
ever-changing process, implemented in various domains, context-dependent, and  
self-directed) can be extracted: chronic disease self-management is a dynamic,  
self-directed, action-oriented, ever-changing behavioral and cognitive process in which 
those with chronic diseases engage, within a family or other system, in order to manage 
various aspects of their disease and its effect on their lives in multiple domains. While it 
often involves aspects of compliance, self-management is not synonymous with this 
concept. 
Epilepsy Self-Management 
Though the well-developed general chronic disease literature provides a 
conceptualization of the way in which persons self-manage chronic diseases in general, 
that all chronic diseases differ in terms of their physiologic and psychological effects on 
those who suffer from them, and that each chronic disease is associated with unique 
treatments, symptoms, and general effects on people’s lives, cannot be ignored. Holman 
and Lorig (2004) noted that, while general principles apply, self-management of 
individual chronic diseases is dependent on individual nuances of those diseases. It is 
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reasonable to expect that diabetes self-management might appear very different from and 
involve different issues than, for example, self-management of human immunodeficiency 
virus. Epilepsy is no exception—those who suffer from this condition face unique 
treatments, symptoms, and challenges. It is thus necessary to consider how  
self-management specific to the disorder of epilepsy has been defined conceptually in the 
literature. 
Though relatively small and still developing, a literature specific to epilepsy  
self-management does exist. Both the medical and nursing professions have contributed 
to this literature, and each defines epilepsy self-management differently. In the medical 
literature, epilepsy self-management is conceptualized chiefly as medication adherence, 
which is not surprising given that the most prevalent medical treatment of epilepsy 
involves the prescription of anti-epileptic drugs (Epilepsy Foundation, 2009). In fact, 
70% of those with epilepsy can become seizure-free with the consistent, appropriate use 
of anti-epileptic drugs (Epilepsy Foundation, 2009). Not surprisingly, and in accordance 
with the previous review of general chronic disease self-management, nursing scientists 
have expanded this conceptual definition to include areas in addition to medication 
adherence. 
In their review of the epilepsy self-management literature, Unger and Buelow 
(2009) characterized the way in which nurse researchers have conceptualized epilepsy 
self-management over the last decade. They found that, as in general chronic disease  
self-management, epilepsy self-management is defined most prominently as a behavioral 
concept and these behaviors occur in the following domains: medication compliance, 
safety, seizure management, and lifestyle management. Medication compliance refers to 
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taking anti-epileptic drugs as prescribed. Safety refers to the maintenance of one’s own 
and others’ safety immediately before, during, or after a seizure. Seizure management 
involves the prevention of seizures via nonpharmacological interventions as well as the 
management of the issues that arise during and immediately after a seizure. Lifestyle 
management refers to the ways in which people with epilepsy manage daily activities 
(i.e., work, school, social relationships) in the context having epilepsy (Unger & Buelow, 
2009). 
DiIorio, who has contributed most substantially to the epilepsy self-management 
literature, with her colleagues Faherty and Manteuffel (1994), defines epilepsy  
self-management as “the sum total of steps taken and processes used by a person to 
control seizures and manage the effects of a seizure disorder” (p. 167). These steps and 
processes occur in five key management areas: treatment, information/support, seizures, 
safety, and lifestyle (DiIorio et al., 1994; DiIorio, Hennessy, & Manteuffel, 1996). 
Buelow (2001), based on a qualitative study exploring the self-management of adults 
with severe epilepsy, conceptualized epilepsy self-management as behaviors executed in 
three domains: those to manage seizures, those to manage medications, and those to 
manage life. Buelow (2001) also characterized epilepsy self-management behaviors as 
being proactive or reactive in nature—the only attempt to form such a taxonomy of 
epilepsy self-management behaviors. 
One of the most recent conceptualizations of epilepsy self-management is offered 
by Unger and Buelow (2009) and is derived from a hybrid concept analysis of epilepsy 
self-management. In the study, the epilepsy self-management literature was reviewed in 
order to determine the ways in which epilepsy self-management had been defined and 
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measured in the literature. The results of the literature review were combined with 
findings from qualitative interview data collected from those newly diagnosed with 
epilepsy (within the previous year) in order to yield both a theoretical- and  
fieldwork-based definition of the concept. From the analysis, three interactive themes 
(emotional and physical comfort, functional ability, and self-management actions and 
behaviors) emerged. The concept analysis resulted in the following definition of epilepsy  
self-management: 
[Epilepsy self-management is] an interactive phenomenon in which 
persons with epilepsy continually evaluate their perceived health status 
(comprised of how they feel emotionally/physically and how they are able 
to function on a daily basis) and implement a variety of behaviors to 
manage their medications/treatments, seizures, safety, physical and 
emotional comfort, functional status, and other factors depending on their 
current perceived health. (Unger & Buelow, 2009, p. 94) 
Thus, a person’s epilepsy self-management might “look different” (Unger & Buelow, 
2009, p. 94) from one day to the next depending on perceived health status. These authors 
note both similarities and differences in their definition of epilepsy self-management with 
those previously described. It is similar in that a key aspect of the definition is  
self-management behaviors and that those behaviors occur in the domains  
(e.g., medications, safety, and so on) which are included in the prior definitions. It is 
different in that it is more process-oriented and contextualized. Instead of epilepsy  
self-management being described as a list of behaviors that occur in different domains, 
what is going on with persons with epilepsy on a daily basis helps determine their 
epilepsy self-management, which is, as a result, ever-changing. DiIorio (2009), too, 
recently has developed an epilepsy self-management model to include the contextual 
variables of personal and environmental factors, though this model remains unpublished. 
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Nurse researchers, therefore, have conceptualized epilepsy self-management in a 
manner consistent with conceptualizations of general chronic disease self-management in 
terms of it involving the use of behaviors and strategies in multiple domains and also by 
recognizing that epilepsy self-management chiefly is concerned with maintaining a 
normal daily life within the context of epilepsy and less so with adhering to a prescribed 
regimen. Nurse researchers continue to work to incorporate some features of general 
chronic disease self-management, such as its dynamic, process-oriented, individualized, 
and context/system-dependent nature, into their definitions and use of the term epilepsy 
self-management. Unger and Buelow’s (2009) definition of epilepsy self-management, as 
well as DiIorio’s (2009) expanded model, demonstrate development in these areas, 
however. More specific research is needed to confirm that these key features exist, and 
how they exist, in those self-managing epilepsy. In addition, the concept of epilepsy  
self-management within a family context needs to be explored. 
Researchers also portray epilepsy self-management as being particularly complex. 
An epilepsy diagnosis necessitates constant management by the person in terms of 
medication adherence, symptoms, monitoring for exacerbations, and the overall effect of 
the disease and its treatment on the person’s life. Epilepsy requires complicated, and 
often synchronized, treatment. Persons with epilepsy face many problems with  
day-to-day functioning, are at high risk for anxiety, often face social stigma, and 
frequently have difficulty securing and maintaining employment (Center for Managing 
Chronic Disease, 2010; Jacoby, 1992; Unsworth, 1999). 
Epilepsy is treated chiefly with anti-epileptic drugs, and management of these 
medications appears to be a main source of the complexity of epilepsy self-management 
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(Buelow & Smith, 2004; DiIorio, Faherty, & Manteuffel, 1992; DiIorio & Henry, 1995; 
Epilepsy Foundation, 2009; Feely, 1999). Persons with epilepsy take, on average, two to 
three doses of anti-epileptic drugs per day, and typically these medications must be on a 
strict time schedule to prevent seizures (Feely, 1999; Yeager et al., 2005). Many 
medications have unpleasant side effects, such as somnolence, dizziness, and cognitive 
effects (Krauss & Crone, 2001). Some anti-epileptic drugs also are highly expensive, and 
the effectiveness of generic anti-epileptic drugs remains under scrutiny. Thus, many 
persons with epilepsy find themselves in a position with no insurance coverage for the 
brand-name epilepsy medications required to abate their seizures (Epilepsy Foundation, 
2009). 
Lack of adherence to prescribed epilepsy medications by those with epilepsy has 
been well documented in the literature. Up to 60% of patients with epilepsy fail to adhere 
to their prescribed medication regimens (Krumholz, 2009; Leppik, 1988), often due to the 
complexity of the dosing schedule, side effects, or financial concerns (Unger & Buelow, 
2009). Buelow and Smith (2004) found, via use of a medication events monitoring 
system, that there is a mismatch between persons’ with epilepsy perceptions of their 
medication adherence and their actual adherence; persons who reported that managing 
their medications was not a problem actually did miss doses of epilepsy medications. 
Lack of medication adherence in epilepsy has been associated with a three-fold increase 
in mortality compared to individuals with epilepsy who take medications as prescribed 
(Faught, Duh, Weiner, Guerin, & Cunnington, 2008). 
A diagnosis of epilepsy also necessitates major lifestyle changes and activity 
restrictions, leading to loss of independence. Persons with epilepsy commonly cannot 
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drive a vehicle or operate machinery. Other activity restrictions associated with their 
disease, in addition to medication side effects, may prevent them from fulfilling everyday 
roles related to parenting, work, and relationships. In fact, persons with epilepsy cite 
inability to drive and alterations in role fulfillment as chief concerns in living with 
epilepsy (Krumholz, 2009). Kobau and DiIorio (2003) and McAuley, McFadden, Elliott, 
and Shneker (2008) found that individuals with epilepsy are less compliant with these 
activity and lifestyle restrictions than taking their medications as prescribed. Also, 
perhaps more so than in other chronic diseases, persons with epilepsy are at high risk for 
bodily injury to themselves or others. Traumatic injury can occur during generalized 
seizures and also during the post-ictal period. Thus, persons with epilepsy must make 
special efforts to alter their environments and activities to maintain safety, and many find 
these alterations at home and at work to be disruptive (DiIorio et al., 1996; Krumholz, 
2009; Unger & Buelow, 2009). 
How Has Self-Management Been Operationally Defined in the Literature? 
General Chronic Disease Self-Management 
Given its process-oriented nature, self-management is decidedly difficult to 
measure (Clark, 2003; Holman & Lorig, 2004). As Lorig and Holman (2003) note,  
self-management is not a thing that lends itself to measurement. Rather, the outcomes of 
self-management (discussed later), and not the self-management process itself, should be 
measured (Lorig, 2003). However, researchers working with a variety of chronic disease 
populations have ventured to do so. Chronic disease self-management has been 
operationalized in two chief ways: (a) as medication and treatment adherence, and (b) as 
the engagement in certain behaviors. 
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Despite the fact that chronic disease self-management is espoused in the literature 
as distinct from, though perhaps overlapping with, medication and treatment adherence, it 
often is operationalized in this way. In their review of the self-management literature, 
Unger and Buelow (2009) found that, from 2000–2009, self-management in medical and 
nursing research studies most commonly was measured as treatment compliance and 
particularly medication adherence. In fact, in some studies, self-management has been 
measured solely via serum concentration levels of prescribed medications (Miura et al., 
2001). More commonly, researchers have measured self-management via self-report of 
medication or treatment adherence. Persons who are more compliant with medications or 
other treatments (e.g., a person with hypertension who abstains from excess salt intake or 
a person with diabetes who performs proper foot care) are seen as practicing “good”  
self-management (Unger & Buelow, 2009). 
Given that a core aspect of self-management is that it involves the execution of 
certain behaviors, some researchers have developed instruments designed specifically to 
measure the degree to or frequency with which persons with chronic diseases engage in 
self-management behaviors. Such scales exist for a variety of chronic diseases, including 
heart failure (Jaarsma, Stromberg, Martensson, & Dracup, 2003), diabetes  
(Charron-Prochownik, Zgibor, & Peyrot, 2007), epilepsy (DiIorio, 1997; DiIorio et al., 
2004), and asthma (Berg, Dunbar-Jacob, & Sereika, 1997; Taylor et al., 1991). These 
instruments are self-report and most commonly ask respondents to rate, on a Likert-type 
scale, how often they engage in certain behaviors. The majority of the behaviors relate to 
treatment adherence, such as adherence to dietary restrictions in those with heart failure 
(Jaarsma et al., 2003). In general, the scales are scored so that the more frequently the 
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person engages in behaviors listed on the instrument, the “higher” or “better” his or her 
self-management is judged to be. 
In many cases, researchers measure self-management via self-report of 
engagement in behaviors, though not via specific, published instruments. For instance, 
researchers may choose a list of behaviors they deem important in the self-management 
of a certain chronic disorder then ask study participants to report how often they engage 
in those behaviors (Unger & Buelow, 2009). In a self-management study involving 
women with diabetes, for example, researchers asked participants to report their 
engagement in prescribed dietary behaviors (Shultz, Corbett, & Allen, 2009). 
Both the measurement of self-management as compliance and as engagement in 
behaviors is problematic given the conceptual definition of self-management discussed 
previously in this chapter. First, measuring self-management strictly as compliance is at 
odds with the basic premise of self-management—that it is self-directed and is mainly 
focused on helping the person to live normally despite having a disease. It also is 
incomplete; qualitative studies with those suffering from chronic diseases often have 
indicated that adherence to medications and other treatments often is least important to 
them in terms of managing their diseases. Second, to measure self-management as 
engagement in behaviors neither captures the process orientation nor the individualized 
or context-bound nature of the concept. It also is far too limiting because a scale with a  
pre-determined list of supposed helpful or positive strategies cannot possibly capture the 
unique and context-dependent ways in which people manage their chronic diseases, nor 
can these instruments detect the fluid, or changing, nature of self-management. Such a list 
of strategies also assumes that the use of the behaviors would be beneficial to all who use 
 31 
them, even though the literature suggests, as discussed previously in this chapter, that 
self-management is highly individualized.  
It is clear that the recent measurement of self-management in the literature is at 
odds with the conceptualization of the concept. As well, the appropriateness of the direct 
measurement of self-management is questionable (Lorig & Holman, 2003). Because  
self-management is a process, frank measurement of it should be avoided in favor of the 
characterization of it (via descriptive use of different types of strategies, for example) to 
provide insight into the processes of self-management that are most beneficial in given 
contexts (Lorig & Holman, 2003). 
Epilepsy Self-Management 
Despite the process-oriented conceptual definition of epilepsy self-management in 
the literature, as is seen in the general chronic disease self-management literature, 
researchers have attempted to directly measure epilepsy self-management. Unger and 
Buelow’s (2009) review of the epilepsy self-management literature revealed that epilepsy 
self-management, the same as general chronic disease self-management, has been 
primarily operationalized as medication compliance and the engagement in epilepsy 
self-management behaviors. 
In both the medical and nursing literature, epilepsy self-management has been 
measured predominantly as medication compliance. In their review of the concept of 
epilepsy self-management, Buelow and Johnson (2000) found that epilepsy  
self-management was operationalized nearly always this way, just as Unger and Buelow 
(2009), in a more recent review of the epilepsy self-management literature, found that in 
studies in which epilepsy self-management was being measured directly, most 
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researchers used medication compliance as the prime or sole measure of the concept. This 
measurement often is achieved via self-report, medication event monitoring-caps data, or 
blood concentration levels of anti-epileptic drugs (Buelow & Johnson, 2000; Unger & 
Buelow, 2009). As is seen in the general chronic disease self-management literature, 
those who comply with epilepsy medication regimens are seen as “high” or “good”  
self-managers (Unger & Buelow, 2009). 
Just as general chronic disease self-management frequently has been measured as 
the degree to or frequency with which individuals with chronic diseases engage in certain 
behaviors, so too has been epilepsy self-management. One published instrument, the 
Epilepsy Self-Management Scale, developed by DiIorio (1997), commonly has been used 
in studies in which epilepsy self-management has been measured directly. The instrument 
is comprised of 38 questions that ask respondents to rate how often they use certain 
behaviors in the domains of medication adherence and, in the latest version, information, 
lifestyle, and safety. The scale items are epilepsy-specific, and the scale includes both 
positive (such as checking with the doctor before taking other medications) and negative 
(such as skipping doses of medication) self-management behaviors. Those engaging most 
in positive self-management behaviors and least in negative self-management behaviors, 
score highest on the scale and are seen as practicing better epilepsy self-management 
(DiIorio, 1997). 
The measurement of epilepsy self-management both as medication compliance 
and as engagement in behaviors is problematic for the same reasons that were discussed 
previously in this section in the review of the ways in which general chronic disease  
self-management most commonly is operationalized: The use of compliance as the main 
 33 
measure is at odds with the conceptual definition of epilepsy self-management and is 
incomplete in that it fails to capture other important aspects of the concept as supported 
by the epilepsy self-management literature. The use of engagement in behaviors to 
measure epilepsy self-management fails to capture the process orientation and 
individualized and fluid nature of the concept. Also, while the Epilepsy Self-Management 
Scale (DiIorio, 1997) was developed based on interviews with people with epilepsy, and 
thus includes behaviors relevant to those with the disorder, utilizing a close-ended list of 
behaviors is limiting in that it cannot possibly capture all the unique ways in which those 
with epilepsy self-manage the disease. Finally, to use such a list of behaviors assumes 
that all of the “negative” strategies included are indeed inappropriate for use in all those 
with epilepsy and that those labeled as “positive” would be equally helpful for all those 
practicing epilepsy self-management—which is an unfounded assumption given that 
epilepsy self-management, just as general chronic disease self-management, is beginning 
to be portrayed in the literature as highly individualized (DiIorio, 2009; Unger & Buelow, 
2009). For example, one item on the Epilepsy Self-Management Scale (DiIorio, 1997) 
asks participants to rate the frequency with which they stay out late at night (item 6). 
According to the scale, a person who indicates that he or she often stays out late at night 
is not practicing appropriate epilepsy self-management, presumably because lack of sleep 
is a common trigger for seizures in those with epilepsy (Malow, 2004). However, staying 
out late at night does not indicate the number of hours that the person sleeps each night, 
and it is possible that he or she may sleep late into the morning or afternoon and is thus 
still sleeping enough to prevent a sleep deprivation-induced seizure. As well, sleep 
deprivation is not a seizure trigger for every person with epilepsy (Malow, 2004) and thus 
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staying out late at night or neglecting to sleep the recommended number of hours per 
night would not negatively affect every person with epilepsy in terms of increasing 
seizure frequency. 
It should be noted that measuring anti-epileptic medication compliance and 
engagement in epilepsy self-management behaviors is not without benefit—medications 
are a key aspect of epilepsy treatment and knowledge regarding what people with 
epilepsy are doing on a daily basis to manage their condition is invaluable—but using 
these measurements as direct reflections of epilepsy self-management is inappropriate. A 
more beneficial approach would be to enrich the available descriptions of epilepsy  
self-management via categorization of epilepsy self-management behaviors and 
processes, as Buelow (2001) has done by labeling epilepsy self-management strategies as 
either proactive or reactive. Doing so would allow researchers to categorize persons’ 
epilepsy self-management behaviors while still allowing for the individualized nature of 
them to be captured. The relationship between different types of self-management 
strategies/processes and important outcomes could thus be explored. 
What Are the Outcomes of Self-Management? 
Chronic Disease Self-Management 
As discussed previously in this chapter, general chronic disease self-management 
is not, in and of itself, an outcome. Rather, self-management is a means to important 
outcomes (Lorig, 2003; Lorig & Holman, 2003). In this section of the chapter, outcomes 
of chronic disease self-management as they are most commonly represented and 
measured in the literature are discussed. The effect of self-management interventions on 
these outcomes are discussed later in this chapter. 
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A review of the general chronic disease self-management literature reveals that 
self-management outcomes are measured most commonly in terms of disease status or 
severity, health status or quality of life, and healthcare resource utilization. Lorig and 
Holman (2003) note that the desired outcome of self-management is the achievement of 
these outcomes in a positive way: decreased disease severity and less frequent 
exacerbations, improved health status or quality of life, and reduced healthcare resource 
utilization. In most research studies, these multiple outcomes are not measured or 
discussed in isolation but as a somewhat- or all-inclusive group.  
Disease status and severity. One of the most common outcomes of  
self-management espoused in the literature is that of disease status or severity. Unger and 
Buelow (2009), via their review of the self-management literature, found that a key 
feature of the concept is that one of its chief outcomes is some degree of disease control 
or, perhaps more descriptively, current status or severity. For example, for a person with 
diabetes, a main outcome of the person’s self-management could be the person’s 
Hemoglobin A1C or daily blood glucose values (Speer et al., 2008). For a person with 
chronic obstructive pulmonary disorder, forced vital capacity, oxygen saturation, and 
arterial blood gas values are disease status outcomes (Bourbeau & van der Palen, 2009). 
Disease status and severity outcomes also can be viewed in terms of frequency of 
exacerbations, as is common in studies with the heart failure (Armbrister, 2008) and 
chronic obstructive pulmonary disease populations (Bourbeau & van der Palen, 2009). 
Similarly, others, such as Ryan and Sawin (2009), refer to the disease status or severity 
outcome of self-management as disease stabilization—or the degree to which, given that 
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there are no cures for most chronic diseases, the disease fails to progress to later, or more 
severe, stages. 
The inclusion of disease status and severity as a self-management outcome is 
derived heavily from the medical, and not the nursing, model. In medicine, health is 
defined primarily as the absence of disease (Newman, 1986; Thomas, 1981); whereas in 
nursing, health is defined as a subjective illness/wellness experience, referring to somatic 
and emotional comfort and functional ability at or near one’s perceived capability level, 
which can occur in the presence or absence of disease (Lyon, 2005; Nightingale, 
1859/1969). From a nursing perspective, then, to consider disease status and severity as 
the sole outcome of chronic disease self-management is severely inadequate, though it 
often occurs in the medical literature (Barlow, Sturt, & Hearnshaw, 2002; Unger & 
Buelow, 2009). While nurse researchers recognize the need to track disease-related 
outcomes, the majority of their self-management research is focused on other outcomes, 
discussed later in this chapter, that are more congruent with nursing’s definition of health 
(Barlow et al., 2002; Lorig & Holman, 2003). 
Health status and quality of life. Given that nursing’s orientation to chronic 
disease self-management is characterized chiefly by a view of persons with chronic 
disease engaging in self-management in order to ensure that their normal lives can 
coexist with their chronic diseases (Lorig, 2003), it is no surprise that nurse researchers 
support and most frequently track and measure self-management outcomes that consider 
the overall effect of chronic disease on people’s lives. In their reviews of the  
self-management literature, both Barlow and colleagues (2002) and Unger and Buelow 
(2009) found that, in the nursing literature, and particularly in the last decade, the prime 
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self-management outcomes measured have included those that can be described best as 
health status and quality of life; further, Gordon and Galloway (2008), in their review of 
the effectiveness of self-management interventions, included health status and quality of 
life as key self-management outcomes. Health status is a general term and has been used 
in a variety of ways. It is comprised of multiple components. Lorig and colleagues (2001) 
define it in terms of symptom experience, disability, health distress, self-rated health, and 
social/role limitations. Others refer to it as psychological and physical health or  
well-being (Grey et al., 2006; Ryan & Sawin, 2009). Health status perhaps is best defined 
as a self-management outcome by comparing it to the concept of wellness in Lyon’s 
(2005) definition of health as it pertains to nursing: a person’s subjective evaluation of 
his/her emotional and physical comfort and ability to function at perceived capability 
level—in other words, a person’s ability to live normally and comfortably despite having 
a chronic disease. Quality of life is closely related to health status and generally is 
defined as a person’s perceived overall well-being or satisfaction with life (Moons, 
Budts, & DeGeest, 2006). Quality of life frequently is measured as an outcome of chronic 
disease self-management in the nursing literature and sometimes is used to capture both 
health status and quality of life outcomes simultaneously (Barlow et al., 2002; Lorig & 
Holman, 2003; Unger & Buelow, 2009). Of note is that the outcomes of disease status 
and severity are not always related to health status and quality of life. For example, 
higher levels of disease control have been shown to be negatively correlated with 
reported levels of quality of life (Clark, 2003). 
Healthcare resource utilization. One self-management outcome that is seen in 
the medical and nursing literatures is that of healthcare resource utilization. In their 
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reviews of the self-management literature, Barlow and colleagues (2002), Gordon and 
Galloway (2008), and Unger and Buelow (2009) found that healthcare resource 
utilization, comprised of physician/clinic visits, emergency department visits, and 
inpatient hospital days, commonly were measured as an outcome of self-management. 
For example, Lorig and colleagues (2001), in their large-scale self-management studies, 
tracked participants’ outpatient and emergency department visits, days in hospital, and 
number of times hospitalized, as self-management outcomes—as have researchers 
investigating self-management outcomes in a variety of disease populations (Gordon & 
Galloway, 2008). In addition, the Centers for Disease Control and Prevention (2009) 
supports healthcare resource utilization as a prime self-management outcome. 
In recognition of healthcare resource utilization as an important outcome of  
self-management, researchers and theorists have begun including this outcome in their 
self-management models. Grey et al. (2006) include the self-management outcome of 
utilization in their model. Other researchers, such as Ryan and Sawin (2009), consider the 
previously listed direct healthcare resource utilization activities as self-management 
outcomes but also what they call indirect utilization costs in the form of fewer productive 
days at work/school as a result of disease-related symptoms or other effects. The Centers 
for Disease Control and Prevention (2009) also recognizes these indirect utilization 
outcomes of self-management. 
Epilepsy Self-Management 
What are considered, in the epilepsy literature, to be outcomes of epilepsy  
self-management are very similar to those of general chronic disease self-management 
previously discussed, though some are specific to those suffering from epilepsy. The 
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Commission on Outcome Measurement in Epilepsy (1998), in association with the 
International League Against Epilepsy, published a list of outcomes associated with 
epilepsy treatment, including self-management of the disease. This list includes seizure 
frequency/severity, health status and quality of life, and healthcare resource utilization. 
Of note is that quality of life as an outcome of epilepsy management is discussed in a 
relatively very small portion of the commission’s report—suggesting that the authors 
viewed the important outcomes of epilepsy care and management from a medical model 
view. A review of the epilepsy self-management literature suggests that these 
outcomes—seizure frequency and severity, health status and quality of life and, to a 
lesser extent, healthcare resource utilization—have been adopted as the main outcomes of 
epilepsy self-management since the publication of the commission’s report. 
Seizure frequency and severity. The outcome of seizure frequency and severity 
is akin to the general chronic disease self-management outcome of disease status and 
severity, particularized for the epilepsy population. In a Cochrane review of epilepsy  
self-management interventions and associated outcomes, nearly all studies reviewed 
measured seizure frequency as an outcome of epilepsy self-management (Shaw et al., 
2009). Buelow and Johnson (2000), in their review of epilepsy self-management and its 
outcomes, found that seizure frequency and severity are considered prime outcomes of 
epilepsy management and, in fact, that seizure frequency often is seen as the “end product 
of epilepsy self-management” (p. 333). Nine years later, Unger and Buelow (2009), in 
reviewing the epilepsy self-management literature, found that, even in nursing research 
studies, number of seizures and severity of the disorder were considered main outcomes 
of epilepsy self-management. DiIorio and colleagues (1994, 1995, 1996), for example, 
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measured seizure frequency as an epilepsy self-management outcome. Researchers and 
clinicians working with those with epilepsy have expressed that diminishing seizure 
frequency is a main self-management outcome for those with the disorder (Center for 
Managing Chronic Disease, 2010). Nurse researchers, and particularly Buelow and 
Johnson (2000) and DiIorio (1997), have begun to note that epilepsy self-management 
outcomes go beyond disease control in the form of seizure frequency and severity. In 
fact, the Centers for Disease Control and Prevention created the Managing Epilepsy Well 
Network (n.d.) to ensure that epilepsy self-management research aimed at enhancing 
other outcomes, namely health status and quality of life, is conducted. 
McAuley and colleagues (2010) executed a study with the aim of comparing adult 
epilepsy patients’ main concerns about the disease with those of their healthcare 
providers. Both patients and their healthcare providers were asked to rate, in order of 
importance, their top five concerns regarding the patients’ epilepsy from the following 
choices: having a seizure unexpectedly, ability to drive, memory problems, being a 
burden to family members, fear of being injured during a seizure, seizures not being 
controlled, and medication side effects. Patients were more concerned with life issues 
(memory impairment and being a burden to others) while practitioners were more 
concerned with clinical issues (seizure control). The most significant finding was 
regarding patients’ concern for memory problems. Regardless of seizure severity or 
control, a major concern for patients was memory problems, while practitioners did not 
even rate this as a top-five concern (McAuley et al., 2010). The results of the McAuley 
and colleagues (2010) study suggest that desired outcomes of epilepsy management 
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amongst persons with epilepsy and the practitioners who provide their medical treatment 
are not always congruent. 
Health status and quality of life. Health status and quality of life, defined 
identically because they are in relation to general chronic disease self-management 
outcomes, have become prime outcomes of epilepsy self-management, particularly in the 
nursing literature. In a recent survey, epilepsy researchers and clinicians noted that 
preservation and improvement of quality of life is the main treatment and management 
outcome for individuals with epilepsy (Center for Managing Chronic Disease, 2010). In 
addition, Unger and Buelow (2009) found in their review of the epilepsy literature, that, 
in addition to seizure frequency and severity, nurse researchers most prominently 
considered the concepts of health status and quality of life as epilepsy self-management 
outcomes. Of note, however, is that, in most nursing research studies pertaining to 
epilepsy self-management, these outcomes have not yet been measured consistently. For 
example, while Buelow (2001) measured quality of life of those with epilepsy via 
Ferrans’ Quality of Life Index-Epilepsy Version (1996), DiIorio and colleagues (2009), 
arguably the most substantial and active contributors to the epilepsy self-management 
literature, though they recognize and suggest that health status and quality of life are 
main outcomes of epilepsy self-management, have not measured them consistently as 
epilepsy self-management outcomes, even in epilepsy self-management intervention 
studies (DiIorio et al., 2009). Thus, in contrast to what is seen in the more well-developed 
general chronic disease self-management literature, the outcomes of health status and 
quality of life are espoused as primary to epilepsy self-management but have not yet been 
consistently measured in the epilepsy population. Despite this gap, it is clear that the 
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importance of health status and quality of life as epilepsy self-management outcomes is 
becoming more recognized, especially with the emergence of the Managing Epilepsy 
Well Network (n.d.), a prime focus of which is facilitating research aimed at improving 
health status and quality of life outcomes for persons with epilepsy. In addition, the most 
recent models of epilepsy self-management include health status and/or quality of life as 
epilepsy self-management outcomes (DiIorio, 2009; Unger & Buelow, 2009). 
Healthcare resource utilization. The epilepsy self-management outcome of 
healthcare resource utilization in the form of outpatient/emergency department visits and 
hospitalizations is indicated by the Commission on Outcome Measurement in Epilepsy 
(1998), but it is not tracked widely or measured in the epilepsy self-management 
literature. For example, a Cochrane review of epilepsy self-management interventions 
(Shaw et al., 2009) revealed that healthcare resource utilization was measured only 
sporadically in the studies reviewed. Resource utilization also is not included as an 
outcome in any of the published epilepsy self-management models. It is unclear why 
healthcare resource utilization is measured less frequently as an outcome of epilepsy  
self-management compared with general chronic disease self-management. However, as 
in general chronic disease self-management, researchers are beginning to recognize the 
need to consider number of productive days, which are generally fewer in those with 
epilepsy due to seizures, medication side effects, and unpleasant emotional symptoms in 
the form of depression, as a potential epilepsy self-management outcome (Center for 
Managing Chronic Disease, 2010). 
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Gaps in Knowledge Regarding Self-Management Outcomes 
The previous discussion of the outcomes of both general chronic disease and 
epilepsy self-management would be incomplete without reference to noticeable gaps in 
both sets of literature. First, it must be noted that many chronic diseases, including 
epilepsy, tend to occur across the lifespan and affect individuals of all ages. However, 
neither the chronic disease nor epilepsy self-management literatures differentiate  
self-management outcomes across the lifespan. That is, researchers have yet to take into 
account the effects of different developmental stages on the pertinence of outcomes. It 
cannot be assumed that the self-management outcomes for a 6-year-old with diabetes are 
identical to those of a 68-year-old with the condition. Outcomes also are not discussed in 
terms of length of time since diagnosis. The self-management outcomes of a person 
diagnosed with asthma two months ago, versus those for a person diagnosed 25 years 
ago, are likely different. The ways in which developmental stages and length of time 
since diagnosis could alter the outcomes of self-management must be explored in order to 
ensure that self-management interventions are targeting and affecting appropriate 
outcomes for all. To address the gap surrounding epilepsy self-management outcomes, 
the Managing Epilepsy Well Network (n.d.) has formed a work group dedicated to 
improving outcome measures for persons with epilepsy. 
What Affects and Influences Self-Management? 
General Chronic Disease Self-Management 
Throughout the chronic disease self-management literature, researchers have 
demonstrated that a multitude of variables seem to influence the ways in which people 
self-manage their chronic diseases and some appear to influence self-management 
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outcomes directly. The relationships between these variables and self-management have 
informed self-management theory and model development with researchers, and 
particularly nurse researchers, including such variables in their theories and models. The 
ways in which these variables are labeled in the literature differ. Some, such as Ryan and 
Sawin (2009) and Grey et al. (2006) refer to them as risk and protective factors. Others, 
such as Clark (2003), call them interpersonal and external factors, and still others, such as 
Lorig (2003), refer to them simply as variables that affect self-management. In this 
section of the chapter, those factors most commonly demonstrated in the empirical and 
theoretical literature as influencing self-management are discussed and, to simplify the 
discussion, are organized into the logical categories of contextual, internal, and external 
factors. 
Contextual factors. Contextual factors influencing self-management are 
generally those variables about a person that cannot be changed but must be considered: 
disease severity, age, gender, and socioeconomic status. Grey and colleagues (2006), in 
developing their family-based self-management theory, reviewed the literature to 
determine ways in which these variables influence self-management. They found that 
those suffering from more severe or advanced diseases require and engage in more 
complex self-management. Regarding age, they found that younger and older persons 
with chronic disease have greater self-management needs and generally require more 
complex self-management. Evidence regarding differences between men and women and 
their self-management has been variable and inconclusive and those of lower  
socio-economic status demonstrate poorer self-management outcomes (Grey et al., 2006). 
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Internal factors. Internal factors refer to those within the person, and they are 
usually cognitive in nature. Three main internal factors influencing self-management can 
be extracted from the literature: knowledge and beliefs, self-efficacy, and self-regulation. 
Knowledge and beliefs. A person’s knowledge and beliefs generally refer to his 
or her current understanding of facts and beliefs about the chronic disease with which he 
or she has been diagnosed, as well as his or her knowledge about its associated course 
and treatments. In their reviews of the self-management literature, both Ryan and Sawin 
(2009) and Clark (2003) found that one’s knowledge and beliefs about his or her chronic 
condition and its treatment affect the way a person self-manages at a basic level. For 
example, in the human immunodeficiency virus literature, research findings have 
indicated that changing the views of persons who are human immunodeficiency virus 
seropositive about their disease to a chronic disease, instead of a death sentence, resulted 
in them being more interested in learning how to self-manage (Moskowitz, Henneman, & 
Young-Holt, 2002). Lorig, too, based on her work with Laurin and Holman (1984), in 
which they reviewed the concept of self-management, including its antecedents and 
consequences, asserts that disease and treatment knowledge are essential to  
self-management. However, it also is recognized that disease and treatment knowledge 
and beliefs are variables that often significantly affect self-management by virtue of their 
relationship with other variables, most notably self-efficacy (Marks et al., 2005a). In 
other words, a person’s knowledge and beliefs about his or her chronic disease act as 
building blocks of his or her self-management and are thus essential to self-management. 
However, as will be discussed later, a person’s self-management as well as  
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self-management outcomes cannot be expected to change based only on a change in his 
or her knowledge and beliefs (Marks et al., 2005a). 
Self-efficacy. The concept most pervasively discussed in the general chronic 
disease literature as influencing self-management is self-efficacy, a core concept of 
Bandura’s (1997) social cognitive theory. All of the major chronic disease  
self-management models (Grey et al., 2006; Holman & Lorig, 2004; Ryan & Sawin, 
2009) include self-efficacy and its other components as prime antecedents of  
self-management and self-management outcomes. In fact, Marks et al. (2005a, 2005b), 
based on their review of existing self-efficacy-enhancing interventions to improve  
self-management, suggested that self-efficacy is at the crux of self-management and  
self-management outcome improvement. Broadly, self-efficacy refers to a person’s 
confidence in his or her ability to carry out behaviors or to change a cognitive state, 
regardless of circumstances, to achieve desired outcomes by doing so. Outcome 
expectancies, a concept related to self-efficacy, refer to a person’s beliefs about how 
engaging in certain behaviors or cognitive states will affect an outcome important to him 
or her. Self-efficacy does not refer to a person’s actual ability to engage in behaviors, 
only his or her confidence to do so. Self-efficacy is not a global concept—a person with 
high self-efficacy to perform one behavior may have very low self-efficacy regarding a 
different behavior (Bandura, 1997). 
According to Marks et al. (2005a), self-efficacy as it applies to self-management 
involves three separate domains: having tactic task knowledge and skills, having an 
explicit sense of confidence in one’s ability to mobilize motivational and cognitive 
resources needed to perform a skill, and having confidence in one’s ability to execute a 
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specific skill in a specific context. Marks et al. (2005a, 2005b) published a two-part 
review of the role that self-efficacy plays in influencing self-management and its 
outcomes. The results of the review are discussed in the following paragraphs. 
First, self-efficacy has been demonstrated to have a direct influence on 
engagement in certain health behaviors. Marks et al. (2005a) cite and review several 
studies involving those with heart disease, asthma, and other chronic diseases in which 
baseline levels of self-efficacy and changes in self-efficacy were associated with changes 
in behaviors. Those with higher levels of self-efficacy engaged more frequently in 
desirable health behaviors. These behaviors involved those of compliance (medication 
adherence) as well as others for managing other aspects of the diseases (managing stress) 
(Marks et al., 2005a). However, as discussed previously, improved outcomes, and not 
engagement in self-management behaviors, is the desired endpoint of self-management. 
There is much evidence indicating that higher levels of self-efficacy are 
associated with better self-management outcomes. As pointed out by Marks et al. 
(2005a), self-efficacy independently can predict health outcomes. This phenomenon has 
demonstrated short-term in outcomes such as functional ability and disease status in a 
variety of disease contexts (Marks et al., 2005b). The most staggering evidence of this 
phenomenon resulted from two of Lorig and colleagues’ large studies, one involving 
those with arthritis (Lorig, Mazonson, & Holman, 1993) and the other of those with a 
variety of chronic diseases (Lorig et al., 2001), in which, up to two years following a  
self-efficacy-based self-management intervention, participants demonstrated improved 
health status (in the specific area of health distress) as well as decreased healthcare 
resource utilization. Interestingly, engagement in self-management behaviors (which also 
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increased) was not associated with the changes in self-management outcomes, but 
baseline measurements and changes in self-efficacy were positively correlated with these 
improved outcomes. Similar findings exist in the asthma literature, where higher levels of 
asthma management self-efficacy have been associated with higher levels of quality of 
life and physical functioning 18 months following intervention (Katz, Yelin, Eisner, & 
Blanc, 2002; Mancuso, Rincon, McCulloch, & Charlson, 2001). These studies utilized 
covariates to control for other variables (disease severity, for example) that could have 
influenced reported outcomes. The synthesis offered by Marks et al. (2005a, 2005b) also 
points out that self-efficacy can influence self-management in other, less direct ways. 
Self-efficacy beliefs can influence mood, motivation levels, and attitudes regarding health 
promotion behaviors, despite previous disconfirming experiences. That is, one’s  
self-efficacy can influence how likely that person is to engage in behaviors that may 
improve his or her outcomes. Self-efficacy also affects the ways in which people set 
goals, including those associated with their chronic disease self-management (Marks  
et al., 2005b). 
To summarize, baseline levels of self-efficacy, as well as changes in levels of 
self-efficacy, are associated with and influence chronic disease self-management and its 
outcomes. Self-efficacy can predict the adoption of health behaviors and, more 
importantly, mediate important self-management outcomes (Marks et al., 2005a, 2005b). 
Self-regulation. Yet another cognitive concept that is associated with  
self-management is self-regulation. Self-regulation is a cognitive process that occurs 
when a person observes, makes judgments, and reacts accordingly to reach a personal 
goal by changing or continuing his or her behaviors (Bandura, 1986). In the context of 
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self-management, self-regulation is the process by which persons with chronic disease 
derive the strategies and behaviors they use in managing their diseases (Clark, 2003). 
Both Ryan and Sawin (2009) and Clark (2003) included self-regulation as a key factor 
associated with self-management in their self-management models. In Ryan and Sawin’s 
(2009) model, self-regulation is an antecedent to self-management, while in Clark’s 
(2003) model, self-regulation acts as a sort of context within which self-management 
occurs. 
Both Ryan and Sawin (2009) and Clark (2003) reviewed the chronic disease  
self-management literature in order to identify the influence of self-regulation on  
self-management, and these authors report similar conclusions. Self-regulation indirectly 
is related to self-management in that it is positively correlated with self-efficacy.  
Self-regulation also is positively associated with engagement in health-promoting 
behaviors (Clark, 2003; Lorig, Ritter, Laurent, & Fries, 2004; Lorig et al., 2001; Ryan & 
Sawin, 2009). Other studies have demonstrated that, as with self-efficacy, self-regulation 
has been positively associated, at least in the short-term, with self-management outcomes 
such as quality of life, disease status, and healthcare resource utilization (Barlow et al., 
2002; Lorig, Ritter, & González, 2003; Wagner, Austin, & von Korff, 1996). 
External factors. External factors refer to those outside of the person  
self-managing the chronic disease. Two of the most frequently discussed external factors 
in terms of a relationship to self-management are social support and access to healthcare. 
These variables are included in multiple models of self-management, including Ryan and 
Sawin’s (2009), Grey et al.’s (2006), and Clark’s (2003). 
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Social support generally is conceptualized in the self-management literature as the 
degree of emotional, informational, and other support available to the person from 
family, friends, and healthcare providers (Grey et al., 2006). Thus, healthcare access is 
embedded in the variable of social support in terms of a person’s access to support from 
his or her healthcare providers (Ryan & Sawin, 2009). 
In the literature, social support and healthcare access have been shown to be 
positively associated with engagement in health protective and promotion behaviors. 
Barlow et al. (2002), in reviewing the self-management literature, and Lorig et al. (1993), 
in a self-management intervention study involving persons with arthritis, found that those 
with higher levels of social support and healthcare access engage more frequently in 
health promotion behaviors such as exercise, smoking cessation, and medication 
adherence. In fact, most of the literature regarding social support and healthcare access 
and self-management has been related to compliance with treatment regimens and, 
although the results of such studies have demonstrated that those with higher levels of 
social support and better healthcare access are more compliant, self-management is not 
synonymous with compliance. Social support and healthcare access have not been shown 
to independently affect self-management outcomes (Barlow et al., 2002). 
Despite knowledge that social support and healthcare access have not been 
associated with self-management outcomes, many researchers include these variables in 
their self-management models. Ryan and Sawin (2009) justify the inclusion of social 
support/access to healthcare in their model by pointing out its relationship to other 
variables important in self-management: knowledge and beliefs and self-regulation. In 
studies involving people with a variety of chronic diseases, those with higher levels of 
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social support/access to healthcare consistently have demonstrated higher levels of 
knowledge and beliefs and self-regulation abilities, as discussed previously, that are 
involved in self-management (Ryan & Sawin, 2009). 
Epilepsy Self-Management 
Most of the key variables related to and influencing general chronic disease  
self-management also appear in the epilepsy literature as influential to epilepsy  
self-management. Contextual, internal, and external factors are discussed in this section. 
Of note is that the epilepsy self-management literature is less well-developed than the 
general chronic disease self-management literature in terms of the existence of empirical 
data demonstrating the ways in which variables affect epilepsy self-management, largely 
because epilepsy researchers have drawn from findings in the general chronic disease 
self-management literature in developing their epilepsy self-management models. 
Contextual factors. As in general chronic disease self-management, these 
variables include disease severity (seizure frequency and severity), age, gender, and 
socioeconomic status. Throughout the epilepsy self-management literature, those with 
more severe seizure disorders are assumed to have different and more complex  
self-management needs than those with less severe cases of the condition. DiIorio et al. 
(1996) found that some persons with epilepsy do require much more complex treatment 
regimens than others with less severe epilepsy, but no studies have been executed to 
ascertain that their self-management is different than that of other people. Others have 
found that the complexity of an epilepsy medication regimen can influence  
self-management in the compliance domain (Leppik, 1988). No studies have been 
executed to determine the precise relationship between age and gender and epilepsy  
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self-management, though Begley and colleagues (2010) found no significant relationship 
between socioeconomic status and epilepsy self-management as measured by the 
Epilepsy Self-Management Scale (DiIorio et al., 1994). 
Internal factors. In the epilepsy self-management literature, the same internal 
factors, apart from self-regulation, as those associated with general chronic disease  
self-management have been considered (based on drawing from the general chronic 
disease self-management literature) or shown, via research with persons with epilepsy, to 
influence epilepsy self-management. 
Knowledge and beliefs. Both Shope (1996) and DiIorio (2009) included 
knowledge (or information), particularly about seizures and their treatment, in their 
models of epilepsy self-management. Neither of these researchers, nor any others, 
however, actually measured the relationship between knowledge and beliefs and epilepsy 
self-management in a sample of persons with epilepsy. Instead, they justified their 
inclusion of this variable in their models via citations of studies from the chronic disease 
self-management literature that demonstrate the relationship between knowledge and 
beliefs and self-management. DiIorio et al. (1996), in testing their original epilepsy  
self-management framework, did examine the relationship between knowledge and  
self-efficacy and found that the two variables were positively related in a population of 
persons with epilepsy just as in those with other chronic diseases. Epilepsy  
self-management researchers recognize that knowledge and beliefs do not, by themselves, 
change behavior or outcomes but that they are foundational to the epilepsy  
self-management process (DiIorio et al., 1996). 
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Self-efficacy. Just as is in the general chronic disease self-management literature, 
discussions and explorations of self-efficacy and its relation to epilepsy self-management 
and its outcomes are prevalent throughout the epilepsy literature. Unger and Buelow 
(2009) found that self-efficacy is measured consistently in studies investigating epilepsy 
self-management and that it is a concept closely related to epilepsy self-management. 
Self-efficacy also is included in models of epilepsy self-management. For example, in 
DiIorio’s (2009) latest version of her epilepsy self-management model, self-efficacy 
influences decision-making, epilepsy self-management behaviors, and epilepsy  
self-management outcomes. While epilepsy self-management researchers do draw from 
findings regarding the relationship between self-efficacy and self-management from the 
chronic disease self-management literature (Unger & Buelow, 2009), some, and 
particularly Kobau and DiIorio (2003), have investigated the precise relationship between 
self-efficacy and outcome expectancies and epilepsy self-management in samples of 
persons with epilepsy. 
In a descriptive study, Kobau and DiIorio (2003) examined the self-efficacy and 
outcome expectancies of persons with epilepsy in relation to their epilepsy  
self-management in the areas of medication and lifestyle management. These 
investigators, then, did not investigate the relationship between self-efficacy and epilepsy 
self-management but described how confident persons with epilepsy felt in managing 
their disease strictly in terms of compliance. Participants demonstrated significantly 
higher self-efficacy and more positive outcome expectations in the realm of medication 
management, suggesting they are much more confident in and expect better outcomes by 
taking their medications as prescribed than in adhering to lifestyle modifications. In a test 
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of their theoretical model of epilepsy self-management, DiIorio et al. (1996) did examine 
the relationship between self-efficacy and epilepsy self-management, but only in the form 
of self-reported medication compliance, and found that the two were significantly 
positively related. 
The two studies discussed in this section are the only two in which self-efficacy 
and its relationship to epilepsy self-management has been explored in those with 
epilepsy. Of note is that, in both studies, epilepsy self-management was treated 
exclusively as compliance. More research is needed to determine the relationship 
between self-efficacy and other aspects of epilepsy self-management. 
External factors. External factors pertinent to epilepsy self-management include 
those discussed previously in reference to chronic disease self-management: social 
support and healthcare access. Very little research has been done to determine the precise 
relationship between these variables and epilepsy self-management; epilepsy  
self-management researchers tend to cite and draw from the general chronic disease  
self-management literature to justify their use of these variables in their epilepsy  
self-management models (DiIorio, 2009; Shope, 1996). In studies regarding the way in 
which these factors affect self-management in those with epilepsy that have been done, 
however, findings have been mixed. 
DiIorio et al. (1992) measured the relationship between social support 
(conceptualized as informational and emotional support) and medication compliance, and 
found a significant positive relationship. However, this relationship was not as large as 
that between self-efficacy and medication compliance. Later, in testing their theoretical 
model of epilepsy self-management, DiIorio et al. (1996) investigated the relationship 
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between what they called specific support, which basically referred to a family member 
or friend reminding the person with epilepsy to take medications as prescribed, and 
compliance with medications. There was a negative relationship found between specific 
support and medication compliance, which the authors explained by noting that such 
support was positively correlated with anxiety. The authors concluded that having a 
person constantly reminding the person with epilepsy about his or her medications 
actually interfered with medication adherence. 
How Effective are Self-Management Interventions? 
A prime goal of chronic disease and epilepsy self-management researchers is to 
determine ways in which those with chronic diseases can be helped—that is, how can 
researchers intervene with those suffering from chronic diseases, and particularly 
epilepsy, to improve their outcomes? What follows in this section is a synthesis of both 
the general chronic disease and epilepsy self-management literatures in terms of the 
degree to which self-management interventions have been shown to influence the 
outcomes of disease status and severity, health status and quality of life, and resource 
utilization. Gaps in the literature regarding the effectiveness of self-management 
interventions also are identified and discussed. 
Chronic Disease Self-Management 
Over the last two decades, various literature reviews and syntheses have been 
conducted in order to establish what is known about the effectiveness of general chronic 
disease self-management intervention effectiveness. Some common conclusions have 
been reached: (a) Self-management interventions are distinct from and more effective 
than straight educational interventions; (b) Self-management interventions based on 
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theory, specifically self-efficacy theory, and those that teach varying skills, such as 
problem-solving, are most effective, though there is an exception to this finding in the 
population of persons with heart failure; (c) In persons with common chronic  
diseases—arthritis and asthma—there is evidence that self-management interventions 
improve self-management outcomes; (d) Evidence regarding the impact of generic  
self-management interventions that target those with a variety of chronic diseases has 
recently become available and suggests that these programs impact self-management 
outcomes; and (e) Limitations and gaps in knowledge regarding self-management 
interventions persist and include, most notably, that outcomes generally are measured in 
the short-term and rarely have been tracked for longer than four years post-intervention, 
improvements in outcomes have been shown to fade over time, and outcomes have not 
been measured consistently. 
Self-management interventions are superior to education. A recent Cochrane 
review (Coster & Norman, 2009) regarding self-management intervention effectiveness, 
as well as reviews of the self-management intervention literature (Lorig & Holman, 2003; 
Marks et al., 2005a, 2005b), demonstrate that straight educational interventions rarely are 
effective in improving outcomes and much less effective than those that involve a true 
self-management intervention. For instance, in persons with diabetes, for whom 
interventions have been shown to lack a theoretical basis and to be predominantly 
information-based and devoid of problem-solving skills, so-called self-management 
interventions rarely have been effective in affecting outcomes and never for longer than 
six months (Coster & Norman, 2009). In a review of self-management interventions for 
those with asthma, out of the 12 studies reviewed in which no improvements in outcomes 
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were noted, only 4 studies qualified as actual self-management interventions, with the 
rest being purely educational (Gibson et al., 2002). Lorig and Holman (2003) 
differentiate between educational and true self-management interventions. Educational 
interventions provide persons with factual information and teach skills. They are 
generally not theory-based. Clark (2003) refers to these interventions as “home grown” 
(p. 299) and notes that such interventions, which focus primarily on the delivery of 
information, are less successful in altering outcomes. In true self-management 
interventions, people are provided with education about their disease and its treatments 
but also learn problem-solving skills that are useful to solve problems from their own 
points of view. Problems with management are identified by the persons with the 
diseases, not the healthcare providers, and skills are applied to these individualized areas. 
The goal in true self-management interventions generally is increased confidence, or  
self-efficacy, to manage one’s disease in multiple, personally important domains  
(Lorig & Holman, 2003). 
The literature clearly demonstrates that, in a variety of chronic disease 
populations, straight education in the form of delivery of information is not as effective in 
significantly changing behavior, self-efficacy, or outcomes when compared to  
self-management interventions (Coster & Norman, 2009; Lorig & Holman, 2003; Marks 
et al., 2005a, 2005b). However, there is an exception to this finding in the population of 
those with heart failure. Powell and colleagues (2010), as part of the large-scale Heart 
Failure Adherence and Retention Randomized Behavioral Trial, reviewed the heart 
failure self-management literature and concluded that, overall, self-management 
interventions teaching problem-solving skills and fostering self-efficacy are no more 
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effective than straight educational interventions in improving disease status, health status, 
and healthcare resource utilization. Powell and colleagues (2010), who hypothesized that 
previous interventions had not been shown to influence outcomes as the result of 
methodological flaws, designed a self-efficacy-based self-management intervention that 
included learning problem-solving skills and devising and executing an action plan and 
implemented it in a large (N = 902) and rigorous randomized controlled trial. In this trial, 
individuals with heart failure who received an educational intervention (reception of 
disease-related information via pamphlets) and a self-management intervention 
demonstrated no differences in various disease status, quality of life, and utilization 
outcomes when compared at three months, two years, and three years post-intervention. 
The reason for the lack of superiority in self-management interventions when compared 
solely to educational ones in this population is not known (Powell et al., 2010). 
Theory-based interventions are superior. Multiple reviews of the effectiveness 
of self-management interventions on key outcomes, mainly disease status and severity, 
health status and/or quality of life, and healthcare resource utilization, reveal that  
theory-based self-management interventions, and particularly those based on the 
theoretical frameworks of self-regulation and self-efficacy, are most effective at 
improving outcomes. Six self-management intervention studies utilizing self-regulation 
as an organizing framework have yielded significant results in terms of improving 
outcomes in a variety of chronic disease contexts (Clark, Gong, & Kacitori, 2001; Clark 
et al., 1997; Janz et al., 1999; Sawicki, 1999; Shegog et al., 2001; van Genugten,  
van Empelen, Flink, & Oenema, 2010). Of note, however, is that self-regulation has been 
shown to improve self-efficacy (Clark, 2003; Ryan & Sawin, 2009), and thus, the 
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positive changes in outcomes seen in these studies may have been the result of positive 
changes in self-efficacy. 
More evidence exists to support the ability of self-efficacy-based interventions to 
positively affect self-management outcomes. For example, in a review of 23  
self-management intervention studies with persons with asthma, researchers found 
significant and desirable changes in outcomes of health status and healthcare resource 
utilization in 63% of studies in which self-efficacy was the guiding framework 
(McGowan & Green, 1995). More recently, Martin and colleagues (2009) developed an 
asthma self-management intervention based on principles of self-efficacy, primarily via 
teaching problem-solving and self-efficacy skills. At follow-up, those in the intervention 
group demonstrated improved quality of life, self-efficacy, and decreased healthcare 
resource utilization when compared to the usual care (straight education) group.  
Self-efficacy-based interventions with other populations, including macular degeneration 
(Brody et al., 1999) and diabetes (Mazzuca et al., 1986), have demonstrated superior 
effectiveness in positively affecting outcomes when compared to other self-management 
interventions designed for those populations based on other theories (Lorig & Holman, 
2003). Lorig and her colleagues (2001) provided the most convincing evidence regarding 
the use of self-efficacy-based self-management interventions to improve outcomes. These 
researchers, in four large-scale, randomized control trials, implemented a  
self-efficacy-based self-management intervention in three samples of persons with 
arthritis (Lorig, González, Laurent, Morgan, & Laris, 1998; Lorig et al., 1993) and later 
with a sample of persons with multiple chronic diseases (Lorig et al., 2001). Persons 
undergoing the intervention were taught problem-solving skills as well as skills in the 
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following areas: techniques to deal with problems such as frustration; fatigue; pain and 
isolation; appropriate exercise for maintaining and improving strength, flexibility, and 
endurance; appropriate use of medications; communicating effectively with family, 
friends, and health professionals; nutrition; cognitive symptom management; and how to 
evaluate new treatments. These skills were taught in highly participatory group classes 
(Lorig et al., 2001). The investigators found that persons in all studies demonstrated 
improvements in health status (health distress) and resource utilization (physician visits). 
Baseline and changes in self-efficacy were positively and independently associated with 
these improvements (Lorig et al., 2001). 
Self-management interventions affect outcomes in asthma and arthritis. 
Substantial evidence demonstrates that self-management interventions, and particularly 
those based on self-efficacy theory, can improve self-management outcomes in the 
common chronic diseases of asthma and arthritis. In a Cochrane review of asthma  
self-management intervention studies (Marks et al., 2005b), significant and desired 
changes in disease status, health status (measured most commonly in terms of symptom 
frequency and severity and quality of life), and resource utilization (measured most 
commonly in terms of emergency room visits and hospitalizations) have been 
demonstrated in 11 random controlled trials in which self-efficacy was used as the 
intervention basis. These effects were noted to persist no longer than 18 months  
post-intervention (McGowan & Green, 1995). In a more recent Cochrane review of 
asthma self-management interventions, Gibson and colleagues (2002), in reviewing 25 
asthma self-management intervention studies, found that persons undergoing the 
interventions had fewer hospitalizations and emergency room visits, fewer nighttime 
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symptoms, and more productive days than those without asthma. More recent evidence 
indicates that true self-management interventions designed for those with asthma are 
effective in improving outcomes (Janson, McGrath, Covington, Cheng, & Boushey, 
2009). 
As mentioned previously, Lorig and colleagues’ work (1993) has demonstrated 
that self-efficacy-based self-management interventions positively influence the outcomes 
of those with arthritis, particularly reduction in pain by 20% and resource utilization by 
40%, up to four years following intervention via their Arthritis Self-Management 
Program. Health status, in the form of health distress, also was decreased, though this 
effect attenuated over the follow-up periods (Lorig et al., 1993). Investigators conducting 
a subsequent cost-effectiveness study of the Arthritis Self-Management Program 
estimated that it has the potential to save $2.5 million over four years if implemented 
with 10,000 persons with arthritis (Kruger, Helmick, Callahan, & Haddix, 1998). To 
investigate the stability of the improvements associated with the Arthritis  
Self-Management Program over a longer period of time, Barlow and colleagues (2008) 
re-assessed 125 participants who completed the Arthritis Self-Management Program 
eight years post-intervention and found that the effects on some outcomes that occurred 
between baseline and the initial four-month follow-up were maintained: reduction in pain 
and improved self-efficacy and psychological functioning. Decreases in healthcare 
resource utilization, however, failed to be maintained at the eight-year follow-up. As 
well, anxiety increased over the follow-up periods, and initial improvements in physical 
functioning attenuated by the eight-year reassessment (Barlow et al., 2008). Several other 
investigators have found that their self-efficacy-based self-management interventions 
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similarly improve self-management outcomes in those with arthritis (Alderson, Starr, 
Gow, & Moreland, 1999; Kovar et al., 1992), though sample sizes in these studies were 
generally small (N = 30 and N = 47, respectively), and outcomes were not measured 
beyond six months. 
Other arthritis self-management intervention studies and reviews of such studies 
revealed that some asthma self-management interventions based on self-efficacy theory 
positively affect some self-management outcomes but not others. In a Cochrane review of 
24 studies testing rheumatoid arthritis self-management interventions, Reimsma, Kirwan, 
Taal, and Rasker (2002) found that these interventions, more than 80% of which were 
based on self-efficacy theory or problem-solving, were effective in improving overall 
health status (akin to quality of life), psychological status, and healthcare resource 
utilization. Reimsma et al. (2002) noted, in contrast to findings associated with the 
Arthritis Self-Management Program (Lorig et al., 1993), that a significant reduction in 
pain was not noted in most studies, and outcomes in the studies reviewed generally were 
measured no longer than six months post-intervention (Reimsma et al., 2002). More 
recently, in a large (N = 812) sample of persons with osteoarthritis, Buszewicz and 
colleagues (2006) implemented an arthritis self-management intervention based on  
self-efficacy theory, which resulted in improved levels of self-efficacy and reduced 
anxiety but failed to affect experience of pain or physical functioning. Because it has 
been shown to positively affect the most self-management outcomes, over the longest 
period of time and for the greatest number of people, the Arthritis Self-Management 
Program, developed by Lorig and colleagues (1993) and Lorig, Lubeck, Kraines, 
Seleznick, and Holman (1985), has become the gold standard self-management 
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intervention for individuals with arthritis. In fact, the Centers for Disease Control and 
Prevention (2010c) advertises and supports the use of the Arthritis Self-Management 
Program, which continues to be offered throughout the United States and abroad. 
Generic self-management interventions can be effective. Compared with what 
was seen in the asthma and arthritis literature, relatively less research has been done to 
investigate the effectiveness of generic chronic disease self-management  
interventions—those that can be implemented with persons with a variety of chronic 
diseases at the same time. Lorig and colleagues (2001), however, via their Chronic 
Disease Self-Management Program, a self-efficacy-based intervention designed for 
persons with a variety of chronic diseases, have provided initial evidence that such 
generic chronic disease  
self-management interventions can improve outcomes up to two years post-intervention. 
Based on the original Arthritis Self-Management Program, the Chronic Disease  
Self-Management Program was delivered to over 900 persons with arthritis, diabetes, 
chronic lung disease, and stroke. As part of the intervention, participants (and their family 
members who could participate if they desired) learned about cognitive symptom 
management, exercise program adoption, fatigue and sleep management, medication and 
community resource utilization, emotions (fear, anger, and depression) management, 
problem solving, and decision making; they also received training in how to effectively 
communicate with a healthcare provider (Lorig et al., 2001). At two years  
post-intervention, significant and desirable changes were noted in healthcare resource 
utilization (in terms of frequency of emergency room visits), health status (in the form of 
health distress), and experience of the symptom fatigue. Perceived disability in terms of 
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functional ability was improved at one year, but this result did not persist to the two-year 
follow-up assessment (Lorig et al., 2001). 
Since the publication of the Chronic Disease Self-Management Program 
intervention results (Lorig et al., 2001), other researchers have implemented this program 
with groups of persons suffering from a variety of simultaneous chronic diseases. Gordon 
and Galloway (2008), in partnership with the Centers for Disease Control and Prevention, 
reviewed 13 studies in which the Chronic Disease Self-Management Program was 
implemented with persons with a variety of chronic diseases. The authors concluded that 
this program, in general, is effective at improving quality of life and physical and 
emotional outcomes, and can decrease healthcare resource utilization. A reduction in pain 
and other symptoms was seen in half of the studies reviewed. The authors also concluded 
that the program saved sufficient money in healthcare expenditures in one year to pay for 
the program. The authors noted that, in all studies, the follow-up periods were no longer 
than six months. In addition, the variation in outcome measures used across the studies 
reviewed made comparison of outcomes difficult. Sample sizes also were generally 
adequate and ranged between 171–1140 participants (Gordon & Galloway, 2008). The 
initial evidence regarding the ability of a multi-chronic disease self-management 
intervention to affect at least some important outcomes is promising, though the more 
long-term benefit of such an intervention remains unknown. In addition, the intervention 
has not been implemented in persons with some common chronic diseases, including 
epilepsy. 
Critique and gaps in knowledge. While evidence suggests that self-management 
interventions, and especially self-efficacy-based ones, can improve self-management 
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outcomes, there are weaknesses in the current state of research which limit the 
conclusions that can be drawn regarding the effectiveness of these interventions. In two 
Cochrane reviews of chronic disease self-management intervention studies, both sets of 
authors noted that the majority of studies reviewed were underpowered due to small 
sample sizes and that very short follow-up periods (generally three to six months) most 
commonly were used (Barlow et al., 2002; Coster & Norman, 2009). As mentioned 
previously, though some studies have demonstrated effects on outcomes up to four years  
post-intervention (Lorig et al., 1993), these effects are generally smaller than at six 
months to one year post-intervention (Barlow et al., 2008), and other investigators have 
found that the effects are completely gone after five years (Caplin & Creer, 2001). 
Clearly, for persons with chronic diseases that last a lifetime, achieving desired effects 
for only four years is insufficient. In addition, though many interventions have led to 
changes in outcomes, the ways in which these outcomes were measured and what they 
truly represent must be considered. For example, in Lorig and colleagues’ (2001)  
large-scale Chronic Disease Self-Management Program study, health status was 
measured in multiple domains: health distress, disability, perceived health, and social/role 
changes. The only portion of health status that was significantly improved two years after 
the intervention was health distress. And, while there was a decrease in emergency room 
visits, hospitalization frequency was not affected. Thus, it is logical to question the 
degree to which these outcomes actually were affected. While self-management 
interventions have shown success in improving outcomes, or portions of outcomes, for 
persons with chronic diseases, even the most effective self-management interventions can 
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be improved. Researchers must endeavor to discover ways in which to achieve more 
lasting and comprehensive effects on self-management outcomes. 
Epilepsy Self-Management 
Self-management interventions specific to those with epilepsy have been created 
and tested, though the number of existing interventions specific to this population is small 
in comparison to those that exist for other chronic diseases such as asthma, arthritis, and 
diabetes. Unfortunately, the epilepsy self-management intervention literature, at this 
point, is so underdeveloped that not many conclusions may be drawn regarding the best 
ways in which to intervene to improve outcomes specific to those with epilepsy. The 
results of the latest Cochrane review aimed at evaluating the effectiveness of  
self-management interventions for individuals with epilepsy, as well as findings from 
studies in which epilepsy self-management-enhancing interventions have been 
implemented since the Cochrane review was published, are discussed in the sections that 
follow. 
In 2009, a Cochrane review (Shaw et al., 2009) was completed to determine the 
effectiveness of interventions for improving the epilepsy treatment and self-management 
outcomes put forth by the Commission on Outcome Measurement in Epilepsy (1998). As 
a consequence of poor study designs, only two intervention studies were evaluated and 
both of them were considered to be of marginal quality. Both studies involved the 
implementation of purely educational interventions aimed at providing participants with 
information regarding medical aspects of epilepsy, social and emotional aspects of 
epilepsy, coping, and accessing epilepsy-related information. Neither study reviewed 
cited a theoretical base. In both studies, significant changes from baseline to six months 
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were seen in knowledge regarding seizures and their treatment, while a small but 
significant decrease in seizure frequency was noted at six months post-intervention in one 
study (Shaw et al., 2009). The authors stated that based on the two studies reviewed, both 
of which had small sample sizes, methodological limitations, and a higher percentage of 
participants with partial seizures than is seen in the population of persons with epilepsy, 
no conclusions could be made regarding the best ways in which to improve the  
self-management outcomes specific to those with epilepsy (Shaw et al., 2009). 
Since the time of Shaw and colleagues’ (2009) Cochrane review, DiIorio and colleagues 
(2009), as a part of the Managing Epilepsy Well Network (n.d.), have implemented an 
Internet-based epilepsy self-management-enhancing intervention called WebEase. The 
intervention is based on self-efficacy theory as well as behavior change theory and 
motivational interviewing. The objective of the intervention is to encourage those with 
epilepsy to take medications as prescribed, manage stress, and engage in good sleep 
habits. Participants take part in online modules that, based on their answers, provide them 
with semi-tailored information and strategies for improving self-management. A new 
intervention, WebEase has been implemented with only 35 individuals. Results indicate 
that, at six weeks post-intervention, there were small but statistically significant 
differences in epilepsy self-management (measured via the Epilepsy Self-Management 
Scale), medication adherence, sleep quality, and self-efficacy. Thus, it is not clear how 
this intervention has affected or may affect epilepsy self-management outcomes. 
Clearly, the epilepsy self-management intervention literature is very limited. The 
use of more theory-based epilepsy self-management-enhancing interventions is needed. 
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The Managing Epilepsy Well Network (n.d.) was created in order to ensure that such 
interventions are developed and tested in those with epilepsy. 
Self-Management in Older Adults 
General chronic disease self-management. A small amount of literature specific 
to chronic disease self-management in older adults exists. This literature largely describes 
the effects of chronic diseases on older adults’ lives and less so their actual  
self-management experiences. 
Research pertaining to older adults with common chronic diseases—hypertension, 
arthritis, and cancer, for example—has been executed, and the findings of such studies 
provide potential insight into the self-management of older adults. Results of studies 
focused on older adults with arthritis and diabetes suggest that older adults’ overall health 
is affected negatively by the presence of chronic disease. In a cross-sectional survey of 
5,000 older adults with arthritis, respondents reported 4.9 more unhealthy days per month 
than the average person living in the United States. More than 80% of participants 
indicated that arthritis-related symptoms accounted for unhealthy days, and 42% reported 
that decreased physical functioning was to blame (Centers for Disease Control and 
Prevention, 2000). In a similar cross-sectional survey of 100,000 individuals with 
diabetes, 20% of whom were older adults, participants experienced 4.8 more unhealthy 
days per month than those without the disease; 76% traced unhealthy days back to 
symptoms such as fatigue, and another 32% blamed stress resulting from  
self-management of the disease (Centers for Disease Control and Prevention, 2001). 
The results of some self-management studies involving both young and older 
adults have revealed that there are specific strategies and behaviors commonly used by 
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older adults in managing a chronic disease. These self-management strategies include 
planning (Buetow, Goodyear-Smith, & Coster, 2001; Funnel & Anderson, 2004), seeking 
assistance (Funnel & Anderson, 2004), self-treatment (Buetow et al., 2001), altering 
schedules and responsibilities (Funnel & Anderson, 2004), using reminders (Yusuff, 
Olubunmi, & Bonatson, 2008), collaboration (Lewis, 2007), and intentional  
non-adherence (Lowry, Dudley, Oddone, & Bosworth, 2005). Some of these strategies 
and behaviors—seeking assistance and collaboration—are used more frequently by older 
adults than younger ones (Diaz & Herring, 2006). 
Self-management interventions specifically targeting older adults with chronic 
diseases have been implemented. Researchers conducting a meta-analysis evaluating  
self-management interventions delivered to older adults with hypertension, diabetes, and 
arthritis found strong support for the effectiveness of self-management interventions 
(particularly those based on self-efficacy theory) in improving outcomes. These 
interventions are most effective in older adults with hypertension and diabetes (Chodosh 
et al., 2005). Chodosh et al. (2005) noted in the analysis that the pool of studies reviewed, 
however, was small, and outcomes were measured over too short of a time period to 
allow for many conclusions to be made. 
Epilepsy self-management. No studies regarding the epilepsy self-management 
of older adults, including those diagnosed in older adulthood, was found in the literature. 
Researchers, however, have investigated the concerns older adults with epilepsy 
have with regard to their condition as well as their quality of life. Martin and colleagues 
(2005) completed a study with a sample of 33 older adults with intractable partial 
epilepsy in which participants were given a blank piece of paper and asked to list, in 
 70 
order of importance, any concerns they had about having epilepsy. Participants’ concerns 
were tallied. Participants listed between one and six concerns each, and 28 unique 
concerns were identified. The most frequently listed area of concern was difficulty with 
transportation (36% listed it as the primary concern), followed by concern with  
anti-epileptic drug side effects (21% listed it as the primary concern). Other prominent 
concerns included safety issues, costs of medication, and job loss (Martin et al., 2005). 
While the study conducted by Martin and colleagues (2005) provides insight into 
some of the concerns held by older adults with epilepsy, its results do not address the 
gaps in the literature related to older adults diagnosed with epilepsy in older adulthood 
that were discussed in Chapter I. First, as the authors of the Martin and colleagues (2005) 
study note, limitations of the study include that the sample included very few older adults 
on the older end of the spectrum (greater than 70 years of age) and did not focus on older 
adults diagnosed in older adulthood (only three participants were diagnosed in older 
adulthood). Thus, these results may not fully reflect the concerns of the oldest older 
adults with epilepsy and those diagnosed with the disorder late in life who are just 
learning to manage the condition. Further, the sample in the Martin and colleagues (2005) 
study was comprised only of older adults whose epilepsy was intractable, and all 
participants had partial epilepsy. Their results, then, do not reflect the concerns of older 
adults who experience fewer or less severe seizures nor those with other varieties of 
epilepsy. 
The methods used by Martin and colleagues (2005) do not qualify the study as a 
qualitative research endeavor. According to Sandelowski (2000), studies which render 
survey-type data that have not been deeply analyzed and do not provide  
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context-dependent descriptions of participants’ experiences with the phenomenon do not 
fall under the umbrella of qualitative research. Rather, the study conducted by Martin and 
colleagues (2005) would qualify more as what Sandelowski (2000) describes as 
quantitative description in which the researchers tabulate participants’ responses without 
analyzing them for context or meaning. The results of such studies do not include 
important contextual factors that can explain the presence or absence of variables in the 
sample (Sandelowski, 2000). 
The Martin and colleagues (2005) study, thus, fails to elucidate the contributing 
factors that lead to these older adults’ concerns, how they handle these concerns, how 
these concerns affect their lives, and what they need from healthcare providers in order to 
address these concerns. 
Regarding the quality of life of older adults with epilepsy, in a review of 
randomized controlled trials regarding the effect of epilepsy medications on the quality of 
life of older adults, Martin and colleagues (2003) found very little empirical evidence to 
guide the treatment of older adults with epilepsy in terms of improving their quality of 
life. Martin and colleagues (2003) noted that there exists no information regarding older 
adults’ goals for epilepsy treatment outcomes and that all available data on the topic has 
been collected from younger adults. These authors called for systematic investigation of 
the needs and preferred treatment outcomes of older adults with epilepsy. More recently, 
Laccheo and colleagues (2008) found that older adults with epilepsy have a significantly 
lower quality of life than those older adults without the disorder, though precisely what 
accounts for or contributes to this discrepancy is unclear. 
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Older adults with epilepsy, by virtue of being advanced in age, experience a number 
of physiologic and cognitive changes that can affect their epilepsy self-management 
(Boss & Seegmiller, 1981; Rowan & Ramsay, 1997). First, the pharmacokinetics of 
medications is altered in older adults. Liver and kidney metabolism are slowed with age, 
affecting drug metabolism. In older adults with epilepsy, anti-epileptic drugs are less 
bound to serum albumin than in younger adults, putting these older adults at higher risk 
of medication toxicity (Perucca, Berlowitz, & Birnbaum, 2006). Medication toxicity with 
anti-epileptic drugs is dangerous and can cause myocardial infarction, electrolyte 
disturbances, and confusion (Leppik, 2001; Rowan & Ramsay, 1997). In addition, most 
older adults do not have a single chronic disease but two or more (Centers for Disease 
Control and Prevention, 2010a). The different medications that older adults take for the 
various diseases they are managing can interact with one another, causing dangerous 
reactions or yielding anti-epileptic drugs less effective (Karceski, 2005; Leppik, 2001; 
Rowan & Ramsay, 1997). The addition of co-morbidity and co-medication to the already 
demanding treatment regimen associated with epilepsy could give rise to unique 
problems for older adults managing this disease, though no research has been conducted 
to explore how such age-related changes affect the ways in which older adults manage 
their epilepsy. 
Second, cognitive functioning, and specifically working memory and attention, 
declines with age (Sweeney, Rosano, Berman, & Luna, 2001), potentially affecting the 
ability of older adults to manage the complex treatment regimens that accompany an 
epilepsy diagnosis. Further, in nearly half of older adults with epilepsy diagnosed at or 
after age 60, the underlying cause of the disorder is a cerebrovascular accident, which is 
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associated with even further decrements in cognitive functioning (Rowan & Ramsay, 
1997). Such cognitive changes can render an already complex disease regimen even more 
difficult for an older adult with epilepsy. 
In addition, older adults with epilepsy demonstrate significantly poorer cognitive 
functioning than older adults without the condition. Martin and colleagues (2005) 
administered standard neuro-cognitive functioning tests to matched pairs of  
community-dwelling older adults with epilepsy and community-dwelling older adults 
without epilepsy. The authors found that older adults with chronic epilepsy demonstrated 
significant impairments across all measures in comparison with older adults who were 
not diagnosed with epilepsy (Martin et al., 2005). 
Finally, older adults are at increased risk for falls and other injuries as a 
consequence of advanced age (Fuller, 2000). Side effects of many anti-epileptic drugs 
taken by older adults with epilepsy, especially in conjunction with medications taken for 
other diseases and conditions, may cause dizziness, somnolence, or balance changes, 
further increasing the risk of injury in this population (Epilepsy Foundation, 2010; Krauss 
& Crone, 2001; Rowan & Ramsay, 1997). Indeed, older adults with epilepsy do 
experience more falls than older adults without the disorder (Rowan & Ramsay, 1997). 
Both the normal age-related physiologic and cognitive changes, as well as the 
cognitive decline often associated with the underlying causes of older adults’ epilepsy, 
have the potential to make the epilepsy self-management of older adults unique, and 
likely more difficult, from that of younger adults with epilepsy. Existing epilepsy  
self-management-targeted interventions do not take these unique circumstances and 
needs of older adults into account. 
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Pilot Study Findings 
In order to evaluate the feasibility of the inclusion/exclusion criteria and the 
interview guide of this study (discussed in Chapter III), a pilot study involving older 
adults diagnosed with epilepsy at or after age 60 was completed. Following Indiana 
University–Purdue University Indianapolis Institutional Review Board approval, five 
older adults (mean age 68 years; two women, three men; mean length of time since 
diagnosis 3.5 years) were recruited via self-referral from January 2010–April 2010 using 
the inclusion and exclusion criteria indicated in Chapter III. Older adults were 
interviewed face-to-face to generate the data set. Interview questions were intended to 
elicit respondents’ experiences with epilepsy self-management, including how their lives 
changed since epilepsy diagnosis, problems encountered in managing the disease, 
management strategies used, and the overall effect of the disease on daily functioning. 
Data were analyzed via the content analysis techniques detailed in Chapter III. 
Three main themes emerged: (a) perceived life changes since diagnosis,  
(b) problems, and (c) types of epilepsy self-management strategies, comprised of  
sub-themes. Respondents reported marked and mostly undesirable changes in their lives 
since being diagnosed, including lifestyle changes, changes in perceived well-being, and 
physical and emotional changes in the form of unpleasant symptoms. Respondents also 
reported problems associated with managing epilepsy, including difficulties in receiving 
a correct diagnosis, receiving inadequate education at the time of diagnosis and feeling 
unprepared for the seriousness of the disease, problems maintaining pre-diagnosis levels 
of independence, and difficulties involving medications. The use of two types of epilepsy 
self-management strategies—those aimed at managing the disease itself and those aimed 
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at managing the life changes and problems associated with having epilepsy—were 
reported. Strategies can be categorized as proactive or reactive. Four out of five 
participants reported that a significant other (three adult children, one spouse) 
consistently assist them with their epilepsy management (Miller & Buelow, 2010). 
Figure 1 provides a schematic depicting the pilot study findings. When an older 
adult is diagnosed with epilepsy, the disease and its required treatments lead to the 
experience of both major life changes and problems. The person perceives undesirable 
lifestyle, physical/emotional, and well-being changes. Each of these changes can 
influence the others. For example, the experience of the physical symptom of fatigue can 
negatively affect one’s lifestyle and thus subjective well-being. Problems with diagnosis, 
medications, and maintenance of independence also are encountered, and these problems 
influence perceived life changes. For example, difficulty maintaining independence can 
affect lifestyle by preventing the person from being active in usual social settings and can 
cause subsequent negative emotions. Epilepsy self-management strategies are aimed at 
managing perceived life changes, problems, and the disease of epilepsy and associated 
treatments. Proactive epilepsy self-management strategies are well planned, systematic, 
flexible, and generally effective. Participants tend to use more proactive strategies later 
into their diagnosis because time and experience with the disease are needed in order to 
develop them. Reactive strategies are unplanned, unpredictable, and often not effective or 
can worsen a situation. Reactive strategies are more common in the early period 
following diagnosis, though some respondents report using the strategies years following 
diagnosis. The use of epilepsy self-management strategies in turn affects the disease 
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(number of seizures experienced, exacerbations, other symptoms) and the degree or 
amount of perceived life changes and problems experienced (Miller & Buelow, 2010). 
 
Figure 1. Results of pilot study show the interrelationships of three themes of  
self-management in adults diagnosed with epilepsy at or after age 60. 
This small pilot study provides initial insight into the epilepsy self-management 
of older adults and suggests that older adults diagnosed with the disorder at or after age 
60 may have some epilepsy self-management experiences and needs and are at risk for 
certain undesirable life changes and management problems that are not all found in the 
younger adult epilepsy self-management literature. This pilot study was conducted in 
order to evaluate the appropriateness of inclusion and exclusion criteria and data 
generation and analysis proceedings discussed in the following chapter as well as to give 
the researcher experience in collecting and analyzing qualitative data. The sample of 
older adults interviewed was insufficient to result in informational redundancy, and thus, 
these findings do not address adequately the gap in knowledge identified in Chapter I. 
However, the results of the pilot study led to the addition of a research question 
concerning older adults’ experiences with being diagnosed with epilepsy. When the pilot 
study was initiated, there was no such research question or any interview questions 
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specifically pertaining to this topic. All five pilot participants, however, spoke of 
difficulties encountered after being diagnosed. Thus, a research question was added to the 
pilot study after the first two interviews were completed, and this research question also 
exists in this study. 
Summary and Critique 
State of the Science of Self-Management 
In reviewing the general chronic disease and epilepsy self-management 
literatures, as well as those specific to older adults, several conclusions can be reached 
and remaining gaps in the literature identified. 
First, there is no single definition of chronic disease self-management. While the 
concept historically has been represented in the literature as behaviors in which those 
with chronic diseases engage, more recent conceptualizations of self-management portray 
the concept as a dynamic, action-oriented, self-directed, ever-changing cognitive and 
behavioral process in which those with chronic disease engage, in the context of a family 
or other system, to manage various aspects of their disease in multiple domains of life. 
Epilepsy self-management has been conceptualized similarly, though the process, 
complex, and system-embedded nature of the concept has been recognized only recently 
and still is being integrated into epilepsy self-management researchers’ use of the 
concept. Despite self-management experts espousing that self-management is not 
amenable to direct measurement given that it is a process, researchers have attempted to 
measure directly both chronic disease self-management and epilepsy self-management as 
medication and treatment compliance and as engagement in certain behaviors. Both of 
these approaches are inappropriate given the process-like nature of self-management and 
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its conceptual components. Researchers must consider the value in characterizing, as 
opposed to directly measuring, self-management and epilepsy self-management. 
The outcomes of chronic disease self-management and epilepsy self-management 
are similar and include disease status and severity, health status and quality of life, and 
healthcare resource utilization. From the medical perspective, outcomes generally are 
measured in terms of disease status and severity, while nurse researchers are more 
attentive to other outcomes that address the ways in which living with a chronic disease 
affects all aspects of life. Researchers must begin to consider the ways in which 
developmental stages and length of time since disease diagnosis affect the pertinence of 
self-management outcomes. Factors influencing self-management and epilepsy  
self-management include contextual, internal, and external ones. Most influential appears 
to be levels of self-efficacy that, in general chronic disease self-management, have been 
shown to directly affect self-management outcomes. Less is known, however, about the 
effect of self-efficacy on epilepsy self-management. 
Conclusions that can be made regarding the effectiveness of  
self-management-enhancing interventions are limited by the small number of  
high-quality studies that have been executed, measurement of outcomes only in the  
short-term, and use of varying measurements for outcomes. While there is strong 
evidence suggesting that self-efficacy-based interventions improve self-management 
outcomes in some disease populations, the effects have not been shown to be  
long-lasting. Regarding epilepsy self-management-enhancing interventions, the literature 
on this topic is so underdeveloped that how best to improve epilepsy self-management 
outcomes is not yet known. More research is needed to determine the best way to achieve 
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improvements in both general chronic disease self-management and epilepsy  
self-management outcomes over the long-term. 
Finally, there is a complete lack of literature regarding the epilepsy  
self-management of older adults and limited literature regarding the self-management of 
general chronic disease in older adults. The effectiveness of self-management-enhancing 
interventions in improving outcomes for older adults is not known due to the small 
number of high-quality studies that have been executed to test these interventions. 
Need for Current Study 
In the United States, older adults are affected profoundly by chronic disease, 
costing the nation billions of dollars annually. One chronic condition notably affecting 
those age 60 years and older is epilepsy. Older adults are more likely than those in any 
other age group to receive a new epilepsy diagnosis. By its nature, epilepsy demands 
complex self-management, and the unique characteristics of older adults (age-associated 
physiologic and cognitive changes and the presence of multiple co-morbidities, for 
example) have the potential to make epilepsy self-management for this population 
distinct from and more difficult than that of younger adults with epilepsy. No studies 
involving investigation of epilepsy self-management of older adults, including those 
diagnosed with the condition at or after age 60, were found in the literature. The limited 
amount of research regarding the epilepsy self-management of younger persons may not 
be applicable to older adults diagnosed with the condition in older adulthood. There thus 
exists a gap in knowledge regarding the epilepsy self-management of older adults 
diagnosed with epilepsy later in life. Research, beginning with an initial description of 
this population’s epilepsy self-management experiences, must be undertaken in order to 
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inform the design of interventions aimed at improving the epilepsy self-management 
outcomes of older adults diagnosed with epilepsy in older adulthood. 
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CHAPTER III 
METHODOLOGY 
This chapter describes the research approach and methods that were used to 
examine older adults’ epilepsy self-management experiences. The chapter begins with a 
description and rationale for the research approach. Sampling methods and procedures 
then are delineated, followed by a detailed discussion of data generation, preparation, 
management, analysis, and interpretation techniques and processes. Finally, ways in 
which validity were protected throughout the study are discussed. 
Research Design 
Background and Description of the Qualitative Descriptive Method 
According to Sandelowski (2000), the qualitative descriptive method, also known 
simply as qualitative description, is a distinct qualitative research method that should be 
used when the goal of the research study is to describe phenomena about which very little 
is known. Sandelowski (2000) has described qualitative description as the “least 
theoretical” (p. 337) of the qualitative research methods, given that researchers 
employing this method, when compared to those utilizing other qualitative methods such 
as phenomenology or grounded theory, are less constrained by a priori theories or 
philosophies. Instead, qualitative description derives from the more general assumptions 
of naturalistic inquiry (Patton, 2001; Sandelowski, 2000), which is a philosophical 
orientation committed to studying phenomena in their natural states (Lincoln & Guba, 
1985). Thus, in qualitative description, in order to ensure that the phenomenon of interest 
is allowed to present itself as though it were not under study, variables of interest are not 
selected a priori, and, though targeted research questions guide data generation, analysis, 
and interpretation, the researcher must remain open to viewing the phenomenon however 
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it naturally presents itself (Sandelowski, 2000). The end product of a qualitative 
descriptive study is a data-near descriptive summary of the phenomenon that best fits the 
data and that is represented in a useful (in that research questions are adequately and 
clearly answered) way (Sandelowski, 2000). As plainly stated by Sandelowski (2000), 
researchers using the qualitative descriptive method strive to “get the facts, and the 
meanings participants give to those facts, right and then convey them in a coherent and 
useful manner” (p. 336) and achieve this goal by providing a “straight descriptive 
summary of the informational contents of data organized in a way that best fits the data” 
(p. 338). 
Though primarily a method that is focused on providing a comprehensive 
summary of events or phenomena, qualitative description also involves interpretation of 
data. That is, the end product of a qualitative descriptive study presents the data in a 
moderately (as compared to that in grounded theory, ethnographic, and 
phenomenological studies) transformed manner (Sandelowski, 2000). For example, a 
researcher seeking to describe the experiences of a particular population with a specific 
phenomenon will not simply list respondents’ experiences, as is characteristic of survey 
research, but present them in a novel and useful way (Sandelowski, 2000, 2010b). The 
descriptive summaries yielded by qualitative descriptive studies serve as valuable,  
stand-alone products and provide idiographic knowledge that can be applied directly in 
nursing practice (Sandelowski, 2000). Qualitative descriptive findings also serve as entry 
points for further, more interpretive qualitative research studies, which can influence 
intervention and instrument development. Furthermore, findings rendered from a 
qualitative descriptive study can influence immediately and directly, in some cases, 
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intervention and instrument development. Such findings, given their idiographic nature, 
also can be used to investigate unexpected findings in quantitative studies. For example, 
findings from a qualitative descriptive study can help explain why the effectiveness of an 
intervention is not equal to its efficacy (Miller, 2010; Sandelowski, 2000). 
The qualitative descriptive method is characterized by several defining features 
that are shared by all qualitative methods. Qualitative methods attempt to ascertain how 
the social world is interpreted, rely on an iterative approach to sampling, data generation, 
analysis, and interpretation, produce idiographic (as opposed to nomothetic) 
generalizations, provide an interpretive reframing of data, are characterized by a 
somewhat emergent research design, emphasize case-oriented analysis, and use data 
generating and analysis techniques that are systematic, yet flexible (Sandelowski, 2010a). 
Rationale for Approach 
The qualitative descriptive method was chosen as the most appropriate for this 
study for the following reasons: 
1. Virtually no research has been done with the population of adults 
diagnosed with epilepsy at or after age 60 regarding their epilepsy  
self-management experiences. A basic knowledge of this population’s 
epilepsy self-management experiences is needed and can be generated best 
via a qualitative descriptive approach (Sandelowski, 2000, 2010b). 
2. The purpose of the study was to explore the epilepsy self-management 
experiences of older adults, and qualitative description is appropriate for 
initial exploration of phenomena about which little is known 
(Sandelowski, 2000, 2010b). 
 84 
3. Qualitative description has been a useful first step in programs of research 
that have focused ultimately on instrument development and the 
developing and testing of interventions to improve outcomes in those with 
chronic diseases (Ferrans & Powers, 1985; McSweeney et al., 2010). 
4. The product of a qualitative descriptive study is a data-near descriptive 
summary of the informational contents of data (Sandelowski, 2000). Such 
a description provides a beginning knowledge base of what epilepsy  
self-management is comprised for older adults diagnosed with the epilepsy 
later in life and can inform future, more interpretive qualitative studies of 
the phenomenon as well as studies aimed at describing and testing the 
relationships pertinent to the phenomenon. Ultimately, the description of 
epilepsy self-management yielded by this study can inform the creation of 
interventions aimed at enhancing epilepsy self-management and its 
associated outcomes by elucidating the specific needs of older adults with 
epilepsy. 
5. Utilization of a combination of Sandelowski’s (2000, 2010b) and Patton’s 
(2001) approaches to the method involves a systematic, step-by-step 
process, providing a beginning qualitative researcher with enough 
structure to reduce the likelihood of premature closure to analysis and 
threats to validity (Sandelowski, 1993). 
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Sample 
Sampling Method: Purposeful Sampling 
In a qualitative descriptive study, the goal of sampling is to obtain  
information-rich cases—that is, respondents who have experience with the phenomenon 
of interest. As per Sandelowski’s (2000) and Patton’s (2001) recommendations for 
qualitative descriptive sampling techniques, recruitment of respondents was achieved via 
purposeful sampling. When using this method, the researcher purposefully chooses 
respondents who have experienced and have knowledge of the phenomenon (Patton, 
2001). The number of respondents needed to describe the phenomenon could not be 
predicted a priori and was based on the point at which informational redundancy was 
reached (Patton, 2001). Participants were recruited purposefully based on sampling needs 
that emerged throughout analysis (Sandelowski, 2010a). 
Inclusion/Exclusion Criteria 
Inclusion criteria for older adult participants consisted of the following:  
(a) diagnosis of epilepsy at or after age 60 years, (b) diagnosis of epilepsy at least six 
months prior to recruitment into the study, (c) prescription of at least one anti-epileptic 
drug, (d) community-dwelling, (e) able to speak and read English, and (f) able and 
willing to share epilepsy self-management experiences. Exclusion criteria included the   
(a) presence of a space-occupying lesion as the etiology of epilepsy and (b) cognitive 
impairment resulting in the inability to understand or answer questions related to epilepsy 
self-management. 
Only those individuals diagnosed with epilepsy at or after age 60 were included 
because this was the target population of interest. Those who were diagnosed fewer than 
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six months before the time of recruitment into the study were excluded because, being 
very early in their disease course, these persons may not have been able to articulate their 
self-management experiences. Older adults having epilepsy but who were diagnosed 
earlier in life were excluded because they have lifelong experiences with epilepsy  
self-management, which could influence their epilepsy self-management as an older 
adult, and the focus of the study was on investigating the self-management of adults 
managing the disease beginning in older adulthood. The inclusion of a prescription of at 
least one anti-epileptic drug was necessary because the vast majority of older adults with 
epilepsy are treated with at least one anti-epileptic drug. Respondents included in the 
study were limited to those living in the community because those in inpatient, extended 
care facilities are not practicing self-management as it is defined conceptually in the 
study. Older adults living in assisted living communities (those in which residents live in 
their own homes, condominiums, or apartments and receive various types of assistance 
with yard work, transportation, and delivery of meals but not 24-hour medical or nursing 
care) were considered to be community-dwelling and were not excluded. Those with 
operable or terminal space-occupying lesions serving as the cause of epilepsy were 
excluded because their epilepsy is potentially transient, and the focus of the study was on 
the self-management of chronic epilepsy. Such an underlying condition also could prove 
terminal, in which case chronic disease self-management would not be applicable. Those 
with a degree of cognitive impairment preventing them from understanding or answering 
questions were excluded to ensure successful data generation. 
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Table 1 
Inclusion and Exclusion Criteria 
Inclusion Criteria Exclusion Criteria 
Age 60 or older 
Diagnosed with epilepsy at or after age 60 
Community-dwelling 
Prescribed at least one anti-epileptic drug 
Speak and read English 
Willing to share epilepsy self-management 
experiences 
Presence of operable or terminal  
space-occupying lesion as etiology of 
epilepsy 
Cognitive impairment preventing the 
person from understanding and 
answering interview questions 
Sample Size 
According to both Sandelowski (1995b) and Patton (2001), sample sizes in 
qualitative research cannot be ascertained a priori. In her article describing proper 
sampling in qualitative research, Sandelowski (1995b) warns against the use of sample 
sizes that are either too small to support plausibly the notion of informational redundancy 
or are too large to allow for the deep, case-oriented analysis that is the hallmark of 
qualitative research. Sample size in qualitative research should be based on the data and 
should not be pre-determined (Sandelowski, 1995b). Thus, no pre-determined sample 
size was used. Rather, sampling was based on ongoing data analysis findings. Sampling 
efforts continued until informational redundancy was reached (Sandelowski, 1995b). The 
final sample size, including the 5 participants from the pilot study, was 20. 
Recruitment 
Following approval of the study from the Indiana University–Purdue University 
Indianapolis Institutional Review Board (Appendix B), respondents were recruited from 
April 27, 2011, to July 22, 2011. The five participants recruited during the pilot study 
were recruited between January 2010 and April 2010, and all were recruited via  
self-referral based on advertisements (Appendix C) placed in three private neurology 
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offices in Bloomington, Indiana. Recruitment of the remaining 15 participants took place 
via collaboration with a private Bloomington, Indiana, neurology practice, Neurology 
Specialists. The physicians or their designees at Neurology Specialists identified patients 
under the care of the providers at their office who were potential participants for the 
study. The names, addresses, and phone numbers of any patients who were age 60 or 
older, had a diagnosis of epilepsy that was given at or after that age, and who were 
prescribed an anti-epileptic medication were provided to the researcher via encrypted  
e-mail. The total sampling pool consisted of 122 older adults. Potential participants were 
mailed physician-signed letters (Appendix D) informing them of the study. This letter 
explained to potential participants the purpose of the study, a description of what was 
involved in taking part in the study, and notification that a nurse researcher would contact 
them via telephone within a few days to provide them with more information about the 
study. The letter included a phone number that potential participants could call if they did 
not want to be contacted regarding the study; it also informed potential participants of the 
voluntary nature of the study and that taking part or not taking part would not affect the 
care they received from their neurologist. 
As discussed previously, sampling in a qualitative descriptive study is determined 
by ongoing analysis findings, with the goal being the attainment of informational 
redundancy (Sandelowski, 1995b). In addition, ongoing data analysis led to the need for 
variation in the sample in terms of the gender and geographical location. Thus, letters 
were not mailed to all 122 potential participants, and mailings of letters were staggered. 
This strategy served two purposes. First, it allowed time for the researcher to become 
engaged in data analysis of early interviews and to render preliminary findings that 
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informed later recruitment and data collection efforts. Second, it allowed the researcher to 
more purposefully sample participants. For example, when it was determined that the 
experiences of more men were needed, the researcher was able to mail letters to a group 
of male potential participants. 
Figure 2 depicts the detailed recruitment activities executed by the researcher. A 
total of 46 letters were mailed in three installments: April 19 (20 letters), June 26 (18 
letters), and July 12 (8 letters), and the potential subjects to whom the letters were mailed 
were based upon analytical findings and emerging sampling needs (Sandelowski, 1995b). 
The recipients of the initial 20 letters were selected randomly by the researcher from the 
sample pool because it was known, based on the criteria upon which the members of the 
sample pool were identified, that they all had experience with the phenomenon of interest 
(Sandelowski, 1995b). The first 20 letters were sent to 12 women and 8 men. Potential 
participants to whom letters were mailed in the subsequent two installments were selected 
purposefully based on initial data analysis findings. For instance, in the second 
installment, the researcher purposefully chose to send letters to potential participants 
living in more secluded, rural areas because findings from early interviews suggested that 
participants living in such areas had experiences distinct from those living in more urban 
areas. In installment three, male participants were targeted because their experiences 
seemed distinct from those of women, but the researcher had not yet met redundancy 
regarding those findings. Table 2 depicts the demographic characteristics (in terms of 
gender and geographical location) of potential participants receiving letters during each 
installment.  
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Table 2 
Demographic Characteristics of Those Receiving Letters 
Installment Male Female Rural City-Dwelling 
1   8 12   7 13 
2 10   8 12   6 
3   8   0   5   3 
Within 72 hours of letter disbursement, the researcher began making phone calls 
to potential participants. The purpose of these calls was to determine if potential 
participants were interested in receiving more information about the study, screening 
interested participants for inclusion and exclusion criteria, describing study procedures to 
those interested participants meeting inclusion criteria, and scheduling a meeting for a 
face-to-face interview for data generation. In some cases, potential participants called the 
researcher (via the phone number provided in the letter) expressing interest in taking part 
in the study prior to the researcher contacting them. 
One participant contacted the researcher to express a desire not to be contacted. A 
total of 38 phone calls were made by the researcher. Twelve potential participants called 
by the researcher were unable to be reached. Three participants called the researcher 
expressing interest in participating. Of the 29 potential participants with whom the 
researcher spoke, 10 declined to participate and 4 were unable to participate as a result of 
failing inclusion and exclusion criteria. Thus, the refusal rate for the study was 36%, and 
approximately 14% of potential participants spoken to by the researcher were unable to 
participate as a consequence of failing to meet inclusion criteria. Thus, 64% of eligible 
older adults who were contacted by (or contacted) the researcher agreed to participate. Of 
note is that following the cessation of recruitment efforts in July of 2011, the researcher 
received phone calls from four potential participants the researcher had been unable to 
 91 
reach or who had not yet been called expressing interest in participating. These potential 
participants were informed that the study was closed to recruitment. 
All participants were screened over the phone regarding inclusion and exclusion 
criteria. Current age, age at epilepsy diagnosis, length of time since epilepsy diagnosis, 
and anti-epileptic mediation status were collected via verbal report from potential 
participants. Cognitive functioning was assessed via the Six-Item Screener for Cognitive 
Impairment (Callahan, Unverzagt, Hui, Perkins, & Hendrie, 2002). Respondents making 
three or more errors during the cognitive screening (n = 2) were excluded from the study 
(Callahan et al., 2002). Two additional potential participants were excluded as a result of 
having been diagnosed with epilepsy prior to age 60. 
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Figure 2. Flowchart demonstrates the recruitment activities for the study. 
The details of study procedures were explained to all older adults who met 
inclusion criteria and who wished to participate (n = 15). Participants were told that they 
would meet with the researcher once, in a private location of their choosing, and that 
following the attainment of informed consent, demographic data would be collected. 
Participants also were informed that they would be completing the Mini Mental Status 
Examination (Folstein, Folstein, & McHugh, 1975) and that it would be an  
audio-recorded interview. Finally, participants were told that they would receive a $20 
Wal-Mart gift card as a token of appreciation if they chose to be in the study. The 
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researcher then scheduled a face-to-face interview with each participant for data 
generation. Fourteen interviews were completed in individual participant homes, while 
one participant was interviewed at a conference room in the local library. 
Ethical Considerations 
Efforts were taken throughout the recruitment, data generation, and data analysis 
phases of the study to ensure the protection of human subjects. The researcher and her  
co-investigators (e.g., dissertation committee) had each previously successfully 
completed the human subjects protection course at the Indiana University  
Purdue–University Indianapolis campus prior to beginning recruitment procedures. No 
sampling or recruitment activities occurred until the study had been approved by the 
university’s institutional review board. 
The utmost care was taken during the recruitment process to protect potential 
participants’ confidentiality. The names, phone numbers, and addresses that were 
provided to the researcher from the staff at the neurology practice were sent via encrypted 
e-mail. This e-mail could not be forwarded, and the contents were never printed. The 
contents remained on the researcher’s password-protected computer and were deleted 
after the completion of recruitment efforts. 
The recruitment letter sent to potential participants clearly explained the voluntary 
nature of the study and explained that the health care provided to potential participants 
would in no way be affected by any decision to take part or not to take part in the study. 
In addition, participants were provided with a phone number to call in the event that they 
should not want to be contacted by the researcher concerning the study. 
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The researcher conducted all interviews in private, quiet areas. Informed consent 
was obtained from all participants (Appendix E) immediately prior to data collection. 
Participants again were informed that participation in the study was voluntary and that 
they could withdraw at any time without consequence. In addition, participants were told 
that they could choose not to answer any interview questions that made them 
uncomfortable. 
All audio-recorded data were deleted immediately after interviews were 
transcribed. Each participant was assigned a number, which appeared on his or her 
transcript. Names of and other identifying information about participants were not 
included in any transcripts, and signed consent forms were kept separately from all data. 
The transcribed interviews and other data collected (demographics, for example) were 
kept on a password-protected computer accessible only to the researcher. Transcripts 
were not printed, and were shared only with co-investigators via secure e-mail. 
Data Generation 
Instrumentation 
Semi-structured interview. The goal of data generation in a qualitative 
descriptive study is to generate information regarding participants’ experiences with the 
phenomenon, especially surrounding the specific research questions guiding the study, in 
their own words. Sandelowski (2000) suggests that the most appropriate means for 
achieving this goal is via the use of minimally to moderately structured interviews. Thus, 
face-to-face interviews were the primary means by which data were generated in this 
study. Sandelowski (2000) and Patton (2001) note that, while the precise way in which 
each participant is interviewed likely will vary, in order to create a comparable dataset 
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(Sandelowski, 2010a), the structure and basic content of the interview should be planned 
a priori. Therefore, before data generation was initiated, the researcher created interview 
questions that were used to direct data generation with participants. However, given the 
iterative nature of qualitative research, the structure and content of the interview changed 
for subsequent participants based on ongoing analyses. The development of the interview 
guide is discussed later in this section. 
Patton (2001) specifies three types of qualitative interviewing: conversational, 
guided, and semi-structured. Conversational interviews are unstructured, informal, and 
similar to normal conversation. A guided interview technique involves preparing a list of 
topic areas about which the interviewer wants to ask but does not involve the use of  
pre-written questions. Semi-structured interviewing is characterized by the use of  
pre-planned interview questions and probes. When using any of these interview 
techniques, all questions asked are open-ended (Patton, 2001). Patton (2001) notes that 
the majority of the time a combination of these three approaches is necessary, and a 
combination approach was used in the proposed study. 
Semi-structured interview questions were developed based on the research 
questions guiding the study. Table 3 identifies all semi-structured interview questions that 
were used and includes a rationale for the inclusion of each question. Questions that were 
added to the interview guide as a result of ongoing analyses also are included in Table 3. 
These questions served as the initial means of generating data during interviews. All 
questions were open-ended in order to allow participants to fully describe their 
experiences (Patton, 2001). Probes, as described by Patton (2001), were used to generate 
full and rich descriptions from participants. Conversational interviewing was used 
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throughout the interviews based on participants’ answers. For example, if a participant 
began to describe an experience about which the researcher had not planned on asking 
but it was pertinent for that person’s experiences with epilepsy self-management, 
impromptu questions were asked in order to facilitate the participant’s full description of 
the experience. Finally, an interview guide was used (see Table 4). Pertinent topics were 
listed on the guide, ensuring that before the close of the interview all important topics 
were addressed. Also, as the content of the interview changed based on ongoing analyses, 
topics were added to the list. Because the importance of precise aspects of these evolving 
topics based on data analyses was not always apparent at first, no semi-structured 
questions were written for them. Rather, the new topics added to the guide were explored 
conversationally with subsequent participants. The researcher checked off these items 
during the interview and reviewed the list prior to the close of the interview to ensure that 
all pertinent topics were addressed. 
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Table 3 
Interview Questions and Rationale 
Interview Question Rationale 
Can you describe the process of how you were diagnosed 
with epilepsy?
a
 
Was it a good experience, why or why not? How long did it 
take to be diagnosed? Do you feel the provider prepared you 
for self-managing your epilepsy?
b
 
Research Question 1 
How has your life changed since being diagnosed with 
epilepsy?
a
 
How do you feel about the changes you have experienced? In 
terms of being able to do what you want to do, tell me how 
your life is different now, if at all, than before epilepsy. Can 
you describe a typical day for yourself now, and how your day 
might have been different prior to being diagnosed with 
epilepsy?
b
 
Research Question 3 
Table continues 
  
9
7
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Interview Question Rationale 
Can you tell me about specific things that you or you and 
your family do on a regular basis to manage your 
epilepsy?
a
 
How do you access your medications? How do you remember 
to take them? How do you handle transportation? Is there 
anything that you do to prevent/control a seizure? Can you 
describe steps you take to make sure that you keep your 
commitments?
b
 
Research Question 4 
What problems have you experienced since being 
diagnosed with epilepsy?
a
 
Have you experienced problems directly related to the 
management of your epilepsy? Have you experienced problems 
that you feel are a result of having epilepsy?
b
 
Research Question 2 
Can you describe a situation for me related to your 
epilepsy that went very well?
a
 
What about the situation made it go well?
b
 
Research Question 4 
Can you describe a situation for me related to your 
epilepsy that did NOT go well?
a
 
What about the situation made it not go well? What would you 
have done differently?
b
 
Research Question 4 
Table continues 
  
9
8
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Interview Question Rationale 
What do you hope to achieve in self-managing your 
epilepsy?
a
 
What outcomes are most important to you?
b
 
Research Question 5 
Is there anything else you would like to share with me 
regarding your epilepsy, how you manage it, or how it has 
affected your life?
a
 
This item ensured that participants discussed all topics important 
to them. 
What information do you wish you had received at the time 
you were diagnosed?
a
 
This item was added because participants reported not receiving 
enough information at the time of diagnosis. 
Have you used any outside sources to find information 
about your condition?
a
 
Do you use the Internet? Do you use the library? Do you rely 
on others to help you?
b
 
This item elicited additional information about how participants 
sought the information they did not receive at the time of 
diagnosis. 
Do you feel comfortable telling others about your 
condition?
a
 
Do your friends and family know that you have epilepsy? Why 
or why not?
b
 
This item was added because several participants spoke of not 
telling family/friends due to embarrassment, while others were 
very open with their family/friends about their epilepsy. 
Table continues 
  
9
9
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Interview Question Rationale 
Do you ever self-adjust your seizure medication?
a
 
Why do you self-adjust your medication? Do you tell your 
doctor about these adjustments?
b
 
This item was added after the sixth interview because three 
participants mentioned self-adjusting seizure medication. 
Does having epilepsy differ from having (another chronic 
disease). If so, how and why?
 a
 
This item was added when it was noted that participants had 
different views of epilepsy than of their other chronic conditions. 
a
Indicates a question added during the study. 
b
Indicates a common probe. 
1
0
0
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Table 4 
Interview Guide 
Topical Guide 
Diagnosis 
Strategies 
Medications 
Changes 
Problems 
Outcomes 
Comparison with other conditions
a
 
Informational sources
a
 
Information needed
a
 
a
Topic added during the study 
In favor of post-data generation member checks, Sandelowski (1993) and 
Maxwell (1992) suggest the use of active confirmation and summarization of 
participants’ experiences during the interview process. Thus, throughout the interviews, 
the researcher confirmed with participants that she was hearing and interpreting their 
experiences correctly via providing summary statements at appropriate intervals and 
seeking clarification when needed. In the event that a participant’s response was not 
heard or interpreted accurately, the question was revisited. 
Throughout each interview, field notes and memos consistently were taken and 
made (Lincoln & Guba, 1985) describing observations that could not be captured on the 
audio-recording. For example, a respondent’s facial expressions, gestural movements, or 
emotional responses all were potentially important in fully describing participants’ 
experiences, and thus, were recorded via field notes and memoranda. Doing so and 
ensuring that such memos and field notes were included in transcripts helped ensure both 
descriptive and interpretive validity (discussed later in this section) of the study 
(Maxwell, 1992) and maintenance of an audit trail (Rodgers & Cowles, 1993). Field 
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notes and memoranda also were taken throughout the interview of any of the researcher’s 
initial thoughts and reactions to the respondent’s answers. As well, immediately 
following each interview, the researcher wrote down initial reactions and reflections 
about the interview. These reflections were kept in a reflective journal (Rodgers & 
Cowles, 1993; Sandelowski, 1993) and used as part of the audit trail, which was 
maintained to ensure descriptive and interpretive validity. 
Mini Mental Status Exam. Participants also completed the Mini Mental Status 
Exam (Folstein et al., 1975; see Appendix F). The purpose of the use of this tool was to 
allow the researcher to describe the participants in the sample in terms of cognitive 
functioning given the advanced age of the participants, as well as the presence of a 
condition (epilepsy) that can alter cognitive functioning. Because of the small sample 
size, the study was underpowered to make statistical correlations with data yielded from 
this tool. 
The Mini Mental Status Exam (Folstein et al., 1975) is a 30-item questionnaire 
used to assess cognitive status. There is substantial support for the reliability and validity 
of this instrument in both younger and older adults (Mitrushina & Satz, 2006). This 
questionnaire takes approximately 10 minutes for respondents to complete and assesses 
various cognitive functions including memory, orientation, language, complex 
commands, registration, attention and calculation, repetition, and recall. A score of 25 
points or higher (out of 30 possible points) is a reflection of normal cognitive 
functioning. A score of 21–24 points is indicative of mild cognitive impairment, while a 
score of 10–20 points suggests moderate cognitive dysfunction. A score of nine or below 
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is indicative of severe cognitive impairment (Folstein et al., 1975). Of note is that this 
questionnaire was not administered to participants taking part in the pilot study. 
Demographics. A demographic form (Appendix G) was used to collect the 
following demographic data from participants: gender, age, race, number of  
co-morbidities in addition to epilepsy, marital status, years of education, type of seizures 
(partial, grand-mal, or other), years since epilepsy diagnosis, years of school, 
employment status (working or retired), living situation (alone or with another), assistive 
significant other (yes or no), insurance coverage (Medicare, private, or none), and annual 
income (≤$20,000; $21,000–$40,000; $41,000–$60,000; $61,000–$100,000,  
and >$100,000). 
Setting and Procedures 
All data collection took place via face-to-face meetings with participants. 
Participants chose the setting in which they wanted to be interviewed, and 14 of them 
chose their homes, while one chose a private conference room in a local library. All 
interview settings were private and quiet. Prior to any data collection or generation, 
informed consent was obtained from each participant. A copy of the informed consent 
statement was given to each participant. Authorization for the release of health 
information also was obtained from each participant, and a copy of the authorization was 
given to each participant. After the attainment of informed consent and authorization for 
the release of health information, each participant was given a $20 Wal-Mart card. The 
researcher then collected demographic data from the participant. In order to capture 
potentially pertinent background information from the participants, the digital  
audio-recorder was turned on at this time (Sandelowski, 2010b). After the demographic 
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data was collected (except in the case of each pilot participant), the researcher 
administered the Mini Mental Status Exam (Folstein et al., 1975). 
Following completion of the Mini Mental Status Exam (Folstein et al., 1975), it 
was explained to each participant that the interview would start at that time. Participants 
were reminded that they were not required to answer any question that made them feel 
uncomfortable, and that they could withdraw from the study at any time. Each interview 
opened with a staging commentary (Miles & Huberman, 1994) during which the 
researcher briefly reminded the participant of the purpose of the interview, the nature of 
the interview questions, and that the participant should feel free to provide any additional 
information that he or she felt was important. The interview commenced using the  
semi-structured interview questions described in Table 3. Probes and conversational 
interviewing were used in all interviews based on participants’ responses to  
semi-structured questions (Patton, 2001). Interviews ranged in length from 40 minutes to 
two hours, and all consented participants completed all data collection and generation 
procedures. 
Data Preparation, Management, and Analysis 
Raw qualitative data must be analyzed in order for the researcher to render an 
interpretation of the data (Sandelowski, 1995a). Sandelowski (1995a) describes data 
analysis as the process by which generated data are broken up or down in a way that 
allows the researcher to see the data in a new way—a means to knowledge production 
involving the separation of elements of data according to, in the case of qualitative 
description, a data-derived system. Prior to being analyzed, however, data must be made 
docile to analysis (Sandelowski, 1995a, 2010a). That is, data must be prepared and 
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managed in a way that allows the researcher to look for things in the data. Sandelowski 
(1995a) notes that data preparation and management occur somewhat concurrently with 
data analysis. Preparing data for analysis, for instance, often will spur thoughts about and 
evaluations of data—a rudimentary type of data analysis (Sandelowski, 1995a). To 
facilitate clarity among the different processes, data preparation and management and 
data analysis activities are discussed and described in this chapter as separate activities, 
though it is acknowledged that they occurred somewhat simultaneously.  
Data Preparation and Management 
Data preparation occurred via transcribing interviews verbatim into Microsoft 
Word™ in order to preserve all elements of the interviews as much as possible 
(Sandelowski, 1995a). All interviews were transcribed by the researcher, a practice that 
assists a beginning qualitative researcher in becoming very familiar with the data 
(Sandelowski, 2010b). All spoken words from each interview were transcribed, and lines 
were numbered to assist with later analysis. According to Sandelowski (2010a), the use 
of a legend in transcribing interviews is necessary to protect descriptive validity. Thus, a 
legend was used in order to describe aspects of the interview that cannot be typed, such 
as pauses in a respondent’s speech. For example, the researcher inserted a hyphen for 
every second that a pause in the recording existed. A pause lasting three seconds, then, 
was represented as “---.” A similar system was utilized for periods of the recordings that 
were inaudible or could not be deciphered. Following transcription, the researcher 
proofread all transcripts for accuracy to support descriptive validity, as well as added 
pertinent field notes, memoranda, and reflections to each transcript in order to protect 
interpretive validity. 
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Data management refers to the ways in which the researcher organizes data to 
allow for easy access of the data, as well as maintenance of an appropriate audit trail 
(Sandelowski, 2010a). It is necessary to, a priori, establish a system for managing and 
organizing all data as doing so will not only facilitate the process of data analysis but also 
will allow for auditability of study proceedings and thus protection of validity 
(Sandelowski, 2010a). This system was established prior to the execution of the study. 
The following discussion pertains to the ways in which data were managed throughout 
generation and analysis and also articulates the ways in which other types of information, 
such as those contributing to the audit trail, were managed. 
Using Microsoft Windows™ and Microsoft Word™, a folder was created for 
each participant. Each participant’s transcript as well as any analysis documents 
pertaining to that transcript was placed in the folder. Such a system allowed for 
organization and easy retrieval of each respondent’s materials (Sandelowski, 2010a). 
A proper audit trail was maintained via the use of guidelines suggested by 
Rodgers and Cowles (1993) and Miles and Huberman (1994). The audit trail was kept to 
provide a record of all of the significant decisions and analytic proceedings that occurred 
throughout the study and led to the transformation and interpretation of raw interview 
data (Sandelowski, 1993). According to Rodgers and Cowles (1993), in creating an audit 
trail, four different types of documentation must be maintained throughout a qualitative 
study: contextual, methodological, analytic, and personal response. Contextual 
documentation refers to the researcher’s descriptive accounts during data collection (field 
notes and memoranda). The field notes and memoranda recorded during data generation 
were added to each respective transcript in the appropriate places using Microsoft 
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Word’s™ track changes functionality. For example, if it were noted that a respondent 
closed his or her eyes or looked away while answering a certain question, the researcher 
inserted a comment containing this information next to the response during in which it 
occurred. Methodological documentation refers to documentation of all methodological 
decisions made throughout the study. As previously mentioned, qualitative research, 
qualitative description included, relies on an emergent research design. Any 
methodological decisions that are made—such as a change in the structure or content of 
the interviews—were noted with specific rationale for the change, the date on which the 
change was made and any other pertinent information, then was placed in a separate 
methodological documentation folder. A running log of such methodological changes and 
decisions was kept throughout the study (Rodgers & Cowles, 1993). 
Analytic documentation refers to maintaining a record of the researcher’s thought 
processes in sorting, categorizing, and comparing data, and conceptualizing patterns 
found in the data (Rodgers & Cowles, 1993). Analytic documentation occurred in several 
forms. First, a standardized analytic log similar to that offered by Miles and Huberman 
(1994) was maintained for each respondent. Table 5 is an excerpt from the analytic log 
used for a participant in the study. This log was updated each time analysis proceedings 
were performed on a respondent’s transcript. After each analytic session, the investigator 
recorded in the log, for each transcript analyzed, the date, a brief summary of data 
analysis activities that occurred (i.e., spent time reading the transcript and getting the 
essence of the case; extracted facts from the case; began initial coding), decision rules 
followed during coding, conclusions drawn, rationale for conclusions, and researcher 
comments regarding reflection on the data analysis session (Miles & Huberman, 1994). 
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Table 5 
Excerpt from Analytic Log 
Participant Date Analytic Activities Conclusions 
2A 4/29 Read over transcript to get 
a sense of it. 
None made—initial pass. 
2A 5/4 Getting a sense of the 
whole. Continue reading 
transcript to get a sense of 
the whole. 
Summary typed up. 
2A 5/9 Continuing to read over 
summary and the 
transcripts. 
Beginning to extract facts. 
2A 5/18 Deeper  
analysis—extracting facts 
and working on a time 
line. Initial codes 
identified. 
Important facts extracted, 
time line made, very rough 
codes begun. Lack of 
awareness about the 
possibility of having epilepsy 
as an older adult is emerging. 
2A 5/24 Dimensionalized timeline, 
finished coding. 
Major finding today was that 
epilepsy is different for  
him—it’s different than his 
other diseases. 
2A 6/1 Beginning cross case 
analysis with 1A and 2A. 
Most codes are there in both 
cases, but 2A seemed to be 
diagnosed more easily than 
1A. 
In addition to the maintenance of individual respondent analytic logs, a more 
general analytic log also was kept via a Microsoft Word™ document and placed in a 
separate folder. Rodgers and Cowles (1993) suggest the use of this type of log to develop 
a history of the data analysis processes and their progression. The researcher documented 
in this log on at least a weekly basis or following significant analytic moves or changes. 
For example, the researcher documented when patterns began to emerge into themes, 
how current themes accounted for existing data, new paths of analysis that needed to be 
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explored, and quotes that supported current conclusions. Data displays and enumeration 
charts used as part of analysis (discussed later in this section) as well as the coding guide 
with decision rules (discussed later) also were included in this log, complete with 
comments regarding the ways in which the information in them supports analytic 
decisions. Finally, as previously mentioned and as is described in detail later in this 
section, different versions of each transcript created as part of data analysis (for example, 
the abstract summaries of each transcript that were created as part of initial data analysis) 
were maintained in each respondent’s folder. 
Personal response documentation refers to the recording of the researcher’s 
personal feelings and reflections throughout the study. As previously mentioned, 
immediately following each interview, the researcher documented in a reflective journal 
the thoughts, feelings, and reflections about the interview. During the period of active 
data generation and analysis, pertinent thoughts and reflections about the study as a 
whole also were documented regularly. The documentation of such information, though 
personal in nature, often proves an integral part of the audit trail and can serve to help 
support and verify research interpretations in ways that are not captured in the 
descriptions of only contextual, methodological, and analytical occurrences (Rodgers & 
Cowles, 1993). 
In summary, data preparation strategies were used to ensure that data were made 
amenable to analysis. Data were prepared via verbatim transcription of interview data 
using legends. Transcripts were checked for accuracy and pertinent field notes and 
memoranda were infused into each transcript. Data management strategies were utilized 
to maintain an organized data set, facilitate efficient access to data, and to maintain a 
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proper audit trail, which helped to ensure the descriptive and interpretive validity of final 
interpretations. Management was achieved by organizing transcripts, as well as 
appropriate contextual, methodological, analytic, and personal response documentation, 
in separate folders using Microsoft Word™ and Microsoft Windows™. 
Data Analysis 
Data analysis refers to the process by which the researcher reconfigures (or “plays 
with”) the raw data so that he or she can go from looking at data to looking for something 
in the data (Sandelowski, 1995a). Data analysis began once the first transcript was 
prepared and remained ongoing and concurrent with data generation/preparation until 
informational redundancy was reached. The researcher utilized analysis techniques as put 
forth by Sandelowski (1995a, 2000). Case-oriented, as opposed to variable-oriented, 
analysis of data occurred via the use of conventional content analysis as described by 
Hsieh and Shannon (2005). In the following sections, key features of the data analysis 
process as it occurred are discussed. These analysis proceedings occurred in tandem with 
continued recruitment and data generation. 
Case- versus variable-oriented analysis. Before discussing the specific analytic 
activities that occurred in the study, it is important to differentiate between case- and 
variable-oriented analyses because all analysis procedures took place in a case analysis 
context. Sandelowski (1996) asserts that, above anything else, qualitative researchers are 
obliged to make sense of individual cases—to understand the particulars in the  
all-together. To meet this goal requires the use of case-oriented, as opposed to  
variable-oriented, data analysis. Thus, case-oriented analysis was employed in all data 
analysis procedures in the study. Variable-oriented analysis, which is the hallmark of 
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quantitative research, is characterized by the study of disaggregated variables from many 
cases so that the relationships between the variables can be examined to explain 
variability among the different cases (Sandelowski, 1996). The goal of the researcher in 
qualitative research, however, is to understand the overall essence of individual cases. In 
case-oriented analysis, what Sandelowski (1996) calls the features of the cases are treated 
as an “ensemble” (p. 526) rather than being separated into variables. While the  
variable-oriented approach seeks to determine how different variables influence each 
other, the case-oriented approach is concerned more with the confluence of features and 
how they shape the experience for respondents. This case-oriented approach is necessary 
in order to arrive at the generalizations that are the goal of qualitative research—not 
nomothetic generalizations, which are the interest of quantitative researchers, but 
idiographic generalizations (Sandelowski, 1996). 
According to Sandelowski (1995a, 1996), it is necessary to analyze each case 
individually prior to making across-case comparisons. Making across-case comparisons 
prior to individually analyzing each case is premature and can yield superficial results 
that lack credibility, which threatens interpretive validity. Thus, in the study, all cases 
initially were analyzed individually, using the guidelines described later in this section, 
prior to across-case analysis occurring. Doing so allowed the researcher to become 
sensitized to features that appeared important in individual cases and thus to determine if 
the same features were important across all cases (Sandelowski, 1996). It also ensured 
that outlying features unique to respondents’ variable experiences were not lost (Ayres, 
Kavanaugh, & Knafl, 2003). Across-case analysis occurred by comparing analytic 
findings from individual cases of older adults with those of the other older adults. The 
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precise way in which these across-cases analyses occurred was emergent (Ayres et al., 
2003) and was based on findings from initial case analyses. As is described later in this 
section, all transcripts initially were coded using the research questions as a guiding 
framework. After all individual cases were coded in this manner, the findings from each 
case, for each question, were compared and contrasted across cases in the dataset to find 
patterns, as well as aberrant findings, in the across-case data (Ayres et al., 2003). 
Initial steps. In her article, “Qualitative Analysis: What it is and How to Begin,” 
Sandelowski (1995a) provides direction for novice qualitative researchers in how to 
begin analyzing their data. Sandelowski (1995a) suggests that the following steps be 
taken when beginning the analysis of qualitative data: getting a sense of the whole, 
extracting the facts, identifying key topics/storylines and dimensionalizing them, and 
using frameworks to reduce data. In a later publication related specifically to data 
analysis via content analysis in qualitative description, Sandelowski (2000) again 
supports the use of these initial techniques; therefore, they were used to guide the initial 
analysis steps in this study. 
Getting a sense of the whole. According to Sandelowski (1995a), the initial 
efforts involved in data analysis should be focused on understanding each transcript as a 
whole prior to developing a consistent approach to accounting for the data. The 
researcher, treating each case as individual and worthy of study, should read each 
transcript as many times as is necessary for him or her to understand its essential features. 
A summary or abstract of each case should be composed then—the purpose of which is 
to provide the researcher with a quick, yet descriptive, glance of the essential features of 
the transcript, and thus the respondent’s experiences (Sandelowski, 1995a). Following 
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proper data preparation of each transcript, therefore, the researcher spent time reading 
each transcript once, very carefully, in order to capture its essence. The researcher 
avoided, as Sandelowski (1995a) suggests, underlining and line-by-line coding during 
this process because doing so can interfere with the ability to grasp the essence of the 
case (Sandelowski, 1995a). For each transcript, the researcher composed a descriptive 
summary that represented the main features of the case. These summaries were placed in 
individual participants’ analysis folders. 
Sandelowski (1995a) suggests that after getting a sense of the whole for each 
case, a more disciplined approach—one that can be applied systematically to all data—is 
needed. As was mentioned previously and will be discussed more thoroughly later in this 
chapter, each technique and all rules that were applied to data during analysis were noted 
in the analytic log as well as changes to analytic techniques and rules as they were made, 
along with supporting rationale for those changes. Sandelowski (1995a) suggests the use 
of three initial techniques that often prove helpful for organizing data—extracting the 
facts, extracting and dimensionalizing storylines, and using frameworks to reduce data. 
All of these techniques were utilized during initial analysis. 
Extracting the facts. Sandelowski (1995a) suggests, once each transcript has been 
carefully read and summarized, using the technique of extracting the facts from each case 
that are likely to be important in contextualizing respondents’ stories. Thus, for each case, 
the researcher extracted facts such as length of time since epilepsy diagnosis, type of 
epilepsy, presence of other co-morbidities, and other factors that appeared pertinent to the 
telling of respondents’ stories. In staying consistent with case-oriented analysis, facts 
were extracted on a case-by-case basis. Sandelowski (1995a) recommends creating, based 
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on these extracted facts, event histories for all respondents by plotting factual information 
for each respondent on a timeline. Such timelines were made for each participant.  
Figure 3 demonstrates a sample timeline that was constructed during analysis. Timelines 
were referred to throughout data analysis assist the researcher in maintaining a 
connection between pieces of data and the stories from which they come. 
 
Figure 3. Sample timeline constructed to demonstrate event history. 
Storylines. Another method that was used to immerse the researcher in the data 
was the extraction of major storylines from each case. Storylines are identified as 
significant events occurring in the respondent’s experience, such as being diagnosed with 
epilepsy (Sandelowski, 1995a). For each case, the researcher extracted storylines, using 
as few words as possible, to form a list of major storylines within the case. The goal in 
creating such a list for each case was to provide the researcher with a parsimonious, but 
complete, index of the major storylines in each case. Next, the storylines were 
dimensionalized—that is, the investigator added descriptions to each storyline. For 
example, if the storyline of being diagnosed was extracted, the researcher described it 
with pertinent information such as how long it took the older adult to be diagnosed, how 
he or she was diagnosed, and so on. While each case was comprised of unique storylines, 
common storylines, such as being diagnosed with epilepsy, were seen across cases. 
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Storylines were referred to by the researcher throughout data analysis. Table 6 displays a 
dimensionalized storyline list constructed for one of the participants. 
Table 6 
Storyline List Sample 
Storyline Dimensionalization 
First seizure Occurred at age 72 on a camping trip. Grand-mal during 
sleep. Taken to ER in a small hospital, referred to his 
primary physician. 
Diagnosed Diagnosed within a week or so of first seizure. Primary 
physician ran tests and referred to a neurologist. He found 
time-to-diagnosis acceptable. He did not know what he had 
was called “epilepsy” until months later. 
Started medication Initiated at ER, changed by neurologist upon diagnosis. 
Changed to Dilantin
TM
 from Tegretol
TM
. Tolerated side 
effects much better. No subsequent seizures from this point 
on. 
Children visited Kids came to stay for the first time since diagnosis.  
Anxiety-provoking because he feared he would have one in 
front of his grandkids.  
Driving Six months after diagnosis, he was allowed to drive for the 
first time. He had been driving a little while on restriction, 
but only around his neighborhood. His wife had taken over 
most of the driving. 
Disclosure Several months after diagnosis, he felt comfortable and 
found it necessary to tell neighbors about condition. He 
does not tell others outside his family. 
Using frameworks to reduce data. Another way to begin analyzing data is via the 
application of an a priori framework to organize the data. Sandelowski (1995a) gives 
examples of ways in which to do this: organizing data by research questions, interview 
questions, or by searching for structures, processes, and outcomes. In qualitative 
descriptive research utilizing conventional content analysis (discussed later in this 
chapter), it is necessary that analysis be data-derived. That is, a priori coding schemes are 
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not used. However, while a researcher conducting qualitative description via 
conventional content analysis should not be looking for particular codes in the data, 
Sandelowski (1995a) supports the use of interview and research questions for guiding 
initial content analysis in qualitative description, with the requirement that the researcher 
recognizes the use of these questions to organize data as purely initial and is not closed 
off to other avenues of analysis. Sandelowski (2000), however, also notes that, given that 
the main purpose of qualitative description is to describe the phenomenon in terms of the 
research questions asked about it, organizing data by research questions is often a fruitful 
strategy in this method and allows for the answering of the research questions. Thus, data 
initially were reduced using the research questions as an organizing framework 
(Sandelowski, 2010a). For example, using the research question, “What problems do 
older adults face in self-managing epilepsy?” the researcher read each case searching for 
the discussions of problems faced by the older adult. The displays and lists of storylines 
generated in the previous analysis steps also were referred to during this process while 
addressing each research question. The process of reducing the data via these questions 
was facilitated using color-coding. Data that did not pertain to the research or interview 
questions were partitioned via the use of color coding for later analysis. Once the data 
were reduced and organized via research and interview questions, as is described in the 
discussion of content analysis later in this chapter, data-derived codes were developed 
and applied. 
Content analysis. The data analysis method of choice for qualitative descriptive 
studies is content analysis (Patton, 2001; Sandelowski, 2000), which is a method aimed at 
summarizing the informational contents of the data (Sandelowski, 2000). Three types of 
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content analysis—conventional, directed, and summative—exist (Hsieh & Shannon, 
2005). The method of content analysis employed depends on the purpose of the study, 
and the three types of content analysis differ regarding how initial codes are developed. 
In conventional content analysis, codes are data-derived, and a guiding theoretical 
framework, other than general research questions, is not used. In directed content 
analysis, codes are theory-based and established a priori, making this method most 
applicable to theory testing and expansion. In summative content analysis, a list of 
keywords of interest to the researcher is developed a priori, and the frequency with which 
the words are found in the data is tabulated (Hsieh & Shannon, 2005). Given that very 
little research has been done and virtually no theories exist regarding the phenomenon of 
epilepsy self-management in older adults, conventional analysis was most appropriate to 
employ in the proposed study (Sandelowski, 2010a). In employing this method using 
little direction other than general research questions, the researcher allowed codes and 
themes to emerge naturally from the data. 
Following the use of the previously mentioned initial data analysis activities 
(getting a sense of the whole, extracting facts, etc.), conventional content analysis was 
used to derive an initial coding scheme for the dataset. With the knowledge generated 
from the initial data analysis steps serving as a context, and the research questions 
serving as an organizing framework (Sandelowski, 1995a), the researcher re-read each 
case very carefully, paying close attention to respondents’ words and phrases that seemed 
to capture important concepts, both those related and those not directly related to the 
research questions. Codes related and not directly related to the research questions 
emerged. Once this process had occurred for each case, it then occurred across cases 
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(meaning that codes from different cases were compared with one another to ensure all 
data had been accounted for and to determine how prevalent each code was), resulting in 
an initial coding scheme that was comprised of 36 distinct codes. Over the course of the 
study, 12 additional codes were generated. The final scheme, complete with decision 
rules, is depicted in Table 7. 
Table 7 
Coding Scheme 
Code Decision Rule 
Delayed Diagnosis Appropriate when a participant reports the existence of an 
unacceptable time frame (to that person) between first 
seizure and diagnosis or when the participant failed to seek 
medical attention for seizures for a prolonged period of 
time resulting in a delayed diagnosis. Any circumstances 
that resulted in a delayed diagnosis, meaning more than 
three months, from first seizure to diagnosis should be 
counted.
a
  
Prompt Diagnosis Appropriate when a participant reports that his or her 
epilepsy was diagnosed promptly (i.e. within three 
months). 
Dismissive Care Providers Appropriate when a participant reports that he or she feels 
that personal care providers, either primary care, 
neurologists, or other providers, initially dismissed 
participant concerns or symptoms as not important or 
serious. 
Shock Appropriate when a participant reports being 
shocked/surprised about the diagnosis or any other aspect 
of the disease. 
Stigma Appropriate when a participant reports feeling (or being in 
fear of feeling) that epilepsy could cause him or her to be 
stigmatized against. 
Lack of Information Appropriate when a participant reports not knowing as 
much about the condition as preferred. 
Table continues 
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Code Decision Rule 
Feeling Unprepared Appropriate when a participant reports not feeling 
prepared for the diagnosis or for the management of the 
disorder. 
Positive Spin Appropriate when a participant reports looking at the 
disorder in a positive light, as in making the best of the 
situation. 
Intentional Non-adherence Appropriate when a participant reports knowingly not 
adhering to provider instructions regarding epilepsy 
medications, treatments, and lifestyle restrictions. 
Unintentional  
Non-adherence 
Appropriate when a participant reports unknowingly not 
adhering to provider instructions regarding epilepsy 
medications, treatments, and lifestyle restrictions 
(forgetting to take medications, for example). 
Finances Appropriate when a participant discusses how his or her 
financial situation affects the epilepsy diagnosis or 
management in any way. 
Feeling Different Appropriate when a participant discusses feeling different 
from others because of having epilepsy or due to its 
treatments or restrictions. 
Co-morbidities Appropriate when a participant discusses co-morbidities in 
the context of it affecting his or her epilepsy diagnosis or 
management. 
Spouse’s Health Problems Appropriate when a participant discusses a spouse’s health 
problems in the context of it affecting his or her epilepsy 
diagnosis or management. 
Medication Side Effects Appropriate when a participant reports undesirable side 
effects of seizure medications. 
Self-titration of Medications Appropriate when a participant reports altering medication 
dosages (including time and frequency of administration) 
without consulting with his or her provider. 
Management Strategies Appropriate when a participant discusses a specific 
strategy he or she uses in managing epilepsy. 
Table continues 
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Code Decision Rule 
System Appropriate when a participant reports other people and 
things assisting in epilepsy management. 
Commitments Appropriate when a participant discusses how epilepsy has 
affected his or her commitments. 
Changed Roles Appropriate when a participant discusses how his or her 
(and possibly his or her spouse’s) roles are changed since 
epilepsy diagnosis. 
Going Forward Appropriate when a participant discusses moving on with 
life. 
Normalcy Appropriate when a participant discusses maintaining his 
or her normal life. 
Staying Seizure-free Appropriate when a participant discusses the desire to stay 
seizure-free. 
Safety Appropriate when the participant discusses safety (of self 
or others). 
Dependence/Independence Appropriate when the participant discusses how his or her 
independence or dependence has been affected by 
epilepsy. 
Positive Changes Appropriate when the participant reports positive changes 
that have come from having epilepsy. 
Negative Changes Appropriate when the participant reports negative changes 
that have come from having epilepsy. 
What is Epilepsy? Appropriate when the participant expresses lack of 
understanding about what epilepsy is (at or since the time 
of diagnosis). 
Denial Appropriate when the participant reports (or suggests) that 
he or she chooses to deny the diagnosis and/or the 
treatments and lifestyle changes associated with it. 
Information-seeking Appropriate when the participant discusses seeking 
information about his or her epilepsy, its treatments, etc. 
Table continues 
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Code Decision Rule 
Communication Appropriate when the participant discusses 
communicating with others (care providers, family 
members) about his or her condition. 
Isolation Appropriate when the participant discusses feeling isolated 
(or not a part of things/events/groups) due to his or her 
epilepsy or its related treatments and restrictions. 
Emotions Appropriate when the participant discusses experiencing 
emotions related to his or her epilepsy or its related 
treatments and restrictions. 
Loss Appropriate when the participant reports experiencing loss 
(in any form) related to his or her epilepsy or its treatments 
and restrictions. Though the participant may not use the 
word loss, it is appropriate to use this code when the 
participant tells a story that demonstrates a feeling of loss. 
Control Appropriate when a participant discusses control in his or 
her life or over epilepsy. 
Acceptance Appropriate when a participant discusses accepting his or 
her epilepsy. Other words or phrases, such as getting used 
to or coming to terms with also fall under this code. 
Planning Appropriate when a participant discusses ways in which 
he or she plans or has planned managing something to do 
with epilepsy. Other words or phrases, such as got things 
in order, also fall under this code. 
Symptoms Appropriate when a participant reports the experience of 
unpleasant symptoms since epilepsy diagnosis. Symptoms 
can be physical or psychological. 
Denial Appropriate when the participant overtly reports denial 
related to his or her epilepsy or when the participant tells a 
story demonstrating denial of epilepsy or its associated 
treatments, restrictions, and effects on the person’s life. 
Fantasy Appropriate when the participant describes a story in 
which he or she pretends to not have epilepsy. 
Table continues 
  
 122 
Code Decision Rule 
Proactive Appropriate when the participant describes anticipating 
problems that may occur as a result of epilepsy and taking 
action to prevent or manage those problems before they 
occur. 
Reactive Appropriate when the participant describes not 
anticipating problems that may occur as a result of 
epilepsy before they occur, and basing his or her responses 
to the problems on his or her initial reaction(s) to the 
problems. 
Adaptation Appropriate when the participant reports adapting, or 
getting used to, having and managing epilepsy over time. 
Also appropriate when the participant reports adapting 
expectations, lifestyle, commitments, etc., to epilepsy and 
its treatments.  
Changed Roles Appropriate when the participant reports that his or her 
roles have changed since the onset of epilepsy, or those of 
family members or friends have changed. This also may 
refer to not being in expected roles as a result of epilepsy. 
Lack of Awareness Appropriate when the participant reports that he or she 
was not aware (at the time of diagnosis or currently) that 
new-onset epilepsy affects older adults. 
Memory Problems Appropriate when the participant reports memory loss 
related to epilepsy or since the epilepsy diagnosis. 
Life Altering Appropriate when the participant tells a story in which he 
or she reports that being diagnosed with and/or 
having/managing epilepsy has been life-changing.  
Epilepsy is Different Appropriate when the participant expresses that there is a 
difference between epilepsy and other chronic diseases 
from which he or she suffers in terms of diagnosis, 
management, as well as other aspects. 
a
The time period of three months was used because it is the mean length of time that 
passes for a person to be diagnosed properly with a chronic disease (Centers for Disease 
Control and Prevention, 2009). 
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Codes then were partitioned into clusters using research questions as the 
organizational framework (Sandelowski, 1995a). Codes not directly relevant to the 
research questions were clustered and placed under separate headings (Table 8). At this 
stage of analysis, some codes were associated with multiple research questions, which 
alerted the researcher of the interactive nature of the phenomenon under study. 
Table 8 
Coding Scheme Clustered by Research Questions 
Research Question Coding Scheme 
1 Delayed Diagnosis; Prompt Diagnosis; Dismissive Care 
Providers; Shock; Communication; Lack of Information; Feeling 
Unprepared; Shock/Surprise; Stigma; What is Epilepsy?; Lack 
of Awareness 
2 Life-Altering; Independence/Dependence; Symptoms; Isolation; 
Stigma; Loss; Communication; What is Epilepsy?; Safety; 
Commitments; Medication Side Effects; Feeling Different; 
Changed Roles; Lack of Information; Control; Dismissive Care 
Providers; Memory Problems; Unintentional Non-Adherence; 
Emotions; Control 
3 Feeling Different; Negative Changes; Positive Changes; Altered 
Roles; Life Altering; Independence/Dependence; Commitment; 
Isolation; Loss; Emotions; Control 
4 Strategies; Proactive; Reactive; Planning; Adherence; 
Intentional non-adherence; Fantasy; Denial; Moving Forward; 
Information-Seeking; Communication; Adaptation; System; 
Control; Positive Spin; Acceptance 
5 Normalcy; Staying Seizure-free; Acceptance 
Other Epilepsy is Different; Information-seeking; What is Epilepsy? 
Following the development of the scheme, which was based from both  
within- and across-case analyses, a coding guide (or code book) was developed for the 
dataset and also maintained as part of the analytic log. In this guide, decision rules for 
each code were maintained. Sandelowski (1995a, 2010a), Patton (2001), and Miles and 
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Huberman (1994) strongly espouse the need to use explicit decision rules for all codes. A 
decision rule explicates what counts as the existence of a code in the data and is 
important in maintaining rigor throughout the data analysis process as well as in 
establishing an audit trail (Sandelowski, 2010a). For example, when the code of 
surprise/shock about being diagnosed was derived, the researcher wrote a rule regarding 
this code so that it could be applied consistently to all data. These rules specified what 
type of content had to be seen in a case for this code to be applicable, how many times it 
would have to appear, and so on. The coding guide was a work-in-progress throughout 
the study, as it was formed soon after the first data were generated, and continually was 
revised based on new data. The initial coding guide was tested for completeness by 
applying codes to all existing data (in the form of raw data, summaries, and storylines) to 
determine the degree to which the guide accounted for all the data. There were points at 
which the researcher discovered that the coding guide did not account for certain portions 
of the data, and made revisions to the guide, decision rules, or both, and the guide was 
tested again. This iterative process occurred until all pertinent data were accounted for 
and informational redundancy was achieved (Sandelowski, 1995a, 2010a). Informational 
redundancy refers to the point in the analysis at which new data fail to generate new 
codes (Patton, 2001). Informational redundancy was met after the researcher analyzed 
data from the 20th participant. 
In order to develop themes, which refer to statements that express salient 
characteristics of the experience in response to the aims of the study, from the  
data-derived codes, a data matrix was utilized (Miles & Huberman, 1994). The goal of 
the matrix was to display codes in a way that allowed for potential relationships and 
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linkages of them, as well as the frequency with which codes appeared in the data, to be 
seen in order to allow the researcher to situate codes under descriptive themes (Miles & 
Huberman, 1994). In order to remain congruent with the purpose of the study and the 
research questions guiding it, the researcher derived and arranged themes to ensure that 
the purpose of the study was being fulfilled and that research questions were being 
answered (Sandelowski, 2010a). For example, the purpose of the study was to describe 
older adults’ experiences of epilepsy self-management and not to describe the meaning to 
those individuals of having epilepsy (as potentially would be the case in a 
phenomenological study); thus, the researcher did not generate themes that would speak 
only to the meaning of epilepsy to the respondents, as doing so would not fulfill the study 
purpose. 
To summarize, following (and in conjunction with) the use of the initial data 
analysis techniques espoused by Sandelowski (1995a) described previously, conventional 
content analysis was used to analyze all data. Data-derived codes were generated and 
tested in terms of their ability to account for data within and across the cases. Codes, 
situated in clusters, were revised as needed in order to account for all data. Data matrices 
were utilized to assist with the transition from cluster-nested codes to descriptive themes. 
Themes were developed based on the way in which clusters of codes best addressed the 
study purpose and driving research questions. 
Counting and visual displays. Counting and visual displays were used 
throughout data analysis proceedings. Sandelowski (2001) strongly encourages the use of 
counting and enumeration in qualitative research and particularly in qualitative 
descriptive research. According to Sandelowski (2001), though qualitative research is 
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often seen as “anti-number” (p. 230), counting can be an effective way to demonstrate the 
complex work involved in qualitative research and to generate meaning, as well as to 
document, verify, and test researcher conclusions. Sandelowski (2001) explains that 
enumerating key features of cases, especially those found during across-case analysis, 
and organizing those features in a numerical display can generate meaning via allowing 
for the emergence of patterns of the generation of new hypotheses and lines of analysis. 
In this study, counting and visual displays were used to document and verify conclusions 
as well as to generate meaning based on techniques provided by Sandelowski (2001). For 
example, when the researcher had an impression that women in the sample had more 
difficulty in receiving an accurate epilepsy diagnosis than the men in the sample, the 
researcher constructed a table enumerating the percentage of women versus men 
reporting a delayed diagnosis of epilepsy (Table 9). The researcher added each 
participant to this table to help verify her impression. 
Table 9 
Delayed Diagnosis by Gender 
Participant Gender Delayed Diagnosis 
1 F Yes 
2 M No 
3 F Yes 
4 M No 
5 F Yes 
6 F Yes 
7 M No 
8 M No 
9 M No 
10 F No 
Table continues 
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Participant Gender Delayed Diagnosis 
11 M Yes 
12 F Yes 
13 F Yes 
14 F Yes 
15 F No 
16 F Yes 
17 F Yes 
18 F Yes 
19 M Yes 
20 M Yes 
Table 9 allowed the researcher to track and confirm initial impressions that the 
women (83%, 10/12) who took part in the study were more likely than the men (37.5%, 
3/8) who took part in the study to have experienced a delay in diagnosis. This confirmed 
impression led the researcher to focus her attention on possible causes or circumstances 
that led to this discrepancy in participants’ experiences. The researcher expanded the 
chart represented by Table 9 to include other demographic characteristics that emerged as 
potentially important. Table 10 depicts an expanded version of the visual aid used by the 
researcher in determining that geographic location (rural versus city-dwelling) and 
symptom presentation (classic versus ambiguous) may contribute to delay in diagnosis. 
Table 10 
Delayed Diagnosis and other Demographics 
Participant Gender Delayed 
Diagnosis 
Geographic 
Location 
Symptom 
Presentation 
1 F Yes CD
a
 Classic 
2 M No CD
a
 Classic 
3 F Yes Rural Ambiguous 
4 M No CD
a
 Ambiguous 
5 F Yes Rural Classic 
6 F Yes CD
a
 Classic 
Table continues 
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Participant Gender Delayed 
Diagnosis 
Geographic 
Location 
Symptom 
Presentation 
7 M No Rural Classic 
8 M No Rural Classic 
9 M No CD
a
 Classic 
10 F No CD
a
 Classic 
11 M Yes Rural Ambiguous 
12 F Yes Rural Classic 
13 F Yes CD
a
 Ambiguous 
14 F Yes Rural Classic 
15 F No CD
a
 Classic 
16 F Yes CD
a
 Ambiguous 
17 F Yes Rural Ambiguous 
18 F Yes Rural Ambiguous 
19 M Yes CD
a
 Ambiguous 
20 M Yes Rural Ambiguous 
a
CD = City-Dwelling 
The researcher used the visual aid represented by Table 10 throughout the study, 
ultimately adding the demographic variables of level of education and income to it as 
well. Further visual aids were made to determine which factors were most prevalent in 
those who had a delay in diagnosis, as well as in those who did not. Creating meaning via 
the use of counting and visual displays refers to supporting findings from the study by 
providing the reader of the study with a visual display of data that led to the findings. All 
visual displays used by the researcher were maintained as part of the analytic log in order 
to protect validity. 
Iteration. The previous discussion of data analysis has been necessarily 
segmented in order to describe the different steps of data analysis that occurred 
throughout the study. However, it is necessary to emphasize that qualitative data analysis 
procedures occur iteratively, within the analysis process itself as well as with data 
generation and interpretation. For example, in the study, new analyses constantly 
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informed later analyses (both within- and across-case), which guided sampling and data 
generation by influencing the need to recruit participants with experiences of particular 
variations of the phenomenon, shaping the interviews used to generate data, as well as 
interpretations. 
Data Interpretation 
Data interpretation refers, ultimately, to the finished product of qualitative 
inquiry—if data analysis is the process of breaking data up or down to see something new 
out of it, interpretation is the reassembling of data in a new way so that a new whole is 
formed (Sandelowski, 1995a). The final interpretation is the knowledge produced from 
the study and is characterized by the researcher rendering the data in a way so that 
something new is created from the data; yet, this new whole remains faithful to the data 
in their initial form (Sandelowski, 1995a). The interpretation rendered from a qualitative 
descriptive study is a data-near, descriptive summary, guided by the study’s purpose and 
research questions; this summary is achieved most usually via the use of themes that 
reduce the data in meaningful ways (Sandelowski, 2000). Thus, the interpretation 
rendered from the study is in this form and presented in such a way that the experiences 
of epilepsy self-management from the perspectives of older adults is described and all 
research questions are answered. Sandelowski (2000) warns against simply giving a list 
of themes as the interpretive product of a qualitative descriptive study. Thus, steps were 
taken to ensure that final themes were dimensionalized, explained, and representative of 
the original data. 
Per the suggestions of Sandelowski (1994) and Miles and Huberman (1994), 
supporting quotes were chosen to be presented in the final interpretation of data. Quotes 
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were chosen based on their ability to support claims embedded in the interpretation as 
well as to illuminate ideas and experiences of respondents (Sandelowski, 1994). The use 
of superfluous quotes, which can lead to “heaped data” (Sandelowski, 1994, p. 481) 
instead of a thick description, was avoided. Quotes selected were used in a way that 
remained faithful to the person who spoke the quote, as well as the researcher’s 
interpretation of its meaning. Prior to choosing a quote for inclusion, its exact purpose 
was considered. No quote was included without the investigator considering, as well as 
documenting, the precise purpose of it—that is, to support the interpretation, to illustrate 
ideas, to demonstrate experiences, to evoke emotion, or to provoke responses 
(Sandelowski, 1994). Quotes also were appropriately staged. Immediately preceding the 
insertion of a quote, in order to guide the reader as to what he or she should “see” 
(Sandelowski, 1994, p. 481) in the quote, the quote is interpreted for the reader in terms 
of what it is meant to exemplify or support (Sandelowski, 1994). 
Visual displays of enumerated data, as previously mentioned, also were used to 
support the final interpretation rendered from the study. These displays were used to 
describe the sample and also to support and justify interpretations and detail the ways in 
which the interpretation was spread across the cases. 
In presenting the interpretation, the researcher used what Sandelowski (2010a) 
calls “parallel comparisons” (p. 15). The use of parallel comparisons, basically, refers to 
the consistent use of verbiage. For example, in the portion of the interpretation involving 
the theme of self-management strategies, the sub-themes comprising this theme, as well 
as the in-text discussion of it, were consistent with this label; that is, sub-themes and the 
discussion would be comprised of actual self-management strategies. Sandelowski 
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(2010a) warns that researchers who fail to use parallel comparisons risk not conveying 
their interpretations adequately or appropriately. 
Validity 
The proper way in which to ensure the validity of qualitative studies has been an 
ongoing controversial issue in the literature for the past two decades. Sandelowski’s 
(1993) views on the insurance of validity in qualitative research served as the guiding 
principles for this study. Prior to discussing the ways in which validity was protected in 
the study, it is necessary to briefly discuss Sandelowski’s (1993) views on both reliability 
and validity in qualitative research. First, Sandelowski (1993) raised and supported the 
issue that it is not appropriate for researchers to seek reliability in qualitative research, 
and that doing so is a clear threat to validity. Sandelowski (1993) explains that, in 
qualitative research, a chief assumption is that reality is “multiple and constructed” (p. 3). 
Seeking repeatability in measurements (i.e., respondents’ stories), then, is inappropriate, 
and validity in this type of research does not depend on replicable outcomes. Multiple 
researchers or respondents cannot and should not be expected to arrive at the same 
conclusions regarding a phenomenon. Sandelowski (1993) suggests that seeking 
reliability necessitates forcing an artificial “consensus” (p. 3) on the data analysis 
process, which will ultimately degrade the validity of the findings. For this reason, she 
rejects the notion of reliability in qualitative research, along with the use of techniques, 
such as member checks and expert review, highly espoused by other researchers  
(Lincoln & Guba, 1985). 
Sandelowski (1993) explains that there are practical, theoretical, representational, 
and sometimes moral problems with executing member checks in the typical fashion of 
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returning to respondents after data have been generated, presenting respondents with 
findings then asking them for confirmation. First, she notes that researchers generally 
present members with the final interpretation—a more abstract view of the data that is 
meant to represent the experiences of many respondents, not just one. Thus, participants 
often have difficulty finding themselves in the interpretation, and many, as lay people, 
simply do not understand the interpretive rendering of results. Participants may also 
simply not remember their initial accounts or, more often, their stories, and feelings about 
them may have changed since the data were generated. Respondents, upon hearing or 
reading about themselves in an emotional state, also can call for the deletion or 
manipulation of original data due to embarrassment or a desire to change how they 
appear in the study. Some respondents, too, upon revisiting the interview, may wish to 
add data. As well, many respondents simply are uninterested in reviewing their 
transcripts or the study findings and do so only out of obligation. Thus, respondents’ 
confirming statements regarding the consistency and accuracy of the data are not very 
useful (Sandelowski, 1993). Finally, Sandelowski (1993) notes that story-telling, a chief 
way in which qualitative researchers generate data from respondents, is “revisionist in 
nature” (p. 4). That is, the stories respondents tell researchers are memories of the past, 
and these memories change regularly—the very act of telling or thinking of them can 
change the story. Respondents’ stories are ever-changing; thus, the notion of validating 
the contents of a story previously told at a later date is a concept at odds with  
story-telling. Sandelowski (1993) warns that researchers who look for consistency among 
respondents’ stories, as well as consistent interpretations from expert researchers, risk 
making serious analytic errors. Thus, reliability was not sought in this study, and no 
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member checks or expert panel were used. However, the researcher consulted regularly 
with her dissertation committee and consultants during the data analysis process. 
According to Sandelowski (1993) and Rolfe (2004), the validity of qualitative 
research cannot be judged using the criteria used in quantitative research, nor can any 
different set of blanket criteria be created for and applied to qualitative research to judge 
the validity of these studies. Given that there is no single qualitative research paradigm, 
the use of predetermined, generic criteria in evaluating the validity of qualitative research 
is inappropriate. Sandelowski (1993) asserts that the validity of a qualitative study is 
judged on an individual basis, and it is the job of the researcher to persuade the reader of 
the validity of the study via making his or her practices throughout the study visible and 
auditable. This is best achieved via the maintenance of an audit trail (previously 
discussed). Sandelowski (1993) considers the types of validity suggested by Maxwell 
(1992)—and not those supported by Lincoln and Guba (1985)—as the most appropriate 
for qualitative research. Both Sandelowski (2000) and Maxwell (1992) suggest that two 
types of validity—descriptive and interpretive—are sought in qualitative descriptive 
studies. Descriptive validity refers to “getting the facts right” (Sandelowski,  
2000, p. 336)—that the researcher is not fabricating or distorting the interviews used as 
data, and that he or she is analyzing data as they actually were generated by respondents. 
When descriptive validity is achieved, an account of the events that people observing the 
same events (interviews) would agree is accurate is reached. Clearly, all other types of 
validity rest on descriptive validity, as interpretations gleaned from inaccurate data will 
not be valid (Maxwell, 1992). Interpretive validity refers to the researcher ascribing and 
explaining the meanings respondents give to the events (interviews) that occurred in a 
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way which the respondents and researcher would agree is accurate. As described 
previously and throughout this chapter, steps were taken throughout the study to ensure 
both descriptive and interpretive validity by treating and respecting the data so that it was 
maintained in its true form (descriptive validity) and all analytic and methodological 
decisions were logged (interpretive validity). 
Efforts to ensure descriptive validity already have been described in this chapter, 
but are summarized here and include the following: audio-recording of interviews, 
verbatim transcription of interviews, proofreading of transcripts by the researcher, use of 
a legend in all transcripts to indicate pauses and inaudible time, and the use of counting 
and enumeration techniques. These actions ensured that data generated from respondents 
were represented as accurately as possible before and during analysis and interpretation. 
Many efforts were taken to ensure the interpretive validity of the final interpretation. 
Most of these strategies are those already discussed in relation to maintaining an audit 
trail that is complete with contextual, analytic, methodological, and personal response 
documentation, which ensures that decisions made throughout the entire study process 
are rationalized, supported, and made available for review (Rodgers & Cowles, 1993). As 
Sandelowski (1993) states, the use of an audit trail ensures interpretive validity by 
making all of the researcher’s activities visible. For example, constructing and 
maintaining numerical visual displays supported interpretive validity by giving credence 
to final interpretations—so, too, did the coding guide and other logs that were kept 
throughout the study, as they provide a history of the rationale used to make 
methodological and analytic decisions. The use of active confirmation and summarization 
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during interviews also ensured, at the time of data generation, that the researcher was 
hearing stories correctly, which also contributed to interpretive validity. 
Summary of Data Generation, Analysis, and Interpretation Process 
Threaded throughout this chapter has been the notion that qualitative inquiry, 
including that used in qualitative description, is an extremely iterative process that is not 
at all linear. Figure 4 presents a schematic designed to represent, in a more parsimonious 
way, the iterative processes of data generation, analysis, and interpretation that occurred 
in the study. The schematic depicts the process that occurred from the time that research 
questions were raised and the method best suited to answer them was chosen. 
 
Figure 4. An iterative process was used in generating, analyzing, and interpreting data. 
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To summarize, data were generated via face-to-face interviews with older adults. These 
respondents were chosen via purposeful sampling in three installments. These generated 
data were prepared via verbatim transcription and managed using separate folders and an 
audit trail comprised of contextual, methodological, analytic, and personal response 
documentation for each participant. Generated, prepared data were analyzed via the use 
of initial analytic steps espoused by Sandelowski (1995a), and counting and enumeration 
techniques with the use of visual displays aided in this process. After these initial steps 
were completed within and across cases for the dataset, formal conventional content 
analysis, also utilizing counting/enumeration and visual displays, was used to derive  
data-driven codes. Codes were tested to ensure all data within and across cases had been 
accounted for. Data interpretation occurred via themes, in the form of a descriptive,  
data-near summary of the data that is in accordance with the study purpose and research 
questions. Quotes and exemplars from cases were used to support themes, which were 
presented via language that allowed for parallel comparisons. All three of the main 
processes—data generation, analysis, and interpretation—occurred concurrently and 
affected one another. 
Summary 
Because very little is known about epilepsy self-management in older adults 
diagnosed at or after age 60, a qualitative descriptive approach is most suitable to 
investigate this phenomenon. Purposeful sampling was employed to recruit older adults 
with various experiences regarding the phenomenon of interest. Data were generated via 
face-to-face interviews and analyzed via content analysis. Documentation was maintained 
throughout the study to form an audit trail and to protect descriptive and interpretive 
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validity. The final interpretation is presented in a manner that answers the research 
questions and remains faithful to the data. Findings rendered from the current study will 
provide the necessary basic understanding of what the epilepsy self-management of older 
adults diagnosed with the condition late in life is comprised, thereby ultimately informing 
the development of interventions designed to improve outcomes in older adults diagnosed 
with epilepsy late in life. 
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CHAPTER IV 
RESULTS 
This chapter presents the findings of this study. First, a description of the sample 
is provided. Next, each research question is answered via themes that emerged during 
analysis. Additional themes that do not pertain specifically to the research questions but 
that emerged during analysis also are discussed. A summary and exemplar of the findings 
then are presented. 
Sample Characteristics 
The data from 20 older adults were analyzed. Data from five participants were 
gathered during the pilot study, and data from the remaining 15 participants were 
gathered during this study. See Table 11 for demographic characteristics of the sample. 
Of those taking part in the study, 12 (60%) were women, and 8 were men (40%). There 
were 19 (95%) Caucasian participants and 1 (5%) African American. The mean age of 
the sample was 70 years, with a range of 60–80 years. The marital status of the 
participants was: 14 married, 4 unmarried (single/divorced/widowed), and 2 lived with 
significant others. Mean years of schooling was 13.5, with a range of 7 to 20. Among the 
participants, 2 had sixth grade educations, 10 had high school diplomas, 2 had some 
college, 2 held bachelor’s degrees, 3 held master’s degrees, and 1 held a doctoral degree. 
Employment status of the participants included: 5 who were working (3 part-time, 2  
full-time); 14 were retired, and 1 was on disability as a consequence of epilepsy. The 
mean length of time since epilepsy diagnosis was 4.1 years, with a range of 0.5–10 years. 
One participant (5%) reported the daily occurrence of seizures. Two participants (10%) 
reported experiencing a seizure on a weekly basis, four (20%) experienced a seizure 
monthly, eight (40%) reported experiencing a seizure bi-monthly, four (20%) reported 
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experiencing a seizure every six months, and one participant (5%) experienced fewer 
than one seizure per year. 
Regarding income: 20% of the sample (n = 4) earned less than $20,000 per year; 
15% (n = 3) had an annual income between $21,000 and $40,000 per year; 30% (n = 6) 
had an income between $41,000 and $60,000 per year; 25% (n = 5) had an annual income 
between $61,000 and $100,000, and 10% (n = 2) had an income greater than $100,000 
per year. Eighty-five percent of the sample (n = 17) received Medicare, 10% (n = 2) had 
private insurance, and 5% (n = 1) had no insurance. Seventy percent of the sample  
(n = 14) reported having a significant other—adult child, spouse, friend, or other 
relative—who directly assists with epilepsy management. Thirty percent (n = 6) did not 
report the existence of an assistive significant other. Twenty percent of the sample (n = 4) 
experienced primary grand-mal, tonic-clonic seizures, while 80% (n = 16) experienced 
partial seizures. All of those who reported experiencing partial seizures also had 
experienced at least one generalized seizure as a result of those partial seizures. The mean 
number of co-morbidities in addition to epilepsy was 2.5, with a range of one to four. The 
mean Mini Mental Status Exam score was 27.73, with a standard deviation of 1.67 and a 
range of 24-30. 
Table 11 
Demographic Characteristics of the Sample 
Variable M(SD) Range N 
Age (in years) 70  60–80  
Years since diagnosis 4.1 0.5–10  
Education (years of school completed) 13.5    7–20  
MMSE Score
a
 27.73(1.67)  24–30  
Co-morbidities in addition to epilepsy 2.5  1–4  
Table continues 
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Variable M(SD) Range N 
Race 
Caucasian 
African American 
   
n = 19 
n = 1 
Gender 
Male 
Female 
   
n = 8 
n = 12 
Income (annual) 
< $20,000 
$21,000–$40,000 
$41,000–$60,000 
$61,000–$100,000 
> $100,000 
   
n = 4 
n = 3 
n = 6 
n = 5 
n = 2 
Employment 
Working full-time 
Working part-time 
Retired 
Disability 
   
n = 2 
n = 3 
n = 14 
n = 1 
Type of epilepsy 
Tonic clonic grand-mal 
Partial with experiences of grand-mal 
at times 
   
n = 4 
n = 16 
 
Assistive significant other 
Yes 
No 
   
n = 14 
n = 6 
Insurance 
Medicare 
Private 
None 
   
n = 17 
n = 2 
n = 1 
Relationship status 
Married 
Single (includes divorced or widowed) 
Living with significant other 
   
n = 14 
n = 4 
n = 2 
Seizure Frequency 
Daily 
Weekly 
Monthly 
Bi-monthly 
Bi-annually 
Fewer than one per year 
   
n = 1 
n = 2 
n = 4 
n = 8 
n = 4 
n = 1 
a
Mini Mental Status Exams were not administered to the five pilot participants. 
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Emergent Themes 
As discussed in Chapter III, the final interpretation of data rendered in a 
qualitative descriptive study is presented best in the form of emergent themes. Here, 
themes (and sub-themes) are organized by research question, and those not directly 
related to the a priori research questions are discussed separately. Themes are displayed 
in tables, summarized in a narrative, and each is then discussed in detail. 
Research Question One 
The first research question concerned older adults’ experiences with the process 
of being diagnosed with epilepsy. Table 12 displays the main themes and sub-themes that 
emerged concerning this question. 
Table 12 
Themes for Research Question One 
Theme Sub-Theme(s) Frequency 
Type of Experience Satisfactory 
Unsatisfactory 
Mixed 
n = 2 
n = 13 
n = 5 
From First Seizure to 
Diagnosis: Time Elapsed 
Delay 
   Caused by Provider 
   Caused by Self 
   Mixed 
No delay 
n = 13 
n = 8 
n = 3 
n = 2 
n = 7 
What is Epilepsy?  Older people get epilepsy? 
Understanding of epilepsy 
   Misunderstanding 
   No misunderstanding 
Post-Diagnosis Education 
   Satisfactory 
   Unsatisfactory 
Patient/Provider Perspectives on 
Impact of Diagnosis 
   Mis-Matched 
   Matched 
N = 20 
N = 20 
n = 17 
n = 3 
N = 20 
n = 5 
n = 15 
 
 
n = 13 
n = 7 
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Three main themes regarding participants’ epilepsy diagnosis experiences 
emerged. During interviews, participants were encouraged to relay experiences that 
occurred from the time of the first seizure experienced until they received an actual 
diagnosis of epilepsy.  
Type of experience. The first theme that emerged for this research question is 
Type of Experience. Participants described their overall experience of being diagnosed 
with epilepsy as satisfactory, unsatisfactory, or mixed. 
Satisfactory. Very few participants (n = 2) described their diagnosis experience as 
completely satisfactory. Both of these participants were male and indicated that they 
would not have changed anything about their experience of being diagnosed with 
epilepsy. For example, one of these participants stated, when asked what he would 
change about the process of being diagnosed, “Honestly, it was handled well. I had it, got 
to a hospital, and they gave the med…. I took it ’til I saw a neurologist, and he said keep 
taking it. It was quick, easy and that’s fine with me.” The other participant whose 
experience with being diagnosed was satisfactory reflected on his diagnosis experience 
similarly, stated, “Nah, I don’t think I’d change a thing…. It was fine. They told us what 
happened and wrote the ’script. I can’t imagine anything else they could do for me.” 
Common characteristics in the experiences of these two participants were 
identified. The first was speed of diagnosis. Both participants were diagnosed 
immediately following their first seizure, and both of them acknowledged that the short 
time elapse from their first symptom to accurate diagnosis and treatment contributed to 
their satisfaction with the process. “There was no waiting…wondering what this was. So 
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that was a relief because I had gone through not knowing with my back…. They told me 
immediately what this was.” 
The second characteristic common to both of these participants is a lack of desire 
for detailed information about their disease. Both men expressed a desire to know only 
what they needed to do in terms of medical treatment of the disorder, neither wanted to 
know the underlying cause or pathophysiology of his epilepsy. When asked how much 
and what kind of information he wanted about epilepsy upon diagnosis, one participant 
stated “I wanted bare bones…. All I need to know was what to do. And that was take 
pills. So I do. It doesn’t matter why I have it…and I probably wouldn’t understand if they 
tried to explain.” Another participant reported not wanting to know the details of his 
disease, but specifically expressed that this desire was based on fear. He stated, in 
response to being asked if he had wanted more information at the time of diagnosis:  
Personally, no. I don’t ever want to know all that stuff. It scares 
me…because I remember when my brother had cancer. They told him 
every damn detail…ended up knowing almost exactly when he was going 
to die. I didn’t want to know all that so I was happy with the lack of info. I 
figure their job is to figure out what’s wrong with me, and the only thing I 
have to do is whatever they tell me to do. Like military…no questions 
asked. 
Lastly, both of these participants described their initial episodes as being 
unmistakably grand-mal seizures, and thus felt that the diagnosis was obvious. As one 
participant noted, “My wife called the ambulance…and she told the operator I had had a 
seizure. So it was clear to us what was going on before we ever saw a doctor.” Both of 
these men demonstrated textbook symptoms of epilepsy during their first seizures, which 
likely led to the ease and swiftness with which they were diagnosed. 
Unsatisfactory. Many participants (n = 13) found their experience of being 
diagnosed to be completely unsatisfactory. Among the participants, 11 women and 2 men 
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did not report anything satisfactory about the experience through which they went in 
being diagnosed. “It was pure hell,” stated one female participant when she was asked to 
describe the diagnosis process. Another participant—a male—answered the same 
question by stating “I have been really sick before…had a lot of things done to me, and 
this was by far the kicker in terms of being awful to figure out what it was. It was no 
good.” Participants who initially expressed dissatisfaction with their experience were 
further questioned to determine if any aspect of the diagnosis process was pleasing to 
them. These 13 participants could find nothing acceptable about the process. As one 
female participant noted, “No, it was all bad. It was agony and I would change everything 
about it if I could.” 
The researcher questioned these participants further about what made the 
diagnosis process so dissatisfying. All 13 participants cited an unacceptable delay in 
diagnosis as the prime dissatisfying aspect of the process. “It just seemed to take 
forever,” explained one participant who waited over six months for an accurate diagnosis. 
Lack of information about epilepsy, including its cause, pathophysiology, prognosis, and 
treatment, at the time of diagnosis also contributed to participants’ lack of satisfaction 
with their diagnosis experience. “We got a lot of information [about epilepsy] ourselves. 
But from the doctors? Nothing at all,” stated one participant when asked about the 
information she received at diagnosis. This participant continued, “I wish they had told 
me more when I was diagnosed.” Specific reasons for and characteristics of the delays in 
diagnosis and lack of information given at diagnosis are described in subsequent themes. 
Older adults who were not at all satisfied with their diagnosis experience 
demonstrated both classic (n = 7) and more ambiguous (n = 6) first seizure symptoms, 
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with more ambiguous first seizures being those unlike typical grand-mal seizures that 
involve full-body jerking.  
Mixed. The remaining five participants, one woman and four men, were satisfied 
with certain aspects of the diagnosis process, but unsatisfied with others. For example, 
one male participant was dissatisfied with the length of time it took for him to receive an 
accurate diagnosis but was satisfied with the rest of the process, including the information 
given to him by his provider. He explained, “The waiting part was bad and I feel like we 
maybe wasted a lot of time, but other than that it was fine.” This participant reported 
receiving limited information about his disorder but stated that he did not desire any 
additional information at the time of diagnosis. The other male participants (n = 2) who 
are included in the mixed experience category had very similar experiences—their 
dissatisfaction was in having to wait for a diagnosis, but they were satisfied with the 
information they received about their epilepsy. All three of these participants 
demonstrated ambiguous seizure symptoms, such as memory loss and strange behavior, 
at the time of diagnosis. 
The remaining two participants (one woman and one man), however, were 
diagnosed quickly but were dissatisfied with other portions of the process. The female 
was not pleased with the information given to her about her condition, and explained that 
she asked the doctor who diagnosed her several questions about her condition and he was 
unwilling to answer them. She stated, 
After I asked him, he said “come back in four months and let’s talk about 
it”…and I would say “no, I want to move on with my life.” But he 
wouldn’t, so that’s when I had to find a new doctor. 
The male participant cited his diagnosing physician’s refusal to consider alternative 
therapies to treat his epilepsy as dissatisfying and stated that “he just did not listen to 
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me…. It was like I was not there. I wanted to be part of what was happening to me but 
instead I was ignored.” This portion of his experience is similar to those of older adults 
who were categorized in the unsatisfied group previously and described their care 
providers as dismissive of their concerns. 
Summary. Participants had one of three different types of epilepsy diagnosis 
experiences: satisfactory (n = 2), unsatisfactory (n = 13), or mixed (n = 5). Those who 
found the experience completely satisfactory were male, and both demonstrated classic 
seizure symptoms and were diagnosed rapidly. Neither of these participants desired  
in-depth information about their disorder at the time of diagnosis. The majority of the 
sample characterized their diagnosis experience as completely unsatisfactory. Most of 
these participants were female, and delay in diagnosis and lack of sufficient information 
about epilepsy, including its cause, pathophysiology, prognosis, and treatment, were seen 
by participants as most contributory to their negative experiences. The remaining 
participants described their diagnosis experience as mixed—certain aspects of it were 
acceptable, and others were not. The majority of the male participants fell into this group, 
and most identified a delay in diagnosis as the primary dissatisfying factor. Based on 
these findings, it is clear that the women in the sample had more purely negative 
experiences with diagnosis than did the men (Table 13). 
Table 13 
Type of Experiences by Gender 
Gender Satisfactory Unsatisfactory Mixed 
Male 2  2 4 
Female 0 11 1 
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The researcher investigated this discrepancy in order to more fully describe 
participants’ experiences. Both the males and the females found a delayed diagnosis to be 
the most dissatisfying aspect of the process, but the women in the sample were more 
likely to find the information given to them at diagnosis unacceptable. All 12 women in 
the study noted a dearth of information at diagnosis, while only 3 of the 8 men had a 
similar complaint. However, the type and amount of information given to both the 
women and men in this sample does not appear, based on participants’ descriptions, 
significantly different. All of the women, though, desired more, and more detailed, 
information while most of the men indicated that they desired less information and were 
satisfied if they were told only what their responsibilities were in terms of managing the 
disease (i.e., taking medications). 
From first seizure to diagnosis: Time elapsed. As briefly discussed in relation 
to the Type of Experience theme previously, length of time to accurate epilepsy diagnosis 
was a significant aspect of the majority of participants’ diagnosis experiences and greatly 
contributed to their satisfaction or dissatisfaction with the process. Participants’ 
discussions of their epilepsy diagnosis experiences were so punctuated with stories about 
the time elapse from their first seizure symptoms to a diagnosis of epilepsy that this 
aspect of their diagnosis experiences emerged as an independent theme. Participants 
reported either a delayed or non-delayed diagnosis.  
Delay. Sixty percent of the sample, 10 women and 3 men, reported that they 
experienced a delayed diagnosis—their epilepsy was not diagnosed within three months 
of the first seizure. Of the participants comprising the sample, 13 of the 20 were certain 
of the exact length of time between their first seizure and diagnosis, while the 7 others 
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could not remember precisely the duration of time between first seizure and diagnosis, 
though they were able to report a general idea of this length of time. The range in length 
of time to diagnosis for the 13 participants who experienced a delay was approximately 
six months to seven years, with the majority of the participants in this group (n = 9) 
reporting a delay of approximately 12 to 18 months. Participants attributed this delay to 
their own actions, those of their healthcare providers, or both. All 13 of these participants 
felt that the delay was unnecessary and could have been avoided, as evidenced by one 
participant’s comment that “epilepsy is not some unknown disease. I think it shouldn’t 
have been such a mystery to everyone what was wrong with me.” 
Among the participants, eight—five women and three men—attributed the delay 
in diagnosis they experienced to the actions of care providers to whom they went for 
treatment. In all but one case, participants identified their primary care providers (six 
physicians and one nurse practitioner) as the providers who caused the delay. In the 
remaining case, a female participant actually was referred to a neurologist by her primary 
care physician, but she felt that the neurologist was responsible for the delay in her 
diagnosis. 
Some (n = 3) felt that the process took so long because their concerns were not 
taken seriously by healthcare providers. Interestingly, all of the participants who reported 
being dismissed by their care providers were female. A 72-year-old participant reflected 
on her experience of being dismissed by a neurologist to whom she was referred by her 
primary care physician after presenting with classic seizure symptoms:  
I’ll never forget what the doctor said….He told me that maybe I was 
pregnant. At my age! I kid you not. He honestly did. I said that is 
impossible and since when did being pregnant make you slump over and 
start shaking? Then he said my symptoms had to be hormonal…and the 
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last time I saw him he said maybe I was just cursed. This was a very 
reputable neurologist. So I went on having untreated seizures for seven 
years….I thought I was mentally ill when I actually had a disease. I can 
never get that time back. 
Other participants (n = 3) felt that their diagnosis was delayed because the 
healthcare providers to whom they went for treatment simply did not know to consider 
epilepsy or seizures as a potential diagnosis. One participant voiced his frustration, 
stating,  
I always had it be a simpler thing. You’re sick, ya go in, and ya tell ’em 
what’s wrong. Then they fix it…but this took forever and I went through 
so many tests and waitin’. The truth is the doctor had no idea what it was. 
He should have sent me to the neurologist a lot sooner. 
 Another female participant relayed a similar experience in which her care provider did 
not consider epilepsy as the cause of her symptoms. She explained, “All those months 
while we were trying to figure it out…no one said anything about seizures. It was just not 
on the table…. A brain doctor was not involved until I asked for a referral.” 
Two participants explained that an accurate diagnosis was delayed because they 
first were misdiagnosed with other conditions. One female participant was initially told 
she was suffering from early-onset dementia. She explained: 
My main complaint was that I was losing and forgetting things. So he did 
the MRI and it was normal…and they said early dementia, like 
Alzheimer’s. I took pills for that, and I just got worse. Every time I went 
back they would diagnose me with something different…so it took almost 
a year and a half to get the right diagnosis. 
In all but one case, participants who contributed their delay in diagnosis to their 
providers felt that the delay was caused by their primary care providers—the providers to 
whom they first went for treatment. In most cases, once participants were referred to a 
neurologist, their diagnosis was made quite rapidly. “[The neurologist] knew what he was 
doing…. It just took a lot of time before I was sent to him. But after I saw him he knew 
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just what it was,” explained one participant. One female participant, though, had a 
different experience. Her primary physician referred her to a neurologist very quickly, but 
she identified the neurologist as causing a significant delay in diagnosis. “He never 
believed that I was having seizures…. He really made me believe I was just going nuts,” 
she stated. She eventually was diagnosed, seven years later, by a different neurologist 
after having a generalized seizure during an out-of-state vacation and currently is being 
treated by a local neurologist. 
Other participants (n = 3) expressed that their own actions caused the delay in 
diagnosis. All of these participants were women, and all of them experienced ambiguous 
seizure symptoms. Each woman reported not seeking medical care for her initial seizure 
symptoms for various reasons. One of those reasons was lack of time. “I was still 
working at the time…. It was low on my to-do list…. I just kept ignoring it because I 
didn’t have time to deal with it,” explained one participant who ultimately was taken to 
the emergency room after experiencing a seizure at work. These women also failed to 
seek treatment due to attributing their symptoms to normal signs of aging or other 
diseases. One participant’s initial symptom was memory loss. “I thought it was just 
aging,” she stated when explaining why she waited several months before seeking 
treatment. Another assumed she was falling victim to the disorder that took her father’s 
life—Alzheimer’s—and failed to seek treatment because she did not want to accept such 
a diagnosis. She explained, “The fluttering in my head started when I was 72…. I thought 
there was a possibility that maybe that was the beginning of Alzheimer’s…but I just tried 
to wait and see because I didn’t want to face that.” Interestingly, two of these women 
reported that during the time of their initial seizure symptoms they saw their healthcare 
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providers for other reasons, such as an upper respiratory infection, but did not mention 
their seizure symptoms. Both women felt uncomfortable mentioning these symptoms to 
their providers. Explained one participant, 
I don’t know exactly why I didn’t mention it to him…. I guess I was sort 
of embarrassed. My symptom was my husband was telling me I was 
acting silly and saying weird things…even though I didn’t remember 
doing it. I didn’t know who to tell. 
Two participants felt that the delay was caused both by their primary care 
providers and themselves. These participants did not immediately seek treatment and, 
when they did, their providers did not refer them quickly to a neurologist. Their reasons 
for delay in seeking treatment were the same as some of those reported by participants 
who felt that they caused their delay in diagnosis themselves: lack of time and attribution 
of the symptoms to aging. “I just figured, you know, I’m 74. Things are starting to break 
down…. I thought it was a natural process until I fell and got hurt…that’s when I went to 
the doctor,” explained one participant. When he was seen by his doctor, he was 
misdiagnosed with syncope secondary to hypotension. He then was diagnosed with atrial 
fibrillation, and his physician attributed his seizure symptoms to that condition. “They 
kept finding stuff wrong, and every time they did they said ‘Oh, that’s what’s causing it.’ 
So it took quite some time to figure out it was seizures,” he stated. The other participant 
in this group had a similar experience—her care provider initially attributed her 
symptoms to a thyroid disorder, which resulted in a delay in an accurate diagnosis. 
No delay. Seven participants (two women, five men) were diagnosed with 
epilepsy within three months of experiencing their first seizure symptom. Three of the 
five men in this group sought treatment within a month of their first seizure treatment and 
quickly were referred by their providers to a neurologist. “No, there was no delay. The 
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first guy sent me to the second one, and he figured it out,” explained one participant 
about his diagnosis process. These participants explained that they sought treatment 
quickly because their symptoms were interfering greatly with their daily activities or their 
loved ones urged them to do so out of concern. “After the first couple of episodes I was 
afraid to get on my ladder, and I was working on painting that barn back there…and I 
wanted it done before winter, so that’s why I went to the doctor,” explained one 
participant. Another went because his family was concerned about him. “My daughter 
thought I was having a stroke…. She told my wife…. So my wife knew, my daughter 
knew. They went on alert, watchin’ my every move. And finally they convinced me to go 
in,” explained one participant. The other two men did not seek treatment immediately 
but, when they did, they were referred to a neurologist quickly enough to allow them to 
be correctly diagnosed within three months. 
Summary. When asked about their experiences being diagnosed with epilepsy, 
participants spoke chiefly of how long it took them to be accurately diagnosed. The 
majority of the sample (65%) experienced a delay in diagnosis due to actions of their care 
providers, themselves, or both. Care providers prevented a timely diagnosis by dismissing 
participants’ concerns, not considering epilepsy as a possibility, and/or misdiagnosing 
them with other conditions or attributing the symptoms to an existing condition or to 
aging. Some participants failed to seek immediate treatment for their epilepsy symptoms 
due to lack of time to seek medical attention, attribution of symptoms to old age or other 
diseases, and embarrassment. The remainder of the sample experienced no delay in 
diagnosis and either sought treatment for their symptoms immediately and then were 
referred in a timely manner to a neurologist or did not seek treatment immediately but 
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were referred immediately to a neurologist by their primary care providers and were thus 
diagnosed promptly. 
Because participants found a delay in diagnosis to be so problematic, specific 
attention was given to this aspect of their experiences during analysis to determine 
characteristics of the sample that appeared more frequently in those who experienced a 
delayed diagnosis versus those who did not. The display of data represented by Table 10 
was constructed to allow the researcher to determine the differing or common 
characteristics between and among women and men who experienced a delayed 
diagnosis, given that women more frequently experienced this phenomenon. One 
difference between women and men whose diagnoses were delayed is seen in the type of 
seizure symptoms most commonly seen in those who were diagnosed late. All three men 
who experienced a delay in diagnosis initially demonstrated ambiguous seizure 
symptoms, while five of the women whose diagnosis was delayed experienced classic 
seizure symptoms, and five of them experienced ambiguous symptoms. In both men and 
women, those living in rural areas were more likely to experience a delay in diagnosis 
than those living within city limits. Thus, participants who were female, presented with 
ambiguous seizure symptoms, and lived in rural areas most frequently experienced a 
delay in diagnosis. However, it is significant that men, regardless of rural or city-dwelling 
residence, were more likely to experience a delay when they demonstrated ambiguous 
seizure symptoms, while women demonstrating both classic and ambiguous symptoms 
experienced a delay in diagnosis. 
To determine if women and men who experienced a delay in diagnosis were 
similar or dissimilar in terms of level of education or income level, Table 14 was 
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constructed. The majority of women receiving a delayed diagnosis were well-educated 
(college graduates or beyond), while none of the men who were diagnosed late in life 
held college degrees. Seventy percent of women diagnosed late in life had an annual 
income greater than $60,000 annually, while all of the men diagnosed late in life had an 
income between $21,000 and $60,000 per year. Thus, women who were more educated 
and affluent experienced a delayed diagnosis, while the opposite was true for the men. 
Table 14 
Characteristics of Those with Delayed Diagnosis 
Dwelling Symptom Type Education
a
 Income
b
 
Women 
Rural (n = 6) 
City-dwelling (n = 4) 
Classic (n = 5) 
Ambiguous (n = 5) 
< 12 (n = 1) 
12 (n = 1) 
12– < 16 (n = 1) 
16 (n = 6) 
18 (n = 1) 
< 20 (n = 1) 
21–40 (n = 2) 
41–60 (n = 3) 
61–100 (n = 3) 
> 100 (n = 1) 
Men 
Rural (n = 2) 
City-dwelling (n = 1) 
Classic (n = 0) 
Ambiguous (n = 3) 
< 12 (n = 0) 
12 (n = 1) 
12– < 16 (n = 2) 
16 (n = 0) 
18 (n = 0) 
< 20 (n = 0) 
21–40 (n = 2) 
41–60 (n = 1) 
61–100 (n = 0) 
> 100 (n = 0) 
a
Education in years. 
b
Income in thousands of dollars. 
What is epilepsy? Prominent in participants’ descriptions of their diagnosis 
processes were stories about their understanding of the disease of epilepsy. This theme is 
comprised of four sub-themes: (a) Older People get Epilepsy? (b) Understanding of 
Epilepsy, (c) Post-Diagnosis Information and Education, and (d) Patient/Provider 
Perspectives on Diagnosis. 
Older people get epilepsy? All 20 participants reported shock at receiving an 
epilepsy diagnosis and had never considered epilepsy a disease that could strike in older 
adulthood. The unexpected nature of the diagnosis was present in all cases, including 
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those for which the cause of epilepsy was unknown, as well as those in which there was a 
clear cause of the condition, such as a stroke. One participant reflected on her initial 
response to being diagnosed with epilepsy, stating: 
It was absolutely the last thing I expected in the world. I had spent all that 
time trying to figure out what’s wrong with me, and I had all these ideas, 
but never that. I thought that little kids got seizures…. It never entered my 
mind that that was something I could pick up at the age of 78. We were 
totally thrown for a loop by it. 
Somewhat surprisingly, the unexpectedness of the diagnosis was present equally 
in both those who experienced ambiguous seizure symptoms and classic seizure 
symptoms. Those who had had ambiguous symptoms were shocked at a diagnosis of 
epilepsy because their symptoms did not resemble those that they believed would have 
been associated with the condition. “I never would have guessed seizures…. What they 
were telling me [I was doing] did not sound anything like a seizure,” explained one 
participant whose main symptom had been bizarre behavior, such as giving away her 
personal belongings to strangers. While those exhibiting classic symptoms often did 
recognize that they were having seizures, they did not expect to be diagnosed with the 
chronic disease of epilepsy. “I thought I had a seizure, yeah, but I never thought I was 
gonna keep having them and have to keep taking medicine forever,” stated one male 
participant. 
Many of the participants (n = 17) explained, without prompting by the researcher, 
that they had never known that older people were susceptible to new-onset epilepsy. The 
remaining three participants reported this same lack of knowledge when asked explicitly 
by the researcher if they had been aware that older people could get epilepsy. “I thought 
this was something that happened to babies, or to little kids…. Everyone I’ve heard about 
with it always got it young,” said one female participant. Interestingly, over half of the 
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sample (n = 12) were still unaware, at the time of their interviews, that epilepsy is most 
commonly diagnosed in older adults. All 12 participants mentioned, at least once during 
their interviews, how rare they felt their conditions are for persons their age, as is 
evidenced by the following quote from a male participant,  
I guess I just got unlucky enough to get something like this at this age…. 
I’ve never heard of an old guy getting epilepsy…. Maybe that’s why it has 
been so hard to control, because not that many old people have been 
through it. 
Understanding of epilepsy. In addition to their lack of knowledge regarding older 
adults’ risk for new-onset epilepsy, most participants (n = 17) had many other 
misunderstandings about their condition, including its potential causes, prognosis, and 
treatments. Some participants’ (n = 12) misunderstandings existed only at the time of 
diagnosis and for a short time after. “I just assumed it was genetic, that it ran in my 
family but I just didn’t know it…. Not until a year or so ago did I realize that was not 
true,” explained one participant. Another participant had a misunderstanding about the 
prognosis of her epilepsy, and stated, “I left thinking I was gonna die. I mean it’s your 
brain. I’d never heard the word epilepsy…. They didn’t say seizure, they said epilepsy. I 
called my daughter crying, and she said ‘Mom, it doesn’t mean you’re going to die!’” A 
male participant found himself initially confused about the treatment of epilepsy. He 
explained, 
After they told me, I got nervous because I had a friend who had brain 
surgery…. I just assumed that was gonna be me because of this. I took the 
pills for six months and finally asked my wife if she thought this doctor 
was going to do surgery on me…and she told me I didn’t need surgery, 
just pills. 
Five participants, at the time of their interviews, still had significant 
misconceptions about their epilepsy. One male participant believed that his anti-epileptic 
 157 
medication would cure his condition. “I’ve been takin’ it for a year now…. I reckon in 
another year it will have healed it.” He also believed that if he ever stopped having 
seizures for more than a month, this would indicate the eradication of his epilepsy and he 
could discontinue his medication. A female participant explained that she still did not 
understand exactly what epilepsy is. “I don’t know what happens…. I know there is a 
connection between my brain and rest of me when it happens, but I don’t know what 
makes it happen,” she said. 
The remaining three participants indicated that from the time of their diagnosis 
they had a satisfactory understanding of what epilepsy is, as well as its causes, prognosis, 
and treatments. Two of these participants had known of other people with epilepsy, and 
one was a practicing nurse. “I knew what epilepsy was…. I knew it was something that 
I’d probably have forever and that taking the medications…was very important,” 
explained a female participant. 
The group of participants who had either initial or persisting misconceptions of 
epilepsy was comprised of 11 women (91% of all female participants) and six men (75% 
of all male participants), indicating that a significant portion of both genders in the 
sample had or have misunderstandings of epilepsy. Interestingly, the group also was 
comprised of participants with a variety of educational backgrounds: two had not 
completed high school, two had some college, four had high school diplomas, six were 
college graduates, two had master’s degrees, and one held a doctoral degree. 
Post-diagnosis information and education. Participants spoke often of the 
information and education that were given to them immediately after diagnosis. Among 
the participants, 15 were displeased with the information given to them at and after 
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diagnosis, while 5 participants were satisfied with the amount and type of information 
they received about their condition. None of the participants reported receiving any 
formal education about epilepsy or how to manage it. All participants received 
information about their disorder from their neurologists or primary care providers. 
Interestingly, the 15 participants who were displeased with the information they 
received about their disorder reported that they were not as bothered by the lack of a clear 
cause of their condition as they were by providers’ unwillingness to discuss the topic. A 
female participant relayed her frustration with her provider’s refusal to even hypothesize 
as to what caused her epilepsy, stating, “Once we knew there was no brain tumor, he said 
it doesn’t matter what caused it…that it would be treated the same no matter what…. But, 
it mattered to me.” A male participant described a similar experience. After he was 
diagnosed with epilepsy, he was told that the cause was unknown. After much research, 
he himself conjectured that an old high school football injury may have caused his 
condition, though his physician was not interested in discussing it. This participant 
explained, “[The healthcare provider] made it clear that he didn’t care what caused it, and 
he jokingly said something like if I wanted to believe it was a battle scar from football 
that was fine…. That actually kind of hurt my feelings…and is why I changed 
neurologists.” 
These 15 participants reported that lack of information given to them about the 
pathophysiology, prognosis, and treatment of epilepsy was particularly troubling. Only 
very basic information was given to these participants about their condition, and it was 
often given in terms they found difficult to understand. One female participant stated, 
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They said the wiring in my brain misfired…but I didn’t even know what 
that meant. I had this vision of wires in my brain. I didn’t say anything at 
the time because I didn’t want to seem stupid…but I had no idea what they 
were talking about. 
Another older adult found herself unsure of her prognosis and treatment. She explained, 
I didn’t really know what this meant for me…. They didn’t say if it would 
go away or not or if I should stop taking the pills when I felt better. They 
said the brain does this and that but not what that meant for my life. 
Other participants could not remember the information that was given to them 
because the information was not provided in written form. A female participant noted, “I 
felt like I was supposed to know what epilepsy was…. They just started the conversation 
like I already had all of this information…. I was confused. Then I forgot everything by 
the time I got home.” However, other participants complained that being given written 
information without any verbal explanation was just as dissatisfying; one male participant 
explained, “They handed us a brochure…like welcome to epilepsy. It had a lot of 
technical mumbo jumbo…. We aren’t dumb but we didn’t know anything about the brain 
so it was more irritating than helpful.” Many of these participants (n = 10) noted that they 
were embarrassed to mention that they did not understand the information given to them. 
“I just didn’t say anything…. I just decided to try to figure it out myself,” explained one 
participant. 
Some participants (n = 11) explicitly mentioned that they had expected and 
desired some kind of formal education about their epilepsy at the time of diagnosis or 
shortly thereafter. Some of these participants (n = 7) compared the information and 
education they received about their epilepsy to that which they received when they were 
diagnosed with other chronic conditions, and felt that they received much more 
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information and education about their other conditions than they did about epilepsy. One 
participant explained, 
When I had my stroke, they gave me all kinds of information…a big bag 
full. I met with a nurse three or four times, and they told me about all the 
medications I would be taking, how things would change…. None of that 
happened with this…. It was like being served cold leftovers. 
Another participant reflected similarly on her diagnosis with Crohn’s disease. “That was 
a big deal in terms of teaching. Lots of information…about diet, when to call the doctor. 
When I was diagnosed with this, it was like nothing, like I just had a cold,” she stated. 
Only five participants, all of whom were male, were satisfied with the education 
and information they were given at the time of diagnosis. As discussed previously, three 
of these participants felt satisfied with the information they received because they did not 
desire much information at all. The remaining two participants, however, found the 
information that they received to be helpful and well-delivered. “When I left there I knew 
what epilepsy was…. He explained all that to me. He also explained all about the 
medication…so I’d say we were happy with that and knew what we were dealing with,” 
stated one male participant. 
Because the information received at diagnosis appeared so integral to participants, 
the researcher specifically questioned them about the exchange during which the 
information was presented from care providers to participants (in half of the cases, 
participants shared this information without prompting). All of the participants reported 
that information was given to them by their neurologists or primary care providers,  
and 16 of them explained that the information given to them was not based on their 
questions to their provider. “I didn’t feel real comfortable asking too much…. I just 
listened to what he said,” explained one participant as she reflected on the information 
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she had been given about her disorder. These participants reported that they did not ask 
questions, as evidenced by the previous quote, because they did not feel comfortable 
doing so, or because they simply did not know what to ask. “I was in shock…and I was 
also recovering from a seizure when they came in and told me. So I was groggy. I did not 
realize until after I left…when I was living the epilepsy, what my questions were.” The 
remaining four participants explained that the information they received was offered from 
their providers with and without questions being asked. “He told me some things then I 
asked questions about it…about what he said,” explained a male participant. 
Patient/provider perspectives on diagnosis. In the majority of cases (n = 13), 
participants expressed a mismatch between their and their providers’ perceptions of the 
seriousness of being diagnosed with epilepsy. Participants felt that providers downplayed 
the seriousness of their disorder, leaving the older adults unprepared for the ways in 
which their lives would be affected. For example, one participant likened his experience 
to being diagnosed with the common cold. “They did not make over it like it was a big 
deal…just like I had a cold or something. Nobody even flinched,” he explained. Another 
male participant, whose epilepsy was caused by a stroke, reflected on his experience of 
being given information about his new diagnosis of epilepsy: 
I left the hospital not really even thinking about the epilepsy…. It was 
glossed over. Just kind of thrown in there by the doctor…barely 
mentioned. He had said I had to take these pills because I had a seizure. 
And that I had to see a neurologist, which I wouldn’t do until three months 
later. My wife had asked him something about the seizure, and he literally 
said, “It’s no big deal, just take the medicine.” So we kind of assumed I 
probably wouldn’t even have another [seizure]. But when we got home, a 
few weeks after that, it really was a big deal. At least for me…. He should 
try not driving for six months! When I got to see the neurologist, he was a  
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lot more informative, but still did not seem to recognize it as the major 
blow it was to my life…and to my wife’s. My new neurologist, she gets it. 
But the first one I went to…he had not a clue what we go through…this 
disease is not simple, and it can change your life. 
Other participants explained that they did not understand that epilepsy, if left 
untreated, could result in death. One female participant noted, 
No, we had no idea…until we went back to the doctor because I was still 
having them. And she explained that it was so very important for me to 
take my medication, but for some reason when I was first diagnosed I did 
not get that…. I was not as careful with my medicine as I should have 
been because I did not think it was that serious. 
Participants were asked to compare their providers’ perspectives on their epilepsy 
diagnosis with those of their other chronic conditions. The majority of these participants 
(n = 10) felt that this mismatch in perspectives did not exist with their other chronic 
diseases, such as diabetes and Crohn’s disease. Participants felt, when diagnosed with 
these conditions, that their care providers communicated the seriousness of the condition. 
“With diabetes…it was made real clear to me that I had to do these things or I could die. 
And I also knew my life was gonna change because of it,” explained one participant. She 
went on to say, “it was not that way with [the epilepsy]…. I thought it was a big deal but 
my doctor didn’t.” 
A small number of participants (n = 3) noted that they did experience a similar 
mismatch when diagnosed with other conditions, including hypertension and arthritis. 
“They never made a big deal about it…but the blood pressure medicine and everything, it 
was not pleasant…I stopped taking it, and I had a heart attack. I never knew I was that 
sick,” explained a male participant. 
No participants reported that their care providers perceived their epilepsy 
diagnosis to be more significant than they did themselves.  
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Research Question Two 
The second research question pertained to problems participants have experienced 
while self-managing epilepsy. Table 15 displays the main themes and sub-themes that 
emerged regarding this question. 
Table 15 
Themes for Research Question Two 
Theme Sub-Theme(s) Frequency 
Maintaining 
Independence 
Transportation 
Continuing life as normal 
n = 8 
n = 16 
Medications Financial concerns 
Side effects 
Polypharmacy 
Remembering 
n = 11 
n = 19 
n = 9 
n = 12 
Achieving Goals  n = 15 
Memory  n = 13 
Maintaining independence. The majority of the participants in the sample  
(n = 18; 90%) indicated that they had experienced or were experiencing difficulties 
maintaining their pre-diagnosis levels of independence. Some of these problems were 
related directly to issues surrounding transportation, and others were related to continuing 
life as normal. 
Transportation. Among the participants, eight reported that since being 
diagnosed with epilepsy, they had struggled to maintain their independence as a 
consequence of driving restrictions. Interestingly, these participants comprised the 
youngest portion of the sample (mean age 63 years, range 60–65 years). As well, six of 
these participants lived in very rural areas without public transportation. All of these 
participants were unable to drive for six to nine months following their diagnosis, and 
two still were unable to drive due to lack of seizure control. These participants reported 
 164 
difficulty in independently managing areas of their lives that required driving, such as 
work or family responsibilities, as well as living spontaneously. As one participant 
explained, 
It was so much more difficult to do simple things…like getting groceries. 
My husband works full time and my kids live out of state. We live out 
here in the middle of nowhere. There is no bus…. There is no grocery for 
almost 20 miles. So I had to get a ride. And I’ll never forget the time I 
took a cab into town because I had to make a cake for church, and I didn’t 
have the ingredients. The cab cost me almost $40. I got home, and realized 
I forgot to get condensed milk. I broke down in sobs. I was…so frustrated. 
All I wanted to do was make a cake…. It shouldn’t have been that hard. I 
was at the mercy of others to get done what I was trying to do on any 
given day. And I spent another $40 and all day going back for the stupid 
condensed milk. 
Another participant felt that he was unable to live spontaneously due to his 
driving restrictions and explained that he was forced to rely on others. He explained, 
It’s sometimes been hard to recognize that this is still my life…. You don’t 
realize how much you do or want to do until that’s all taken away. I’m 
dependent now in many ways…and I hate it but I’ve had to deal with it. 
Of note is that almost all participants (n = 6) who had difficulties with 
transportation, including those who were still unable to drive, felt that these problems 
were worst immediately following diagnosis and tended to lessen with time. These 
participants credited the attenuation of this difficulty to devising a system for 
transportation. As one city-dwelling participant explained,  
It was horrible at first…because I never planned. Now I have 
this…system. I use the buses…. I figured out which ones are the quickest 
routes to where…. So, no, I can’t drive anymore, but I still get around 
when I need to.” 
A participant living in a more rural area also had devised a system to assist with her 
transportation needs. She stated, 
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We are on our own out here, and that was very tough…but there are some 
neighbors all around, you just can’t see them because of these trees. We’re 
mostly old out here…. I had the idea of putting together a women’s car 
pool into town twice a week. I did it by saying it was to save money on 
gas…. They are very frugal. Of course that was not the real reason, but it 
worked for them. So we take turns driving…when it’s my turn I just let 
one of them drive my car, so it’s my gas and my car being used. I know I 
have two days a week…to get everything done in town. And I simply plan 
around that. 
Continuing life as normal. Many participants (n = 16), including some who cited 
loss of independence related to transportation, also had problems maintaining their  
pre-diagnosis levels of independence in ways that were not related to transportation. 
These participants found themselves less independent during their everyday activities due 
to epilepsy, and thus had difficulty continuing life as normal. As one participant 
explained, 
It’s the little things…. I can’t change those light bulbs up there, the ones in 
the ceiling. I can’t go getting on a ladder. If I seize and fall from there, I’m 
probably going to die. So those two lights there have been out for almost 
six months. I’m waiting for my son-in-law to come do it…boy, I wish I 
could still do those things myself again. 
Another participant was forced to sell her home and move into an assisted living 
facility because of her epilepsy. She explained,  
They didn’t feel right me being at home…. My daughter insisted that I 
move into some kind of community. It was too much for me to take care 
of my house with the lawn. And I need help with things now. 
Other participants reported that their epilepsy, or the side effects of their seizures 
and/or treatments, prevented them from living independently. One female participant 
related that the frequency of her seizures and post-ictal fatigue forced her to move in with 
her daughter and then eventually to an apartment near her daughter. She explained: 
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I literally could not take care of myself…if I wasn’t having a seizure, I 
was so tired I couldn’t do anything because of the meds. I wouldn’t  
eat…. It just became a nightmare for my daughter trying to be with me all 
the time. It was just best that I moved near her…. She had to take care of 
me. 
Unlike that which was seen in the sub-theme of transportation-related lack of 
independence, there does not appear to be a temporally related waning of  
non-transportation-related difficulties involving independence. 
Medications. All participants reported experiencing problems with their 
medications—both those used to treat epilepsy and those they were taking for other 
conditions. 
Financial concerns. More than half of the participants in the sample (n = 11) 
reported that they had financial difficulty paying for their epilepsy and/or other 
medications. All but one of these participants had Medicare insurance, while one was 
uninsured. Those receiving Medicare explained that financial problems surfaced when 
they entered the donut hole—a gap in Medicare coverage—each year. As one participant 
explained, “I’m usually okay until I get to that donut hole. Then I have to dip into my 
savings…and that savings just keeps shrinking. Not sure what to do when it’s gone.” 
Other participants did not have the luxury of a savings account and either relied on family 
to help them with medication costs or simply did not fill prescriptions for their  
anti-epileptic drugs. “Sometimes it’s like pay the electric or get my medicine…. I want 
my lights on,” explained one female participant. 
Participants (n = 10) also explained that costs of their medications taken for other 
conditions often competed with costs required for their epilepsy medications, especially 
in the midst of a donut hole. Explained one male participant: 
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It’s not just one thing I’m trying to pay for during that time. I also have 
arthritis, diabetes, blood pressure, and gout. I mean what are you gonna 
do? You choose whichever ones are bothering you most right then, and 
you buy those. Skip the rest til the donut hole’s over. 
As well, nine of these participants had spouses who also had chronic health 
problems for which medications are required, which caused further financial strain for 
some of the participants. Explained one female participant, “Around the same time of my 
epilepsy, he was diagnosed with cancer…. We have a lot of medication bills each month, 
and if something has to be given up it’s the seizure pills.” 
Some participants (n = 3), all of whom were women, noted that they often had 
difficulty purchasing their epilepsy medications because of general financial distress 
caused by non-epilepsy-related issues, such as continuing to support adult children or a 
significant other. These issues ranked higher in priority to participants than did 
purchasing their epilepsy medications. As one female participant relayed, 
I have a younger son, I’m helping him with money right now. It’s more 
important for me to make sure he’s got food on his plate than to make sure 
I don’t have a seizure. I have a seizure, so what? Who cares? I wake up 
and I’m fine, right? 
Side effects. All but one of the participants noted the regular experience of 
epilepsy medication side effects. Participants reported experiencing the following  
anti-epileptic medication side effects: somnolence (85%), fatigue (60%), impaired 
concentration (60%), dizziness (40%), gastrointestinal upset (30%), loss of appetite 
(30%), irritability (20%), and memory problems (5%). Participants explained that they 
often suffered from more than one side effect but, for the majority of participants  
(n = 17), somnolence and fatigue were the most troubling because of their effects on 
participants’ abilities to carry out their normal activities. “I’m an avid reader…but on that 
medication I just fall asleep. I miss my reading,” explained one female participant. 
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Polypharmacy. None of the participants were managing epilepsy in isolation—all 
of them had at least one other chronic condition. As a result, some participants (n = 9) 
had problems stemming from polypharmacy. As mentioned previously, these 
participants’ complex medication regimens can lead to financial issues surrounding 
medication. Others (n = 7) found that the mixing of medications exacerbated side effects 
or made them feel unwell. For example, a female participant explained, “It’s just a lot. I 
don’t just take these. I take some for high blood pressure, some for diabetes, some for 
thyroid. Taking them close together makes me feel sick and foggy.” Many participants  
(n = 12) expressed that their already complex medication regimens were made even more 
so by the addition of epilepsy medications, as explained by a male participant who stated, 
“It’s just one more variable to keep after…. I take over 12 pills a day now. With each 
new one, I get more confused about what I’m supposed to be doing.” 
Remembering. Among the participants, 12 reported having difficulty 
remembering to take their epilepsy medications, especially in the first year after 
diagnosis. Most of these participants (n = 9) claimed that they often take these 
medications late, while a minority of the participants (n = 3) reported that they miss doses 
on a regular basis. Participants blamed these late and missed doses on a decline in their 
memory since being diagnosed with epilepsy and the complexity of their medication 
regimens. “I just can’t always remember,” stated one participant. She continued, “I’m 
foggy up here…ever since I got this, it just takes me longer to remember things…. I’ve 
been being late on all my medicines since this.” A male participant explained that he did 
not necessarily forget to take his epilepsy medication, but that he sometimes became 
confused about which of his nine medications should be taken at which time of day. This 
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confusion especially was pronounced at the time of his interview given that he had 
recently experienced changes in both his epilepsy and Parkinson’s disease medications. 
He explained: 
I can’t tell you exactly how many times I’ve made a mistake, but I know 
that sometimes I get really mixed up about what I should take and when. 
And I may get to the end of the night and realize…I didn’t do it right. I 
have one left over or something. You can feel how heavy this box is…. 
It’s full of pills and I can’t always keep it right on track…and they keep 
changing them, too. 
Achieving goals. A majority of the participants (n = 15) reported that they had 
experienced difficulty achieving some of their goals since being diagnosed with epilepsy. 
The majority of these goals were related to their personal lives. In 12 cases, participants’ 
difficulties were related to their ability to be grandparents in ways they had imagined 
before being diagnosed with epilepsy. They found that their lack of independence 
coupled with seizure symptoms and medication side effects made grandparenting more 
difficult than it was pre-diagnosis. One female participant reflected on the problems she 
has faced in this area, 
Before…I saw them almost every day. They’d call and say “let us stay all 
night with you, granny.” And you know I never said no. I would make a 
big dinner for them, and we’d watch movies and eat popcorn. Stay up late. 
I just…can’t do all that now. I’m too sleepy from the medication or if I’ve 
had a seizure. And I can’t drive to go pick them up. I have no energy for 
them, and it’s devastating to me. This is not how I pictured being a 
granny. 
Others noted that they did not feel it was safe for them to supervise small 
children. One male participant explained, “I’m not fit to take them out on the fishing boat 
anymore…the young one especially. It’s hard for me but I can’t do it anymore.” 
In three cases, participants became grandparents for the first time after being 
diagnosed with epilepsy. These participants, in particular, found that they were not able 
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to grandparent in the ways in which they had imagined. One female participant 
explained, “That fantasy of being perfect grandma…taking care of the baby so mom and 
dad can sleep…it’s just not going to happen for me.” 
Memory. Among the participants, 13 specifically mentioned having memory 
problems since being diagnosed with epilepsy. In all 13 cases, participants felt that their 
short-term memories had suffered. Participants noted problems not only with 
remembering to take medications, as described previously, but also misplacing items, 
forgetting appointments, and not recalling previously held conversations. These 
participants found this memory loss to be very distressing and problematic. Explained 
one male participant, “The worst thing since has been my memory. I can’t keep track of 
anything…. It makes everything hard. I don’t know if it’s seizures or the pills, but I just 
forget things I never used to would’ve.”  
Research Question Three 
The third research question pertained to the perceived changes in participants’ 
lives that had occurred since the onset of epilepsy. Table 16 displays the themes and  
sub-themes that emerged for this question. 
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Table 16 
Themes for Research Question Three 
Theme Sub-Theme(s) Frequency 
Negative Changes Lifestyle 
Social 
Relationships with family and friends 
Number of important commitments made 
Daily functional abilities 
Ability to fulfill age-appropriate roles 
and responsibilities 
Changes in perceived well-being 
Physical and emotional symptoms 
 
 
n = 13 
n = 12 
n = 16 
N = 20 
n = 12 
 
n = 9 
N = 20 
Positive Changes Relationships with family and friends 
Perspective 
Spirituality 
n = 4 
n = 5 
n = 5 
Negative changes. All participants mentioned experiencing negative, or 
undesirable, changes since the onset of their epilepsy. These negative changes can be 
categorized as lifestyle changes, changes in perceived well-being, and physical and 
emotional changes. 
Lifestyle changes. Participants described experiencing negative changes in their 
general ways of life. These negative changes are discussed in the sub-themes in this 
section. 
Social. Participants (n = 13) reported that their social lives were affected 
undesirably by epilepsy and its associated treatments and restrictions. Some (n = 6) 
reported that lack of transportation kept them from enjoying their pre-diagnosis social 
life. “It’s hard to get anywhere…. We used to go to the breakfasts twice a week with 
church. But [my wife] doesn’t drive and now I’m not supposed to either…. We miss it,” 
explained one male participant. Others (n = 9) found that stigma, or fear of 
embarrassment as a result of having a seizure, kept them from pursuing their usual social 
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endeavors. One male participant, who continues to work full time, explained that he now 
forgoes socializing with his colleagues due to fear of having a seizure in front of them. “I 
don’t want to risk that…maybe later once I’m more used to it…but it would be 
devastating to me for them to see that. So I just quietly avoid anything extra outside of 
work,” he stated. A retired female participant explained that she no longer ventures out of 
her house alone for fear of having a seizure and embarrassing herself. “My social life…is 
completely destroyed. But I won’t do what I used to do…even little things like go to a 
card party. I just don’t want to make a fool of myself,” she explained. 
Others (n = 3) found that their usual social activities did not mix well with 
epilepsy. “Whenever I get together with my colleagues, we have a few drinks. That used 
to be fine, but on this medication I am drunk after two glasses of wine…so I just don’t 
go,” explained a male participant. Another participant who enjoyed hiking with her 
husband and their friends explained that she abandoned the hobby as a consequence of 
fear of injury. “It was my favorite thing to do…but I have fallen so many times during an 
episode that it is not worth the risk,” she explained. 
Relationships with family and friends. A majority of participants (n = 12) had 
experienced undesirable changes in their relationships with family members and friends 
as a result of their epilepsy. Alterations and reversals in usual roles were the cause of 
changes experienced with family members. For example, many (n = 9) participants 
became more reliant on family members and were unable to carry out their usual 
responsibilities at home. One female participant explained: 
We’ve been together almost 40 years, and we love each other, but we’ve 
been real independent. I had my things…. He had his. With this, it was a 
big change there. He had to…for the first time ever, he had to help me. 
There was no more give-you-a-kiss and I’ll see you later. He had to hover, 
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and I hated that. But it was necessary. And even now he hovers. My whole 
family does. It’s like I went from being wife and mother to child. 
Another participant reported a similar role reversal with her adult child. “She took 
care of me instead of the other way around…. It’s not supposed to be that way,” she 
stated. 
Relationships with friends were altered most by the social isolation that resulted 
from the diagnosis. Participants felt that their lack of ability to participate in normal 
activities negatively affected their friendships. “I can’t do what I used to be able to do. 
And that’s not going to go away…. I don’t think I’ll ever be able to have fun with my 
friends like I used to,” explained one female participant. Others found that they felt more 
comfortable isolating themselves from their friends as a consequence of embarrassment 
and a lack of desire to disclose their diagnosis. One male participant explained, “It was 
just easier to kind of fade out for a while so I wouldn’t have to tell anybody…but by the 
time I wanted to come back in I felt like I’d distanced myself from [my friends] too 
much.” 
Number of important commitments made. Many participants (n = 16) also felt that 
they could no longer manage and keep as many important commitments as they could 
pre-diagnosis. Those who still were working began working fewer hours once they were 
diagnosed. Explained one male participant who worked as a crossing guard, “I went from 
part-time down to really part-time…one day every other week. It’s all I can do now.” A 
few participants (n = 2) found that they could no longer keep their jobs after being 
diagnosed. “They took my job away from me…that was the worst part, but I understood 
that it was not safe,” explained a female participant who is now on permanent disability 
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due to her epilepsy. Others who no longer were working found that they simply could not 
keep as busy of a schedule. As one female participant explained: 
It took me a while to accept that I was going to have to put the brakes on. 
My volunteering was like a full-time job to me. At least six hours a day I 
was involved with the church or our missions groups. Seizures took that 
away. I can do a little bit but, no, not what I could do even right before all 
this started. 
Daily functional abilities. All participants noted undesirable changes in their 
abilities to carry out normal, daily activities. These abilities included self-care and 
general household responsibilities. One female participant explained how even the way in 
which she gets dressed every morning has been altered. “I have to sit in a chair…and I 
don’t do it in the bathroom. I fell once and got stuck between the tub and toilet. So to be 
safe I sit in a chair, but I wish I didn’t have to,” she stated. Others felt that seizure- and 
medication-related fatigued severely limited their ability to carry out normal functions. 
“It’s hard to sit and wonder…will I have the energy to do what I have to do today. What I 
want to do is no longer considered,” explained a female participant. 
Ability to fulfill age-appropriate roles and responsibilities. Participants (n = 12) 
experienced undesirable changes in their ability to fulfill age-appropriate roles and 
responsibilities. As described previously, most of these changes surround the role of 
grandparenting. Participants felt that they could no longer fulfill this role in the same way 
that they could prior to diagnosis. One grandmother explained that this change was the 
most difficult she had experienced in relation to her epilepsy: 
What do most normal grandmas do? They take the baby for the 
parents…and no one worries about anything. That really is just not an 
option for me. My daughter won’t leave her baby in the room with me 
unattended…and she won’t let me babysit the older one anymore. I don’t 
blame her, I guess, but it makes me very angry. All the sudden no one can 
trust me to do what I am supposed to be doing…what I’ve looked forward 
to doing since I retired two years ago. 
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A male participant whose wife lives in a nursing home expressed a similar 
sentiment regarding his ability to maintain what he felt were his responsibilities for her: 
I can’t go visit her every day like I want to anymore…. I used to spend all 
day, every day there with her. But I can’t now because I don’t have the 
stamina and I can’t always get a ride. It’s been horrible. 
Other participants felt that their family members—in most cases, their spouses or 
adult children—had to take on responsibilities that they themselves should have been 
fulfilling. As one female participant explained, 
My husband had to start doing the grocery shopping. What a mess! He 
kept saying he could do it but you should have seen what he brought 
home…. So I had to give him all types of instructions or go with him. It 
was a major change because groceries became such a big deal in our 
household. 
Changes in perceived well-being. Many participants (n = 9) reported that they 
have experienced negative changes in their general well-being since being diagnosed 
with epilepsy. One female participant explained, 
I have something now. Before this I was always pre-something… 
pre-diabetic, borderline hypertension. There is no borderline epilepsy. I 
just don’t feel healthy anymore…. I’m sick now, and I’m always going to 
be because it can’t be cured. 
A male participant felt similarly, explaining, “It’s just been kind of a big letdown. 
I really just don’t feel well. I mean I’m here, but I’m like a walking zombie.” 
Physical and emotional changes. All 20 participants relayed that they have 
experienced unpleasant physical and emotional symptoms since the onset of their 
epilepsy. Physical symptoms were related to seizures and the after-effects of seizures, as 
well as medication side effects. One male participant described his physical ailments: 
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I get so tired from the meds and from the seizures. Dizzy, too. I’m just not 
as sharp. I can’t stay awake. I sleep…until noon sometimes. The whole 
day is gone by the time I get up but I’m just wiped out. But I don’t have a 
choice…. Stop taking the meds and I have seizures, and I’ll feel the same 
way or even worse. 
Emotional changes also were experienced. Participants reported experiencing, 
from the time of diagnosis until the time of their interviews, anger (60%), sadness or 
depression (50%), and anxiety (50%). These emotions often were the result of other 
changes and problems they experienced as previously described. One female participant 
shared her experience with anger: 
I just…want to be able to do what I did. Go to work, pick up my 
grandkids, take them for ice cream…drive them around to see Christmas 
lights. I get so mad, and that is wrong. But I hear people talk…. They 
chatter about doing the things I want to do, that I ought to do, and I get 
mad. I just squeeze my fist hard and don’t say anything…but it makes me 
boil. 
Half of the sample indicated that they had experienced depression since being 
diagnosed, and that this depression was worse immediately following diagnosis. One 
male participant explained, “Yeah, I was depressed…. Who wouldn’t be? Your life has 
just been turned upside down. I still am but it’s being treated and I’m a lot better.” 
Participants (n = 10) also reported experiencing anxiety related to their epilepsy. 
Participants were anxious about having a seizure, hurting someone else or themselves, 
and the multitude of changes and problems they experience as a result of having epilepsy. 
One female participant explained, “I’m so nervous all the time…not just about having a 
seizure, but that at some point I’m not going to be able to do this anymore, to live here by 
myself.” 
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Positive changes. Some (n = 6) participants found that they experienced positive, 
or desirable, life changes since their diagnosis. Of note is that participants’ positive 
changes did not occur, or they were not aware of them, until well after they were 
diagnosed. 
Relationships with family and friends. Just as many participants experienced 
negative changes in their relationships with family and friends, several (n = 4) of those 
same participants also recognized that positive changes occurred in these relationships as 
a result of epilepsy. One female participant explained how her new-found dependence on 
her husband, while frustrating, ultimately brought them closer and improved their 
relationship. She explained: 
I’ve always been so independent…and he has, too. I mean we did things 
together, but once we were where we were going we would split up and do 
our own thing. When I first got this, we fought all the time. About the 
driving and how long should he give me at the grocery store before 
picking me up, that kind of thing. But then we found ourselves…laughing. 
And falling in love all over again. It felt like this had to happen to bring us 
back together, back to how we wanted to be. 
Perspective. Several participants (n = 5) also reported that being diagnosed with 
epilepsy caused positive changes in their lives in terms of their perspective of life in 
general. These five participants spoke of finding comfort in having epilepsy instead of 
another, more life-threatening disease. “I’ve decided it could be a lot worse and I’m just 
thankful…I don’t have cancer,” explained one participant. Another remarked how 
fortunate she is to have a disease for which there is a well-established treatment. He 
explained, “Other things could be worse…Alzheimer’s they don’t know what to do for 
you. At least with this there is a pretty good idea of what makes it better…. I’m thankful 
for this and not having that.” 
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Spirituality. Among the participants (n = 5) experienced positive changes in their 
spirituality due to being diagnosed with epilepsy. All five of these participants saw 
epilepsy as a challenge that resulted in them ultimately feeling closer to their God. As one 
female participant explained: 
Epilepsy was the best thing to happen to me in a long time. I had drifted 
from Jesus. I was never a bad person but I wasn’t going to church and 
living for God. This happened to me…. This horrible epilepsy hit me. And 
I had to turn back to Him for help…to survive it. He was there for me and 
now I am even closer to God…. So I am glad that it happened. 
Research Question Four 
Research question four was concerned with different strategies used by older 
adults in self-managing their epilepsy. Table 17 displays the themes emerging for this 
research question. 
Table 17 
Themes for Question Four 
Themes Frequency 
Disease/Treatment-focused Strategies N = 20 
Life Changes and Problems-Focused Strategies N = 20 
Proactive n = 13 
Reactive N = 20 
Disease/treatment-focused strategies. All 20 participants reported the use of 
disease- or treatment-focused self-management strategies—strategies aimed at managing 
epilepsy symptoms (seizures and the post-ictal period) or treatments (medication 
adherence and side effects). For example, one male participant explained that he quickly 
learned that lack of sleep and dehydration were seizure triggers for him. Thus, he devised 
and uses strategies to prevent these triggers and, thus, seizures. “I avoid my triggers… I 
have a bed time just like a little kid. It may seem silly but it makes my life a whole lot 
easier,” he explained. Many participants (n = 17) also claimed to use strategies designed 
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specifically to manage medication adherence. Most of these participants relied on marked 
pill boxes, and over half of them (n = 9) relied on a spouse or adult child to help 
administer their medications correctly. “My wife takes care of that,” explained one male 
participant when asked how he manages his multiple medications. 
Life changes- and problem-focused strategies. The remainder of strategies used 
by all 20 participants can be classified as life changes and problem-focused; that is, they 
are not used to managing the disease of epilepsy directly, but are used to managing the 
life changes and problems that arise from having the disorder and that were discussed in 
the previous themes. For example, 12 participants spoke of strategies used to manage 
problems regarding independence and transportation. One male participant stated, “Every 
time I wanted to go more than a mile became a production…. I wanted to deal with it my 
way. So I had to come up with a system…and that’s when I started living by a schedule.” 
This participant used a color-coded system in a daily planner to organize his 
transportation. He explained, “Days highlighted in blue, I have to take the bus…that’s 
also the day I have to take my laundry in. Pink days I get a ride with my neighbor.” 
Another example of a problem-related strategy used by several (n = 4) 
participants is self-titration of medications. Participants reported decreasing medication 
dosages as a result of lack of money to buy their medications and also to prevent side 
effects. As one participant explained, “I figure half a pill is better than no pill…so if 
we’re low on cash I stretch them out.” Another participant—a female—described how 
she alters her medication based on how she is feeling and on what activities she has 
planned for the day: 
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If I’m feeling good, and haven’t had a seizure in a while…I might start 
taking less. Just a little at a time. And if I’m leading group at church, I 
always take only half of it. It just feels more confident up there if I’m 
more alert. So, yes, I mess with my medication a little bit without my 
doctor knowing. 
Proactive versus reactive. All of the self-management strategies used by 
participants can be classified as proactive or reactive. Proactive strategies are 
characterized as systematic, flexible, and effective; whereas, reactive strategies are 
characterized as unplanned and unpredictable. Participants (n = 16) used both proactive 
and reactive strategies, while four used only reactive strategies. A female participant 
provided an example of use of a proactive management strategy: 
It’s like we’ve got a system set up…with [my friend] and the groceries…. 
I rely on her and I know that I have those certain days of the week to get to 
the store. Otherwise, it wouldn’t get done and I’d get desperate. I just plan 
ahead to avoid that. 
A male participant shared a story that demonstrated the use of a reactive 
management strategy. He explained: 
I was with a group of friends from church, and I don’t think they realized 
why I no longer drive…. I think they thought that it was just because I 
don’t have a car. The man who was supposed to be driving was very sick. 
So it was me, a very sick guy, and these two women. I didn’t know what 
to do. None of them knew about my seizures. I felt this huge urge to help 
them because we needed to get him home. And I said I would drive the 
rest of the way. And I did drive. And I’m not supposed to…. I shouldn’t 
have. I never should have done that…but I wanted to prove that I’m fine 
and I’m just like them. But it bothers me to this day because…my seizures 
are almost daily. I could have killed us. 
Participants consistently reported having unpleasant experiences when using 
reactive strategies, and much more pleasant and successful experiences when using 
proactive strategies. One participant shared, “I’ll never run out of medicine again. I went 
on vacation and didn’t get it filled…. What was I thinking? It was bad.” 
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While the majority of participants (n = 16) reported the use of both types of 
strategies, four of the participants did not appear to use any proactive strategies. Two of 
these participants were women, and two were men. All lived in rural areas, and all were 
fairly newly diagnosed with epilepsy (all were within one year since diagnosis). These 
participants also reported having the most and the most significant negative changes and 
problems since being diagnosed with epilepsy. None of these four participants seemed to 
have a well-defined plan when it came to managing their disease—their strategies were 
not executed until after a problem already had occurred. 
Research Question Five 
The purpose of research question five was to determine what outcomes older 
adults hope to achieve in self-managing their epilepsy—what they hope to achieve in 
managing their condition. The themes that emerged for this question are presented in 
Table 18. 
Table 18 
Themes for Question Five 
Themes Frequency 
We Want to be Involved n = 15 
Normalcy N = 20 
Well-Equipped n = 8 
Seizure-Free n = 5 
We want to be involved. When asked what they hoped to achieve, a large portion 
of the sample’s participants (n = 15) indicated that they wanted to become more involved 
in the treatment of their disorder. Participants expressed a desire to build a relationship 
with their care providers that would allow them to provide input regarding the treatment 
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of their epilepsy. At the time of their interviews, these participants felt that they lacked 
control over the treatment of their disorder. One female participant explained: 
I want more to do with it…. I want to be able to have some kind of say in 
what’s going on, or at least have it all explained to me. I don’t know what 
questions to ask them…but I can tell them what’s bothering me and then 
we can talk about how to fix that. I don’t just want to accept that I have 
this and there’s nothing I can do about it. I want to work with the 
doctors…. Sometimes they miss the boat on what I’m needing. 
Normalcy. All 20 participants indicated that they wanted their epilepsy  
self-management to allow them to carry on with their normal lives. Normalcy was, of 
course, different for every participant, but the goal was the same for each—live a normal 
life in spite of having epilepsy. One male participant stated: 
The most important thing to me is that it doesn’t interfere with my life. 
The seizures or the treatments. Or the things I am not allowed to do. Let’s 
figure something out and make it work for me so that I can still build stuff 
out in my shed…so I can take my grandson fishing. That’s where I want to 
get. I want to be a normal retired guy doing the stuff he likes…. I’m not 
there yet and…I’m not sure that my neurologist understands that. 
For many participants, normalcy meant being very involved with their 
grandchildren. “I want to be able to babysit my grandbaby unsupervised,” explained one 
female participant. Another participant indicated that she wanted to be able to stay up and 
watch movies with her granddaughter. She stated, “I don’t want to be so drowsy…. I 
want to keep up with her.” 
Many of these participants (n = 9) indicated that they did not feel their healthcare 
providers were aware of their goals. “We’ve never talked about it,” explained a male 
participant. A female participant indicated that her neurologist is focused mostly on the 
frequency of her seizures. She explained: 
Well I just love [my neurologist]…but I guess the most important thing to 
them is how many seizures am I having. And, to me, sometimes the 
seizures are not as bad as the medicine, but I don’t think they know that. I 
 183 
think sometimes I’d be better off just having the seizures. They don’t 
hurt…and the medicine makes me feel worse than they do. 
Well-equipped. Nearly half the sample (n = 8) shared that they hoped that, 
through managing their epilepsy, they would become well-equipped to handle the 
disorder more effectively and more independently. “I want to know what to do [about my 
epilepsy] without having to ask someone or think about it,” explained a female 
participant. She continued, “It’s such a weird disease that I don’t always know…and I 
want there to be no second guesses. I just want to be able to know what I or my family 
should do,” she explained. 
Others expressed a desire to know, through their management, more about 
epilepsy so that they could explain it to their family and friends. “I want to know it inside 
and out, and understand it…. So many people think it’s a mental illness. So I should be 
an expert to explain it to them that it’s not,” stated a male participant. 
Seizure-free. Interestingly, only five participants explicitly mentioned wanting to 
be seizure-free when asked what they hoped to achieve in self-managing their epilepsy. 
When participants did mention seizure freedom, it was in the context of wanting to 
maintain normalcy. “I don’t want any more seizures…so I can get back to working  
part-time and back to doing what I want,” explained a male participant. A female 
participant stated, “Even though the seizures aren’t the bad part…I don’t see them and I 
don’t remember them, if I didn’t have them I think my life would be a lot easier.” 
Other Themes 
Two other themes that were not specifically related to the a priori research 
questions but were quite salient also emerged. These themes are displayed in Table 19. 
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Table 19 
Other Themes 
Themes Frequency 
Epilepsy is Different n = 14 
Lack of Resources and Skills to Seek out Information n = 17 
Epilepsy is different. Apparent in many participants’ (n = 14) stories is the 
uniqueness of epilepsy to these older adults. In many ways, epilepsy remains somewhat 
of a mystery to them. “I don’t know anyone else with epilepsy…. All my friends have 
breast cancer, but no epilepsy,” explained one female participant. Another participant 
explicitly stated that he found epilepsy to be somewhat mysterious. “I don’t really get it, 
understand it…. I know when they did open heart surgery what they did, but I have a 
hard time explaining this to people,” he stated. 
Epilepsy also seemed different to participants due to the stigma associated with it. 
In fact, one participant did not even want the word epilepsy to be used during his 
interview. “You can call it seizures,” he said, citing that the word epilepsy sounded “too 
weird.” Other participants explained that, while they were very open with their other 
health problems, they often desired to keep their epilepsy a secret. One male participant 
explained that no one outside of his wife and a close neighbor knew of his epilepsy—and 
the neighbor knew only because he witnessed the participant having a seizure once. “I tell 
absolutely no one. I just don’t want anyone to know that part of my business…. It would 
be misunderstood,” he explained. 
As discussed previously, epilepsy is different in how care providers educate their 
patients about it. According to the participants in this sample, much less formal education 
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is given to patients newly diagnosed with epilepsy when compared to that provided upon 
diagnosis of other chronic conditions. 
Lack of resources and skills to seek out information. Many participants  
(n = 17) expressed a lack of ability and resources to seek out the information they 
desired. Many of these participants (n = 11) did not have computers, and the ones who 
did said they did not know how to use them to gather information. “I don’t know where 
to even begin to find answers to the questions I have,” explained a female participant. 
Participants also were often unable to interpret the information they (or their family 
members) found online. “My daughter brought over a pile of papers about epilepsy…but 
we had no idea what they said. It was all very scientific,” stated a male participant. 
Furthermore, participants felt that they needed to talk to someone about their epilepsy, as 
opposed to only reading about it. “I need that connection…one-on-one to ask questions,” 
explained a female participant. 
Summary of Findings 
In this chapter, research questions were answered by presenting themes that 
emerged during analysis. Three additional, non-research question-related themes also 
were discussed. Regarding research question one, the majority of participants were 
dissatisfied completely with the process through which they went to be diagnosed with 
epilepsy. This dissatisfaction stemmed chiefly from a delay in diagnosis and lack of 
adequate education and information at the time of diagnosis. Women more commonly 
experienced a delay in diagnosis than did men. Most participants reported being very 
surprised and unprepared for their diagnosis of epilepsy and did not realize that they, as 
older adults, were at relatively high risk for this disorder. The majority of the participants 
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also had misconceptions about the disease of epilepsy, its prognosis, and the treatment 
both at the time of diagnosis and at the time of their interviews. Most participants also 
reported a mismatch between their and their care providers’ perceptions of the 
seriousness of being diagnosed with epilepsy. Regarding research question two, 
participants reported problems maintaining independence, managing medications, 
achieving goals, and remembering. Regarding research question three, participants 
reported the experience of both negative and positive life changes since being diagnosed 
with epilepsy. Negative changes included undesirable changes in lifestyle, perceived 
well-being, and physical and emotional health. Positive changes included desirable 
changes in relationships with family and friends, perspective, and spirituality. Regarding 
research question four, participants reported using strategies to manage epilepsy and its 
treatments, as well as those to manage the problems and life-changes that emerged in the 
discussion of question three. These strategies can be categorized as proactive or reactive. 
Finally, regarding research question five, participants expressed the outcomes that they 
hope to achieve in managing their epilepsy. These outcomes included being involved in 
treatment decisions, maintaining normalcy, being well-equipped to handle and explain 
their epilepsy, and being seizure-free. 
Additional findings also emerged. The first included that epilepsy is  
different—participants’ experiences with it are unique to those of other chronic 
conditions from which they suffer. In addition, participants perceived a pronounced 
stigma related to their epilepsy. Participants also expressed that they lacked the skills and 
resources to access the information they desired about their disorder. 
  
 187 
Interactive Nature of Themes: A Participant Exemplar 
None of the themes discussed previously exists or occurs in isolation. Rather, 
these themes are interactive and dependent on and resultant from one another. Figure 5 
depicts this interactive nature of the themes. 
 
Figure 5. Schemata depicting the interaction of themes. 
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The most effective way to demonstrate the interactive nature of the themes that 
comprise epilepsy self-management for this population is via a participant exemplar 
(Sandelowski, 2010b). The following story provides a summary of the experiences of one 
of the participants from this study. This story serves to demonstrate, in a real-life case, 
how the themes described exist and interact for members of this population: 
Susan began experiencing odd behavior and memory problems when she 
was 72 years of age. She promptly mentioned these symptoms to her 
physician, who ordered blood work and an x-ray of her brain. When all of 
these results were normal, she was sent to be evaluated for Alzheimer’s 
disease. She was diagnosed with Alzheimer’s and began a medication 
regimen for it. Three months later, however, her symptoms had not 
improved. She re-visited her physician, who told her that her worsening 
symptoms were due to old age. She continued taking her Alzheimer’s 
medications and continued having symptoms. Another six months later, 
she had a generalized seizure while in a water aerobics class. An 
emergency department physician confirmed that she had had a seizure and 
referred her to a neurologist, who ultimately diagnosed her with epilepsy. 
This diagnosis came over a year after her initial visit to her physician. 
Susan was very shocked to receive this diagnosis and could not imagine 
what caused her to develop it. Despite asking her neurologist what may 
have caused it, she was told that the cause was irrelevant and that 
medication would prevent future seizures. Susan was dissatisfied with this 
information but felt uneasy questioning her neurologist. 
Susan’s neurologist prescribed an anti-epileptic medication and told her 
she should not drive until she was seizure free for six months. She was not 
told, however, that the symptoms that initially brought her to her 
physician—odd behavior and memory loss—were seizures and part of her 
epilepsy. Thus, when six months passed and she had had no generalized 
seizures, she resumed driving. However, her odd behavior and memory 
loss continued. Susan ultimately ran her car into a ditch during one of 
these episodes. It was only at this point that Susan became aware that her 
odd behavior and memory loss were seizures. 
Susan’s medications were altered, and she began experiencing extreme 
fatigue as a result. She began sleeping until 11:00 a.m. every day and was 
forced to give up her volunteer activities. She no longer had the energy to 
cook Sunday meals for her extended family, either. Susan was not 
satisfied with this level of fatigue, and thus she sometimes reduced her 
medication dosage when she felt she needed to be more productive. She 
also began taking scheduled naps every day. 
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Susan’s husband took on new roles at the time of her diagnosis. He 
became her chauffer and did much of the housework. Susan was not 
comfortable with these changes, and they made her feel depressed. She 
also experienced anger related to her inability to live her normal life. 
Susan devised and used many strategies to manage her epilepsy. For 
instance, she paid extra for her pharmacy to organize her medications in 
dosage packets because her memory problems prevented her from 
consistently being able to take her medications correctly. Because she was 
uncomfortable being dependent on her husband for transportation, she 
began using a taxi. She managed to work out a reduced fare agreement 
with the taxi service. When she didn’t feel well as a result of having a 
seizure or due to medication side effects, Susan responded accordingly by 
resting or cancelling commitments. For instance, because she could never 
predict her level of fatigue for a week, she refrained from making plans 
well in advance and chose to take part in activities that she could join at 
the last minute. She also found a back-up volunteer to fill in for her at 
church in case she was too fatigued to do her duties, thus allowing her to 
fulfill her commitments despite experiencing negative physical symptoms. 
Sometimes, though, Susan found herself trying to manage epilepsy-related 
problems after they had already occurred. For instance, Susan was 
scheduled to perform some music at the wedding of a friend’s daughter. 
Susan had a bout of seizures the day before because she had cut down her 
medication in order to be alert for the wedding. Susan had not thought to 
schedule a back-up person for her performance. She missed the wedding 
and was unable to find another musician due to her general poor health 
(post-ictal fatigue) on that day. She feels that her lack of being able to 
perform at the wedding, as well as her lack of planning, negatively 
affected her friendship with the bride’s mother. 
Susan has read books about epilepsy, but desires more information about 
her condition that is presented in layman’s terms. She does not have a 
computer and has been relying on her adult daughter to find articles for 
her about epilepsy, though she admits she has difficulty interpreting these 
articles. She does not know anyone with epilepsy and wishes to join a 
support group, but is unsure how to do so. 
In this exemplar, the existence of themes that were presented in the findings 
previously is apparent. Susan underwent a difficult diagnosis process and was displeased 
with the timing of her diagnosis and the lack of information she received about her 
disorder at that time. She also had misconceptions about her disorder and did not 
recognize her main symptoms as being those of epilepsy, which ultimately led her to 
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being a victim of a car accident. She experienced several problems related to her disorder, 
including lack of independence and the experience of unpleasant physical and emotional 
symptoms. Susan, with her husband, devised proactive strategies to manage these 
problems. Susan did not use the same strategies every day, but rather the type of day she 
was having dictated which strategies she used. On a day during which she was 
experiencing problems with medication side effects, for instance, strategies to ameliorate 
them were used. These strategies were not needed every day, indicating that  
self-management is not a stagnant phenomenon, but fluid and responsive to the needs of 
the person managing the disease. She also used reactive strategies, which she felt led to 
negative outcomes. Susan desires more information about her disorder but does not 
possess the skill set to retrieve such information on her own. She feels isolated as a 
consequence of her epilepsy. 
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CHAPTER V 
DISCUSSION 
This chapter discusses the study methods, the findings, and the application of 
those findings to practice. To maintain clarity, findings associated with each research 
question are discussed separately, followed by a more general discussion of other key 
points. Recommendations for future research are made throughout the chapter. Finally, a 
summary of the chapter is provided. 
Discussion of Methods 
The discussion of methods is separated into three sections. First, lessons learned 
from the recruitment process are described. Second, a description of how the sample 
characteristics may have influenced the findings is presented. Third, key data collection 
strategies believed to help produce rich data are identified. 
Recruitment Lessons 
In the pilot study that preceded this study, self-referral was the only recruitment 
strategy utilized. Advertisements were placed in local neurology offices, and participants 
contacted the researcher if interested in taking part. While this strategy was successful in 
meeting recruitment goals for a small pilot study (five participants were recruited over a 
three-month period of time), it would not have been adequate in this study due to the 
requisite larger sample. Persons with chronic diseases can be difficult to recruit from  
in-office settings given the somewhat low frequency with which they visit their care 
providers. Once they are diagnosed, persons with chronic disease only may see their 
specialized care provider bi-annually or even annually, and problems and exacerbations 
often are managed without patients even physically attending the clinic—prescriptions or 
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tests are called in, for example (Lorig & Holman, 2003). Thus, patients often are simply 
not available for recruitment from the clinic setting. 
For the current study, a recruitment strategy that would allow more access to 
potential participants was devised (see Chapter III). This strategy, in which potential 
participants were sent physician-signed letters informing them of the study and that they 
would be contacted via phone by a researcher in the coming days, proved very fruitful. 
Refusal rates were low (36%), and the strategy greatly assisted the researcher in 
purposively sampling, as she had a large pool of potential participants from which to 
draw. Such control over sample selection was not possible using the pilot study 
recruitment strategy. Because sampling in qualitative descriptive research is key in 
generating valid results and is based on emerging findings, a strategy similar to the one 
used in this study should be considered by researchers using similar methods. 
The use of a letter informing potential participants of the study and indicating that 
they would soon be contacted by a researcher may have contributed to the low refusal 
rate in this study. While no data were collected in this study regarding participants’ 
opinions about the ways in which they were recruited, many participants noted that they 
appreciated receiving the letter about the study, and all of the potential participants who 
called the researcher themselves regarding an interest in the study did so as a result of 
receiving the letter. 
Influence of Sample Characteristics 
The composition of sample in terms of gender, race, and age may have affected 
the findings of this study. Epilepsy affects both genders equally (Epilepsy Foundation, 
2010), though the study sample was predominantly female (60%). However, the 
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distribution of males and females in the sample is reflective of a predominantly female 
population in the United States (51% female, 49% male), and the discrepancy between 
men and women is even more apparent in those over age 65 (United States Census 
Bureau, 2009). Further, the interpretive validity of the study is protected by the use of 
data-derived sampling and informational redundancy—both women and men were 
recruited until informational redundancy was met. 
Epilepsy affects all racial groups equally (Epilepsy Foundation, 2010). A 
limitation of the current study is a lack of minority representation. All participants, except 
one African American, were Caucasian. The lack of minority participation was not due to 
refusal rates from minority participants. Rather, only one participant in the sampling pool 
was a minority, and this participant did take part in the study. The results of this study 
may not be fully generalizable to minorities. 
Another limitation of this study is a lack of participants in old old age. The oldest 
participant in the study was 80 years of age. New-onset epilepsy does affect those over 
age 80 (Epilepsy Foundation, 2010), though not as commonly as younger older adults. 
While two potential participants older than age 80 (84 and 91 years, respectively) were 
contacted about participating in the study, both of them were excluded due to cognitive 
impairment. The findings of this study may not be fully generalizable to older adults with 
epilepsy who fall in a more advanced age range. 
Key Data Collection Strategies 
Data collection procedures used in this study were effective in generating a rich 
data set. The following strategies were helpful in producing this rich data: 
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 Instructing participants, during their initial recruitment phone call, to think 
about their experience with being diagnosed with epilepsy, as well as how 
their lives are different now that they have epilepsy, in the time prior to 
their interviews allowed participants to come to the interviews prepared 
and already thinking of which stories they wanted to tell. 
 Informing participants that their confidentiality would be protected made 
participants feel more comfortable answering questions. While informing 
participants of the protection of their confidentiality is standard in any 
research study, the researcher felt that doing so explicitly allowed 
participants to be more open with their responses. In the initial several 
interviews, participants commonly asked the researcher if their physicians 
would be shown any of their interview statements, and sometimes showed 
concern about discussing medication adherence, for fear of their 
physicians being made aware of non-adherence. As a result, in subsequent 
interviews, the researcher spent more time discussing what protection of 
confidentiality meant because some participants seemed to believe that the 
researcher had been referring to confidentiality of interviews between her 
and their care providers. After participants understood that only the 
researcher and her co-investigators would see the data, they felt 
comfortable to talk freely about their experiences. 
 Using story-telling assisted participants who had difficulties knowing 
where or how to begin. While most participants had no difficulty 
discussing their experiences, others struggled with knowing where to start. 
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The researcher asked these participants to try to express their feelings via 
telling a story—giving an example—about something they had 
experienced that conveyed what they were trying to express. This strategy 
worked very well. 
Discussion of Findings 
Research Question One 
Key findings related to research question one—what are older adults’ experiences 
with the process of being diagnosed with epilepsy?—emerged in this study. The majority 
of participants were dissatisfied with the process through which they went to become 
diagnosed with epilepsy, and this dissatisfaction largely stemmed from a delay in 
diagnosis and a lack of education and information received about the diagnosis and  
long-term management of the condition. Women in the sample had these dissatisfying 
experiences more often than the men. In addition, the majority of older adults in the 
sample were not aware of the high prevalence of epilepsy in people their age. They also 
failed to have a proper understanding, both at the time of diagnosis and persisting beyond 
that point, of the nature of the disease, its prognosis, and treatment. Finally, there was 
commonly a mismatch in the perceptions of participants and their providers in terms of 
the seriousness and overall life impact of the disease. 
Dissatisfaction with diagnosis. During the pilot study that preceded the current 
study, an unexpected and robust finding was participants’ dissatisfaction with their 
diagnosis processes. In fact, the researcher, or her committee, had not considered 
including a research question regarding participants’ satisfaction with their diagnosis 
process until it became clear that it was a very salient issue for the pilot participants. The 
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literature review presented in Chapter II did not reveal any publications demonstrating 
this or the younger adult population’s strong dissatisfaction with the diagnosis process. In 
the case of younger adults with epilepsy, it is not clear if this population has simply not 
been asked, during a formal research study, about their satisfaction with their diagnosis 
processes, or if they actually differ from older adults in this way. 
Delay of diagnosis. The most common reason for dissatisfaction with the 
diagnosis process was an unacceptable delay in diagnosis. Females comprised the 
majority of participants who experienced such a delay. In reviewing the literature, one 
study that partially corroborated this finding was identified. Rowan and colleagues (2005) 
conducted a retrospective chart review of 159 (157 men and 2 women) older adult (age 
range 59–96 years) patients of Veterans Affair who experienced new-onset epilepsy late 
in life. They found that a delay in diagnosis was very common in the sample, with a mean 
length of time of 1.7 years from first seizure to diagnosis. Only 49 patients were 
diagnosed with the condition immediately when they presented to their healthcare 
providers. 
Rowan and colleagues (2005) identified several factors that contributed to this 
delay. As was seen in the current study, many patients (about half) did not immediately 
report their symptoms to their healthcare providers because they did not recognize them 
as seizures. However, once patients did seek treatment, 70% of patients were not 
accurately diagnosed immediately. As was seen in the current study, many were 
misdiagnosed with other conditions, including Alzheimer’s disease. In addition, 23% of 
patients with partial seizures were misdiagnosed as having transient ischemic attacks. 
 197 
Patients who initially were misdiagnosed with these conditions then went on to receive 
inappropriate treatment for many months or years before being accurately diagnosed. 
Rowan and colleagues (2005) also found that type of seizure symptoms  
(grand-mal versus partial or complex partial) was a significant factor in determining 
length of time to diagnosis. Half of patients exhibiting symptoms of grand-mal seizures 
(classic symptoms) were diagnosed immediately, while only 20% of 86 patients with 
complex partial seizures (ambiguous symptoms) were diagnosed immediately. Results of 
the current study are congruent with this finding, but only for the male participants. Male 
participants in the current study who demonstrated classic grand-mal seizure symptoms 
rarely experienced a delay in diagnosis, while female participants who reported a delay in 
diagnosis commonly presented with either grand-mal or complex partial seizure 
symptoms (50% in each group). These women also reported that their care providers 
were dismissive of their concerns about their symptoms, while no males in this sample 
had a similar experience. Rowan and colleagues (2005) did not report this finding in their 
male-dominant sample, either. In their study, there was no evidence that patients’ 
symptoms were not taken seriously but rather that providers initiated incorrect diagnostic 
paths (Rowan et al., 2005). 
While Rowan and colleagues (2005) reported some findings consistent with those 
resulting from this study, aspects of their investigation leave remaining gaps in 
knowledge. First, the charts of only two female patients were reviewed in the study. This 
lack of female representation is significant in light of the findings from the current study 
which suggest that women are more likely to experience a delay in diagnosis regardless 
of symptom presentation. Secondly, Rowan and colleagues’ (2005) study, though  
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multi-site, was conducted solely within the Veterans Administration system. The majority 
of older adults do not receive care from this system but rather present to primary care 
providers in the community (Collins, Shapiro, & Ramsay, 2006). Furthermore, in the 
current study, many participants initially sought care in rural clinics. Finally, the findings 
from Rowan and colleagues’ (2005) study are nearly a decade old (data were collected 
between 2001 and 2003). It is unclear if, in the last eight to ten years, the diagnosis 
process of older adults with new-onset epilepsy has changed. 
The review of literature did not reveal any reports of younger adults experiencing 
such a delay in epilepsy diagnosis, though it appears that it is not uncommon in children 
with the disorder. Buelow and Shore (2006) interviewed 21 parents of children with 
epilepsy about their experiences with diagnosis of the condition. A correct epilepsy 
diagnosis often was delayed due to parents not seeking treatment and healthcare 
providers not recognizing children’s symptoms as seizures. Children often were 
misdiagnosed with other conditions and thus received inappropriate treatment for varying 
amounts of time. 
While no literature, apart from Rowan and colleagues’ (2005) study, was found 
regarding older adults with epilepsy commonly experiencing a delay in diagnosis, it is not 
uncommon for older adults with other chronic conditions to experience a delay in 
diagnosis or to be misdiagnosed with other conditions. For example, older adults have 
been shown to be misdiagnosed with osteoarthritis when they are actually suffering from 
more acute, reversible causes of pain (Spiera, 1987). In more recent studies, investigators 
have found that Alzheimer’s disease is over-diagnosed in the older adult population. 
White (2011) autopsied the brains of 426 older adults who had, before their deaths, been 
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diagnosed with and treated for Alzheimer’s disease. Half of those brains autopsied failed 
to show signs of Alzheimer’s. Some brains demonstrated evidence of various types of 
dementia, and some brains were normal. White (2011) noted that expense and decrements 
in quality of life are associated with such misdiagnoses and lack of appropriate treatment. 
Interestingly, two participants in this study and some in Rowan and colleagues’ (2005) 
study (exact number not reported) were misdiagnosed initially with Alzheimer’s disease 
when they presented to their care providers with seizure symptoms. 
Older adults with Lewy Bodies disease, a type of dementia, often experience a 
great delay in diagnosis. In a survey of 935 caregivers of older adults with Lewy Bodies 
disease, 78% reported that their loved ones initially were misdiagnosed with Alzheimer’s 
disease, Parkinson’s disease, or psychiatric or mood disorders. Over half of those 
surveyed indicated that a correct diagnosis took over a year (Galvin, Duda, Kaufer, & 
Lippa, 2010). While it does share some commonalities with Alzheimer’s and Parkinson’s 
diseases in terms of initial presentation, Lewy Bodies disease causes unique  
symptoms—usually hallucinations—that set it apart from other diseases (Galvin et al., 
2010). Yet, most older adults with this condition are misdiagnosed and receive 
inappropriate treatments. 
A review of the literature did not yield any evidence that older adult women are, 
as they were in this study, more likely to experience a delay in diagnosis or misdiagnosis 
when presenting with chronic conditions. Strong evidence, though, demonstrates that 
women in general are more commonly incorrectly diagnosed when presenting with 
symptoms of heart disease, including myocardial infarctions. In a landmark study 
involving 10,000 participants, Healy (1991) found that women who presented with 
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cardiovascular symptoms were significantly less likely than were men to be referred for 
diagnostic procedures. Other investigators have found that this discrepancy is often due 
to the way in which many women present with cardiovascular disease, including acute 
myocardial infarctions. Women are significantly less likely than men to present with 
chest and left arm pain during a myocardial infarction. Their main symptoms are often 
more vague, less classic than those of men, and commonly include fatigue (Healy, 1991). 
In the current study, however, the women in the sample did not describe initial seizure 
symptoms that differed from those of the men in the sample. Women with both classic 
and ambiguous seizure symptoms were more likely to experience a delayed diagnosis 
than were men. 
As was discussed in Chapter IV, both women and men living in rural areas were 
more likely to experience a delay in diagnosis. This finding is not surprising, given that it 
is known that older adults living in rural areas have fewer resources and are less likely 
than their city-dwelling counterparts to seek medical attention. They also tend to have 
fewer financial resources, which can prevent them from traveling to seek care (Bailey, 
2009). Curious, however, is the finding that the women in this sample who experienced a 
delay in diagnosis were all well-educated and affluent, while none of the men who 
experienced a delay held a college degree and all had lower annual incomes. 
The men in this sample experienced a delay in diagnosis only if they 
demonstrated ambiguous seizure symptoms, resided in a rural area, were less  
well-educated, and had a lower socioeconomic status. All of these characteristics seem 
reasonably contributory to their delay in diagnosis. Ambiguous seizure symptoms often 
are not recognized by primary care providers as seizure-related (Rowan et al., 2005), 
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those in rural areas have less access to health care (Bailey, 2009), and those of lower 
education and socioeconomic status are less likely to utilize health care resources (United 
States Department of Health and Human Services, 2003). The question, then, is why did 
the women in this sample, who did not have characteristics that would pre-dispose them 
to a delay in diagnosis, consistently report a delay in diagnosis? The answer to this 
question is not clear, and a literature review revealed no investigations that have focused 
on answering it. 
Lack of information. The second most common reason that participants were 
totally or partially dissatisfied with their process of diagnosis was due to lack of 
education and information given at the time of diagnosis and beyond. Women were more 
likely to have this complaint than were the men. Most of the participants reported that 
they expected to have some kind of formal education given to them about their epilepsy, 
and this expectation was based on their experiences with other conditions such as stroke, 
diabetes, and hypertension. While there is evidence that parents of children with epilepsy 
have difficulty communicating with their children’s healthcare providers about their 
children’s condition (Buelow, McNelis, Shore, & Austin, 2006), this finding is not 
corroborated in the younger adult epilepsy literature. However, this finding is consistent 
with Clark and colleagues’ (2010) findings which indicate that care providers of adults 
with epilepsy (neurologists and primary care providers) find their biggest challenge in 
treating those with epilepsy to be lack of time available to spend with patients for the 
purposes of educating them about their disorder. It appears, then, that older adults with 
epilepsy may want and need more education about their disorder, but their care providers 
do not have time to deliver it to them. 
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Misunderstanding of epilepsy. All participants were shocked at receiving an 
epilepsy diagnosis and reported that they were not aware that older adults were at risk for 
the condition. Epilepsy is not a publicly well-discussed disease. It is associated with 
stigma and is often viewed by the public as mysterious (Leppik et al., 2006). While other 
diseases that affect older adults—Alzheimer’s, heart disease, and cancer—are  
well-advertised and discussed with older adults, such efforts with epilepsy have been 
undertaken only recently and are not aimed specifically at older adults. In 2008, the 
Epilepsy Foundation initiated Purple Day—a day on which, annually, events are held to 
raise awareness about the disease of epilepsy. The Purple Day campaign has been in 
existence only for three years, and thus may not have yet have been fully effective in 
spreading awareness to the older adults involved in this study. 
Participants in this study also reported many misunderstandings about the disease 
of epilepsy, its prognosis, and available treatments. These misunderstandings likely stem 
from the lack of education delivered to patients at the time of diagnosis and may have 
great potential to affect outcomes. For example, some participants believed that their 
epilepsy was curable—that taking their medication eventually would eradicate the 
epilepsy and that they could stop taking their seizure medication when they stopped 
having seizures. Such misunderstandings could have devastating results for older adults 
with epilepsy, including seizure exacerbations, accidents, and injury to themselves and 
others. 
Patient/provider perspectives. A key finding regarding older adults’ diagnosis 
experiences is that they often felt that their care providers’ perspectives on the 
seriousness of the disease of epilepsy, especially in how it would affect their daily lives, 
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was not well-matched with their actual post-diagnosis experiences. Participants felt 
unprepared by their providers regarding the ways in which life would be different after 
the diagnosis. This finding is somewhat consistent with that of McAuley and colleagues 
(2010), who found that adults with epilepsy were most concerned about the life issues 
caused by epilepsy and its associated treatments and restrictions, while practitioners 
treating those patients were more concerned with clinical issues, such as medication 
adherence. This mismatch in perceptions of patients and care providers also has been 
shown to exist in Parkinson’s disease—a disease that primarily affects older adults 
(Stanley-Hermanns & Engebretson, 2010). 
Implications and recommendations. Several practice implications and 
recommendations for future research can be made based on the findings related to 
research question one. First, time and effort must be invested to prevent the delay in 
accurate diagnosis that was so pervasive in this sample and in the only other study that 
could be found investigating this exact issue (Rowan et al., 2005). The delay in diagnosis 
is not distressing only to older adults with epilepsy and their families, but lack of a timely 
diagnosis can, and did in the cases of many of these participants, lead to months or years 
of improper, unnecessary, and ineffective treatments and their associated costs, as well as 
decrements in quality of life (White, 2011). It remains unclear, however, how widespread 
the problem of delayed diagnosis is in this population currently, as well as how long the 
delay usually exists. More research with a larger and more geographically and  
racially diverse sample is needed in order to fully describe this problem. Such research 
must be done utilizing different methods than those used in this study because the 
prevalence of delayed epilepsy diagnosis and length of that delay need to be precisely 
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quantified. Once the problem of delayed diagnosis in this population has been described 
adequately, it can be solved only if factors contributory to it are identified. 
Based on findings from this study and others (Rowan et al., 2005), primary care 
providers often do not recognize older adults’ seizure symptoms as readily as they would 
in younger adults with epilepsy. It is known that older adults do indeed exhibit seizure 
symptoms that are distinct from those in younger adults and children. Seizure symptoms 
in older adults often present more subtly than in younger people and may include slight 
confusion, memory loss, or staring spells. Their post-ictal periods, however, are generally 
prolonged and characterized by more marked confusion than that which is seen in 
younger people. Older adults also often have co-morbidities, which can mask or seem to 
explain away the symptoms of seizures (Rowan et al., 2005; Rowan & Ramsay, 1997). 
The differences in seizure symptom presentation in older adults likely contribute to 
primary care providers’ lack of recognition of these symptoms as potentially  
epilepsy-related. It is possible that an intervention with primary care providers, the 
providers to whom older adults most often present with seizure symptoms, is needed in 
order to educate them not only of the symptoms of seizures in older adults but also of the 
high prevalence of new-onset seizures in this population. While Locharernkul and 
colleagues (2010) assessed the knowledge of primary care providers and nurses regarding 
the treatment of persons (and not specifically older adults) with epilepsy, no literature 
documenting primary care providers’ knowledge of and ability to recognize epilepsy 
symptoms in older adults could be found. Thus, future research should first focus on 
assessing the knowledge of these providers in terms of their recognition of seizure 
symptoms in older adults, as well as any misconceptions these providers may have 
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regarding the diagnosis of epilepsy in this population. Results from such an investigation 
could inform an intervention designed to improve providers’ awareness of older adults’ 
seizure symptom presentations and diagnostic steps that should be taken when those 
symptoms are seen in an older adult. For instance, epilepsy, once it is suspected, is not 
difficult or expensive to diagnose. A noninvasive outpatient test called an 
electroencephalogram can be used to make the diagnosis (Epilepsy Foundation, 2009). 
Thus, primary care providers could be made aware that when an older adult presents with 
new-onset memory loss or other symptoms that might be seizure-related, epilepsy should 
at least be ruled out as a potential cause. Of note is that the American Epilepsy Society 
and the Epilepsy Foundation have both tried to address primary care providers’ lack of 
knowledge of seizure symptoms (for all ages) and have had difficulty gaining the interest 
of providers in participating due to the low frequency with which they see patients 
presenting with new-onset epilepsy (J. Buelow, personal communication, September 12, 
2011). However, because these providers do not commonly see persons with epilepsy 
and, at least in the case of older adults, tend to misdiagnose this condition when it is 
presented, such an assessment and intervention is warranted. 
Such an intervention would need to be tailored to providers depending on the 
areas in which they practice and such tailoring likely could be achieved via the use of 
online modules, each of which would be crafted to contain information about the needs of 
different types of primary care providers (those in rural versus more metropolitan areas, 
for example). This intervention also may help promote epilepsy awareness to older 
adults, as primary care providers might be more likely to discuss it with their patients if 
the providers were aware of its high prevalence in the population. 
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The findings of this study indicate that women may be more likely than men to 
experience a delay in diagnosis and that the delay experienced by these females often can 
be associated with the dismissiveness of primary care providers to whom these women 
present with their seizure symptoms. An investigation aimed at determining the breadth 
of this problem and contributory factors is needed. Because there was no apparent reason 
for the discrepancy seen between men and women in this sample in terms of delay of 
diagnosis, further qualitative inquiry with both women (those who have experienced a 
delayed diagnosis as well as those who have not) and care providers is appropriate to 
identify contributing factors. 
Second, researchers must invest in determining how best to meet the educational 
needs of older adults who are newly diagnosed with epilepsy. Participants were very 
dissatisfied with the type and amount of education they received at the time of diagnosis, 
and this lack of education undoubtedly contributed to many participants’ continued 
misunderstanding of their disease. While the findings of this study have highlighted some 
of the information participants want and need to know at the time of diagnosis, it remains 
unknown precisely what types of information they are receiving. Inquiry into what 
information is given routinely to older patients at the time of epilepsy diagnosis by their 
care providers would be worthwhile and likely would be achieved best by interviewing 
neurologists and their associated nursing staff regarding the education that is given to 
newly diagnosed older adults with epilepsy and to determine if it differs from that given 
to younger adults diagnosed with the condition. Such a study would serve as a type of 
needs assessment regarding education delivered to older adults at the time of diagnosis 
and would thus highlight areas of missing information or the inappropriate use of 
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education materials (dispensing brochures with medical jargon, as was described by 
participants in this study, for example). 
Participants in this study indicated that they did not receive any formalized 
education about their disorder and that the lack of this education was surprising to them 
based on their experiences with other chronic conditions. Results from other studies, 
however, indicate that neurologists do not have time to deliver formalized education to 
their patients newly diagnosed with epilepsy. This issue is likely amenable to intervention 
via the use of advanced practice nurses (on-site or remotely) who could speak with older 
adult patients at the time of diagnosis or soon after in order to provide them with more 
structured, comprehensive education about their disorder. The development and testing of 
such an intervention in terms of its cost-effectiveness and ability to meet older adults’ 
needs is warranted. This intervention would be combined with theory-based epilepsy  
self-management interventions designed for this population (discussed later in this 
chapter). 
Participants also felt that neurologists down-played the seriousness of their 
disease in terms of how it ultimately would affect their lives. This problem may be 
related to the lack of education neurologists give their newly diagnosed older adult 
patients or could be a result of an actual misperception on the part of the providers. 
Because evidence suggests that patients and providers often have very different concerns 
regarding epilepsy (Clark et al., 2010), it is possible that neurologists may not even be 
aware of the ways in which epilepsy affects the lives of their patients. Researchers must 
inquire of neurologists how they perceive their patients’ lives changing after an epilepsy 
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diagnosis and possibly intervene with them regarding how to prepare patients for these 
changes. 
Research Question Two 
Key findings related to research question two—what problems are experienced by 
older adults while self-managing epilepsy?—emerged in this study. Participants reported 
experiencing, post-diagnosis, problems maintaining independence, problems with 
medications and memory, and problems achieving goals. 
Maintaining independence. Older adults in this study reported difficulties 
maintaining pre-diagnosis levels of independence. As is seen in the younger adult 
epilepsy literature (Krumholz, Fisher, Lesser, & Hauser, 1991; Unger & Buelow, 2009), 
several of the participants involved in this study, and particularly the youngest 
participants and those living in rural areas, found that their independence was negatively 
affected by their lack of ability to drive. This finding is not surprising as many older 
adults continue working past 65 years of age and thus must be able to drive to work 
themselves, especially in the event that their spouses also are employed. Even those who 
were not working, however, but lived alone or had an employed spouse found driving 
restrictions to be very disruptive to their normal lives. Martin and colleagues (2005) also 
found that a prime issue of importance to older adults with epilepsy was difficulties with 
transportation. Similar findings have emerged in studies investigating driving issues in 
older adults with Parkinson’s disease (Uitti, 2009). 
Unique to the current study is the finding that problems surrounding driving 
tended to attenuate with time for participants. For younger adults with epilepsy, there is 
evidence that issues related to driving occur in those newly diagnosed (Unger & Buelow, 
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2009) and those who are in the more chronic stages of the disease (Krumholz et al., 
1991). Participants in this study felt that the development of a system to manage their 
transportation was effective in improving their independence problems related to driving. 
In addition to transportation-related issues, participants reported that their condition and 
its treatments interfered with their ability to live independently on a daily basis. This 
finding is related to participants’ claims that epilepsy is a life-changing diagnosis, though 
their providers often do not alert them of or prepare them for these changes. While the 
researcher could locate no other published studies that corroborate this finding in the 
older adult population, Unger and Buelow (2009), in a study with newly diagnosed 
younger adults with epilepsy, found that participants commonly described the diagnosis 
as life-altering. However, the findings of this study are distinct from Unger and Buelow’s 
(2009) in terms of how participants’ independence was affected by epilepsy. Older adults 
reported much greater losses in independence than did the younger adults in Unger and 
Buelow’s (2009) study. Several older adults in this study were forced to move out of their 
homes and into those of family members or into assisted living facilities because their 
epilepsy and its treatments made them incapable of managing a household. While Unger 
and Buelow’s (2009) study involved only five participants, none of them reported such a 
drastic upheaval as a result of epilepsy. 
Medications. Older adults reported several problems related to managing their 
medications. First, lack of ability to pay for seizure medications was a concern to many 
participants. While it is known that younger adults who are uninsured have difficulty 
accessing their seizure medications (Epilepsy Foundation, 2010), findings from only one 
other study, in which older adult participants were asked to write down their concerns 
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about epilepsy, have indicated that access to seizure medications is a major issue for 
older adults (Martin et al., 2005). Unique to these older adults is the type of health 
insurance they use—Medicare. Most older adults with epilepsy are retired or not 
working, cannot afford private insurance, and thus are forced to rely on Medicare for 
their healthcare needs, including prescriptions. A large portion of the sample found that 
Medicare and its donut hole left them unable to pay for their seizure medications. 
Financial concerns regarding medications were compounded for participants as a result of 
the existence of multiple co-morbidities. Unlike younger adults with epilepsy, older 
adults are not only paying for their anti-epileptic drugs, but also drugs for a variety of 
other conditions. Participants in this sample were more likely to pay for medications 
related to heart disease, diabetes, or pain and to forgo buying seizure medications when 
finances were limited—that older adults’ epilepsy goes untreated due to financial 
limitations is thus a valid concern. 
Participants also expressed difficulties with side effects of seizure medications, 
and these side effects contributed to both loss of independence and decisions made not to 
purchase epilepsy medications in favor of drugs for other conditions. Epilepsy 
medications are known for causing undesirable side effects in adults (Unger & Buelow, 
2009), but participants in this sample reported that these side effects were much more 
pronounced when seizure medications were taken with medications for other conditions. 
Thus, a unique issue for this population is that of polypharmacy. 
Finally, participants reported that they often had problems remembering to take 
their medication and attributed this problem to increasing memory problems since the 
onset of epilepsy (discussed later in this chapter), the number of medications prescribed 
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to them, and the frequency with which those medications and their dosages changed. In 
studies with younger adults with epilepsy (Jacoby, 1992; Unger & Buelow, 2009; 
Unsworth, 1999), medication management has been shown to be an extremely complex 
portion of epilepsy self-management. However, in none of these studies has memory loss 
been highlighted as a key reason for difficulties in managing medication. Such memory 
loss coupled with polypharmacy likely deems epilepsy medication management in older 
adults even more complex than that which has been reported in younger adults. 
Memory. In addition to difficulties remembering to take seizure medications, 
participants also complained of general memory deficits since the onset of epilepsy. 
While McAuley and colleagues (2010) found that younger adults were concerned with 
general memory loss after the onset of epilepsy, the findings of this study are the only 
that can be found regarding the existence of a similar problem for older adults. Because 
McAuley and colleagues (2010) did not ask participants in their study to describe their 
memory loss, it is difficult to compare the memory loss experienced by younger adults 
with epilepsy with that of older adults with the condition. In this study, participants 
complained mostly of short-term memory loss since suffering from epilepsy. 
Interestingly, their scores, as a whole, on the Mini Mental Status Exam (Folstein et al., 
1975) were most abnormal in the section of the tool that tests short-term verbal memory. 
Achieving goals. Participants reported that epilepsy, in addition to medication 
side effects, memory problems, and other seizure-related symptoms, has made achieving 
personal goals, and specifically those associated with grandparenting, difficult to achieve. 
Younger adults with epilepsy have reported difficulties in maintaining normal parental 
roles (Buelow, 2001; Unger & Buelow, 2009), but no published studies reporting the 
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concern of older adults with epilepsy in relation to their ability to be grandparents could 
be found. Many of the participants in this study who voiced difficulty with 
grandparenting abilities cited safety of their grandchildren as the major concern. While 
Martin and colleagues (2005) found that older adults with epilepsy were concerned with 
safety issues, they did not report the exact types of safety issues that were concerning to 
their sample participants. 
Implications and recommendations. Several implications for practice and 
recommendations for future research can be made based on the findings associated with 
research question two. First, based on the findings of this study and others (Martin et al., 
2005), it must be recognized that driving restrictions are very problematic to older adults 
with epilepsy. Though members of this population are more often retired or unemployed 
when compared to younger adults with epilepsy, care providers of older adults with 
epilepsy must not assume that they will be unaffected by the driving restrictions that 
accompany an epilepsy diagnosis. In addition, because participants reported that their 
lack of independence related to driving restrictions improved over time due to the use of 
system-based strategies, it is important that such strategies be discussed and included in 
epilepsy self-management interventions, which are discussed later in this chapter. 
Secondly, older adults with epilepsy may be at high risk for significant loss of 
independence, including upheaval from their personal dwellings. Such a transition can be 
incredibly stressful for older adults (Uitti, 2009), as well as their family caregivers 
(Bakas, Austin, Okonkwo, Lewis, & Chadwick, 2002). Neurologists and nurses 
interacting with older adults with epilepsy must be aware of these older persons’ risk for 
loss of independence given that participants in this study did not feel prepared for this 
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change based on interactions with their neurologists. Epilepsy self-management 
interventions designed for this population (discussed later in this chapter) must be 
focused on preventing and managing this loss of independence. 
Thirdly, current findings indicate that older adults with epilepsy commonly, for a 
variety of reasons, do not take the appropriate dosages of their anti-epileptic medications. 
Clinical outcomes (e.g., seizure frequency/severity, healthcare resource utilization, and 
safety) could be affected greatly by these medication errors. Results of this study 
highlight several barriers that prevent older adults with epilepsy from taking their 
medications as prescribed. Self-management interventions designed for this population 
(discussed later in this chapter) thus must include an assessment and intervention aspect 
related to identifying and overcoming these barriers. 
Fourthly, older adults in this study reported problems with short-term memory 
loss following the onset of epilepsy. This memory loss was severe enough to interfere 
with their ability to live normally. Neuropsychological testing of these patients at the time 
of diagnosis and beyond may be needed to facilitate the diagnosis and treatment of 
epilepsy-related memory loss. None of the older adults in this sample reported having 
received any type of neuropsychological testing done since the time of their diagnosis. 
Finally, neurologists and nurses working with older adults with epilepsy must be 
aware of the influence a diagnosis of epilepsy has on older adults’ abilities to achieve 
their personal goals related to grandparenting. Again, participants expressed that they 
were unprepared by their neurologists regarding the potential for this problem.  
Self-management interventions designed for this population (discussed later in this 
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chapter) should include content regarding the achievement of personal goals in the 
context of an epilepsy diagnosis. 
Research Question Three 
In responding to research question three—how do older adults perceive that their 
lives have changed since being diagnosed with epilepsy?—participants reported 
experiencing mostly negative changes since their diagnosis of epilepsy, though some did 
report that positive changes had occurred in their lives since the diagnosis. 
Negative changes. Participants in this study reported experiencing negative 
changes in lifestyle, perceived well-being, and physical and emotional status. 
Lifestyle. Negative lifestyle changes included those to participants’ social lives, 
relationships with family members and friends, the number of important commitments 
made, daily functional abilities, and ability to fulfill age-appropriate roles and 
responsibilities. No other published studies reporting similar results for older adults with 
epilepsy could be found. However, somewhat similar findings from studies involving 
younger adults with epilepsy do exist. Younger adults with epilepsy have been shown to 
perceive negative life changes in all of these areas (Buelow, 2001; Unger & Buelow, 
2009). However, while negative changes in these areas of life appear common to both 
older and younger adults with epilepsy, the nature of these changes is not identical for 
both sets of groups. For example, while older adults reported a declining ability to 
independently maintain their homes (a negative change related to daily functional 
abilities), younger adults more often noted negative changes related to being productive 
at school or work (also a negative change related to daily functional abilities). Thus, 
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while both older and younger adults with epilepsy experience negative lifestyle changes, 
that the general lifestyles of younger and older adults differ cannot be ignored. 
Perceived well-being. Participants reported feeling less well as a result of their 
epilepsy. In other words, their perceived health was affected negatively by epilepsy and 
its treatments. While no other published evidence could be found to corroborate these 
findings in older adults with epilepsy, younger adults with epilepsy (Unger & Buelow, 
2009) and older adults with other chronic neurological conditions such as Parkinson’s 
disease also have reported a decline in their overall health due to the disease and its 
treatments (Gotham, Brown, & Marsden, 1986). In the current study, negative changes in 
perceived well-being were seen in participants with well- and poorly-controlled seizures, 
indicating that infrequent seizures or even seizure freedom does not guarantee that older 
adults with epilepsy will necessarily be feeling well or more well than older adults whose 
seizures are not as well-controlled. Similar findings resulted in a study with younger 
adults with intractable epilepsy (Buelow & Johnson, 2000). 
Physical and emotional status. Participants reported experiencing unpleasant 
physical and emotional symptoms related to their epilepsy and its treatments. These 
symptoms likely contribute to their experience of decreased wellness (discussed 
previously). Unger and Buelow (2009), in a study of younger adults newly diagnosed 
with epilepsy, found that those in their sample experienced physical and emotional 
symptoms, similar to those reported by older adults in this study. The physical symptoms 
experienced by both older and younger adults with epilepsy (fatigue, for example) may 
have more of an effect on older adults than on their younger counterparts. As discussed 
previously, older adults with epilepsy experience more dramatic changes in levels of 
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independence than has been reported in younger adults. Physical limitations experienced 
by older adults with epilepsy may be more severe than those experienced by younger 
adults due to older adults’ age-related physical changes and co-morbidities; these more 
severe physical symptoms may contribute to older adults’ lack of ability to continue 
living as independently as they did prior to being affected by the disorder. 
Positive changes. Participants did experience some positive changes as a result of 
being diagnosed with epilepsy, including those related to relationships with family and 
friends (becoming coming closer to family and friends during times of dependence), 
perspective (finding comfort in being diagnosed with epilepsy as opposed to other 
diseases that participants perceived as more harmful), and spirituality (feeling closer to 
their God during the difficult times associated with epilepsy). Buelow (2001) found that 
younger adults with epilepsy sometimes found that having epilepsy brought about 
positive changes in their self-image. 
Implications and recommendations. It is clear that epilepsy has an 
overwhelmingly negative effect on the lives of older adults diagnosed with this condition. 
This is an important finding in light of participants’ perceptions that their neurologists 
downplayed the seriousness of the disorder and did not convey that the disease of 
epilepsy could be so life-changing. Epilepsy self-management interventions designed for 
this population (discussed later in this chapter) must include strategies aimed at 
diminishing negatives changes experienced by older adults with epilepsy, while also 
maximizing their positive epilepsy-related experiences. 
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Research Question Four 
In responding to research question four—what strategies do older adults utilize in 
self-managing epilepsy?—participants reported the use of disease/treatment-focused and 
life changes/problem-focused self-management strategies. That is, participants used 
strategies aimed not only at managing epilepsy symptoms and treatments but also the 
negative life changes and problems discussed regarding research questions two and three. 
These strategies were further categorized as proactive and reactive. 
Disease/treatment-focused. All participants reported the use of strategies that 
were aimed at managing the disease of epilepsy (seizures and other symptoms, such as 
post-ictal fatigue and confusion) and its treatments (medication side effects, for example). 
While the use of these types of strategies was pervasive throughout the sample, the 
specific strategies used were diverse and depended on each individual older adult’s 
context and circumstances. For example, one participant found that avoiding sleep 
deprivation was key in helping reduce the frequency of his seizures, while another 
participant reported that avoiding dehydration helped prevent seizures. Both of these 
participants took steps to avoid seizure triggers, but the strategies they used were very 
different given their specific contexts. Another example of the diversity in strategies used 
by the sample to attain a similar goal was seen in how they organized their medications. 
One participant reported that he had his wife organize all of his medications. Another 
older adult became friends with her pharmacist, who pre-packaged her medications 
(epilepsy and others) in such a way that all she had to do was open a pouch to take the 
correct pills each morning, afternoon, and so on. And another participant simply placed 
all of his morning medications in a bottle labeled “morning,” and all of his evening 
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medications in a bottle labeled “night time.” While all of these participants were taking 
measures to organize their medications, the ways in which they went about it were very 
different. 
Life changes/problem-focused. All participants also reported the use of 
strategies aimed at managing the life changes and problems they experienced since being 
diagnosed with epilepsy. As was seen with seizure- and treatment-related strategies used 
by participants, differing strategies were used by participants to manage these issues. One 
participant managed medication side effects by self-titrating her seizure medication, 
while another participant achieved the same goal by scheduling and taking a three-hour 
nap every afternoon. The goal of both of these participants was to attenuate the side effect 
of fatigue caused by their seizure medications, but each behaved very differently to arrive 
at that goal. 
Proactive versus reactive. The previously described management strategies 
could be further categorized consistent with Buelow’s (2001) proactive versus reactive 
taxonomy. Both proactive (planned, systematic, and flexible) and reactive (unplanned 
and unpredictable) strategies were used by the majority of the sample in this study, while 
four participants used only reactive strategies. Participants consistently reported having 
unpleasant experiences when using reactive strategies, and much more pleasant and 
successful experiences when using proactive strategies. Participants who used only 
reactive strategies reported more and more significant epilepsy-associated problems and 
life changes than those who utilized some proactive strategies. Buelow (2001) had similar 
findings in her qualitative study involving younger adults with intractable  
epilepsy—those who used more reactive strategies actually demonstrated a lower quality 
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of life. All participants in Buelow’s (2001) study suffered from intractable epilepsy, 
while the sample in the current study was comprised of those with varying degrees of 
seizure control. It is interesting that those in this study, regardless of seizure frequency, 
reported more desirable experiences when relying on proactive strategies. 
In this study, participants reported that the prevalence of proactive strategies 
increased as they spent more time managing their disease. In addition, all four 
participants who did not report using proactive strategies had been recently diagnosed 
with epilepsy. Thus, it appears that there is a temporal component involved in the types 
of strategies (proactive versus reactive) used by older adults with epilepsy, with proactive 
strategies requiring more time and experience to develop. 
Implications and recommendations. Important implications and 
recommendations for both practice and research can be made based on the findings 
related to research question four. First, these findings support the notion, which was 
alluded to in Chapter II, that there does not exist a homogenous list of self-management 
strategies which are “good” or “bad.” Rather, older adults with epilepsy utilize a wide 
variety of unique strategies that are derived out of their particular contexts. There are 
commonalities, however, in what older adults hoped to achieve by using these various 
strategies—all were aimed at managing seizures/treatments or life changes/problems. 
Self-management interventions (discussed later in this chapter) must be developed with 
the context-bound nature of self-management in mind. Second, proactive strategies 
appear to be more effective than reactive strategies. However, more research is needed to 
quantify the relationship between type of strategy used (proactive versus reactive) and 
important outcomes. While Buelow’s (2001) findings suggest that the use of proactive 
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strategies is associated with higher quality of life, these findings were rendered only from 
younger adults with intractable epilepsy. The relationship between types of epilepsy  
self-management strategies used and a variety of outcomes (quality of life and healthcare 
resource utilization, for example) needs to be quantitatively assessed in a larger sample of 
older adults with epilepsy. If findings from such a research study further support the 
notion that proactive strategies improve outcomes in this population, these findings could 
be used to inform the development of epilepsy self-management interventions that 
facilitate the development and use of proactive strategies. As will be discussed later,  
self-management interventions in older adults with epilepsy must focus on teaching 
problem-solving skills to those older adults, so that they may use those skills to devise 
and implement proactive management strategies. 
Research Question Five 
Participants in this study responding to research question five—what outcomes do 
older adults hope to achieve in self-managing their epilepsy?—shared the outcomes they 
hope to achieve in self-managing their epilepsy. These included wanting to be more 
involved in their care, maintaining normalcy, being well-equipped and, to a much lesser 
degree, achieving seizure freedom. Participants felt that their neurologists were not aware 
of their desires in terms of these outcomes. 
Older adults also reported that their neurologists mostly are concerned with and 
usually only discuss seizure frequency and severity. As was described in Chapter II, 
seizure frequency and severity have been viewed, especially in medicine, as the prime 
outcomes of epilepsy management (Commission on Outcome Measurement in Epilepsy, 
1998). However, findings from this study indicate, for older adults, that seizure freedom 
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is a desired outcome of management only when it allows a return to normal life. That is, 
participants in this sample were most interested in managing their epilepsy in such a way 
that would allow them to live normally, regardless of seizure frequency. This finding is 
congruent with the general chronic disease self-management literature review presented 
in Chapter II and Buelow’s (2001) findings in a sample of younger adults with intractable 
epilepsy. 
As was demonstrated in the literature review presented in Chapter II, those 
involved in epilepsy research have become aware of the need to improve the ways in 
which outcomes are defined and measured for those with epilepsy. The Managing 
Epilepsy Well Network (n.d.) has a taskforce devoted to this issue. Findings from the 
current study provided some initial insight into the outcomes important to older adults 
with epilepsy. Chiefly, older adults’ desired epilepsy self-management outcomes appear 
to differ from those of their neurologists and are more related to maintaining a normal 
lifestyle in the context of having epilepsy. Seizure freedom is not a requisite for 
achieving this goal, as many participants reported they found seizures less disruptive to 
their lives than the amount of medication required to suppress them. Neurologists and 
nurses interacting with older adults with epilepsy must keep these outcomes in mind 
when devising ongoing treatment plans for older adults with epilepsy. In addition, 
because every person’s version of a normal life is different, neurologists and nurses 
caring for older adults with epilepsy must be sure to ask what outcomes older adults are 
interested in achieving. 
Current findings also can contribute to improving the measurement of outcomes 
important to older adults with epilepsy. As was discussed in Chapter II, an outcome of 
 222 
epilepsy self-management most commonly measured in the nursing literature is that of 
quality of life. At present, there exist several quality-of-life measures specific for those 
with epilepsy, including the Impact of Epilepsy Scale (Jacoby, Baker, Smith, Dewey, & 
Chadwick, 1993), the Quality of Life Index—Epilepsy (Ferrans & Cohen, 1996), and the 
Quality of Life in Epilepsy—31 (Cramer et al., 1998). 
A critique of each of these existing measures in light of this study’s findings 
highlights the need for the development of an outcome assessment tool for this 
population. None of these three tools were developed based on research with older adults, 
and none were based on research regarding patients’ desired outcomes. In addition, the 
Impact of Epilepsy Scale (Jacoby et al., 1993), though epilepsy-specific and sensitive to 
measuring perceived changes in the concepts it measures, lacks evidence of reliability 
and validity and a theoretical basis. Both the Quality of Life Index—Epilepsy (Ferrans & 
Cohen, 1996) and Quality of Life in Epilepsy—31 (Cramer et al., 1998) are useful tools 
in assessing quality of life in adults with epilepsy. Both have evidence of reliability and 
validity, a strong theoretical basis, and are epilepsy-specific. However, neither of these 
tools measure perceived changes in quality of life since being diagnosed with epilepsy. 
The goal in administering an outcome assessment tool to members of this population is to 
determine the effect that epilepsy has had on their outcomes. Tools that do not include 
this change component, thus, are less helpful in determining how epilepsy has affected 
the person’s outcomes. 
Instruments that measure changes in outcomes caused by chronic diseases do 
exist. Bakas, Champion, Perkins, Farran, and Williams (2006) designed and 
psychometrically tested the Bakas Caregiving Outcomes Scale, the purpose of which is to 
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measure change in stroke caregivers’ adaptational outcomes. This instrument has 
evidence of reliability and validity and has been used in a variety of caregiver populations 
(Bakas et al., 2006). Findings from the current study could inform the development of 
such an intervention for older adults with epilepsy by guiding the development of 
pertinent instrument items. 
Finally, self-management interventions (discussed in the next section) that are 
devised for this population must be aimed at affecting outcomes other than seizure 
frequency and severity. 
Other Findings 
Other findings that were not related directly to the a priori research questions also 
emerged and are discussed here. 
Epilepsy is different. Participants in this study expressed that epilepsy is, in 
several ways, a different type of disease. To the older adults in this sample, epilepsy 
remained a mysterious disease about which they felt much stigma. Very few of the 
participants felt comfortable describing what epilepsy is, and most of them knew no other 
people with epilepsy. The stigma and mystery associated with epilepsy has been  
well documented (Epilepsy Foundation, 2010), but the findings from the current study 
provide new information about the uniqueness of epilepsy, at least from the viewpoint of 
older adults. All of the older adults involved in this study had at least one other  
co-morbidity. Thus, they were familiar with other chronic diseases, including the 
diagnosis and treatment that accompany them. Many participants expressed how 
differently their diagnosis and treatment of epilepsy was handled by healthcare providers 
when compared to other chronic diseases from which they currently or had suffered. 
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They often were surprised with the lack of information given to them about their epilepsy 
when compared to that of diseases such as hypertension and stroke. 
Lack of resources and skills to seek out information. While the participants in 
this study had many questions concerning their epilepsy, they reported a lack of resources 
and skills to seek out that information. They reported being uncomfortable with using the 
Internet and overwhelmed with scientific literature they found in libraries. They often 
relied on younger family members to retrieve Internet-based information for them about 
their epilepsy but commonly found that they could not interpret it accurately. 
Implications and recommendations. The stigma and mystery surrounding 
epilepsy are likely to continue as long as epilepsy is treated as a different kind of disease. 
Because epilepsy is seen as a specialized condition, neurologists and nurses may not feel 
comfortable discussing it at length with their patients. In order to assist older adults with 
epilepsy at the time of diagnosis and beyond, those involved in their care must have a 
thorough understanding of epilepsy, its treatments, and how this disease can affect the 
lives of these patients. 
Those providing care to older adults with epilepsy, as well as those designing  
self-management interventions for this population, must be aware of the limitations in 
both access to and skills in using online resources reported by participants in this sample. 
The ways in which this finding may affect intervention development are discussed later 
in this chapter. 
Overall Findings 
Apart from the distinct themes that emerged as findings in the current study, 
overall characteristics of the major findings are worthy of discussion. In this section, the 
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system-embedded and process-like nature of epilepsy self-management in older adults is 
discussed. Next, ways in which the findings from the current study can influence 
intervention development are reviewed. 
Systems. The literature review presented in Chapter II introduced and supported 
the notion that chronic disease self-management, including epilepsy self-management, is 
a system-embedded phenomenon. That is, any person self-managing a chronic condition 
does so within his or her own unique system. The results of this study lend further 
support to the system-bound nature of epilepsy self-management in older adults. 
In the case of all participants in this study, there was evidence that their  
self-management was system-based. That is, participants did not report managing their 
epilepsy in complete isolation. Rather, even for those who lived alone and were 
extremely isolated socially, other people were involved in their epilepsy management. 
For example, one female participant lived alone, did not drive, and often was unable to 
afford her medications. She found that forming a relationship with a local pharmacy 
allowed her to get her medications when needed. “The main pharmacist just gave me a 
charge account there…and when I need them he brings them to me, even if it’s just one at 
a time and I can’t pay. They won’t let me go without,” she explained. Even participants 
who used no proactive strategies were practicing management within a system—they 
were surrounded by people (family and friends) who facilitated their reactive behavior. 
One female participant explained, “I think my husband is in denial…so I’ve kind of been 
too. That’s just how we’ve handled it, even though it’s not for the best.” Participants 
spoke explicitly of devising their own systems, often with other people, to manage all 
aspects of their condition. Participant quotes included throughout Chapter IV provide 
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examples of participants managing epilepsy by creating systems for handling 
transportation, medications, side effects, seizures, physical and emotional symptoms, and 
other problems and life changes. As discussed previously, the range of self-management 
strategies used by participants in this study is large, and, while pre-planned, proactive 
strategies appear to yield better outcomes than unplanned, reactive ones, no list of best or 
worst strategies can be extracted from the data. Appropriate self-management strategies 
must, rather, be devised individually based on older adults’ available systems and their 
particular contexts. 
Researchers conducting studies involving other chronic disease populations also 
have uncovered the system-based nature of self-management. Moore (2009), in her 
ongoing research with cardiac rehabilitation patients, has found that these persons’  
self-management as it relates to weekly exercise is influenced greatly by the family, or 
system as it is referred to by Moore, in which those persons live and exist. Accordingly, 
Moore and her colleagues (2009), as part of a National Institutes of Health-funded study 
(P30 NR010676), are in the process of devising and testing a self-management 
intervention that involves the entire family, or system, in which persons in  
post-myocardial infarction cardiac rehabilitation exist. Participants will design their own 
self-management action plans with others in their family or system, and action plans are 
devised with the needs and desires of the entire family or system in mind (Moore, 2009). 
Moore (2009) reports that the preliminary findings of the ongoing study are promising in 
terms of those participants undergoing the system-oriented self-management intervention 
exercising more often and more consistently than those receiving the individual 
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intervention. Similar interventions (discussed later in this section) may be effective in 
improving outcomes in older adults with epilepsy. 
Process. As explained in Chapter II, self-management is a process. Despite 
researchers often measuring self-management as an outcome, it is a process that leads to 
outcomes. Not surprisingly, epilepsy self-management in older adults emerged, in this 
study, as a process. All of the aspects of epilepsy self-management that were described in 
the findings appear to be highly interactive (see Figure 5). As was found in Unger and 
Buelow’s (2009) concept analysis of epilepsy self-management in younger adults newly 
diagnosed with the condition, this process is not stagnant but fluctuates as often as daily 
depending on the older adult’s circumstances. In the case of the older adults with epilepsy 
in this study, the personally important outcomes to which their self-management leads 
include being involved in the treatment of their epilepsy and maintaining normalcy. 
These outcomes can be attained with or without seizure freedom. This finding is 
significant, as the literature largely promotes seizure frequency and severity as the two 
main goals of epilepsy management (Buelow & Johnson, 2000). In order to ensure that 
older adults with epilepsy and their neurologists are working collaboratively in managing 
these older adults’ epilepsy, it is imperative that the desired outcomes of both groups be 
made explicit. 
Implications and recommendations. As will be discussed in more detail later in 
this section, interventions that are designed for older adults self-managing epilepsy must 
be uniquely tailored to each older adult’s context. Secondly, Figure 5 depicting the  
self-management process of older adults with epilepsy needs to be tested to confirm the 
proposed relationships and to determine, more clearly, the impact of the process on  
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self-management outcomes. Such testing could be done qualitatively using a grounded 
theory method, quantitatively using a correlational design, or via mixed methods. Such a 
study would render a better developed model of epilepsy self-management in older 
adults, and this model could be used to guide the development of self-management 
interventions. 
Intervention development. The findings from the current study can inform the 
development of a variety of interventions, some of which can be aimed at improving 
older adults’ experiences with epilepsy diagnosis (previously discussed), and also those 
that can be aimed at improving their epilepsy self-management outcomes. 
As was discussed in Chapter II, there is currently a paucity of effective epilepsy 
self-management interventions, and those that do exist have not been tailored to the needs 
of older adults. Findings from this study, and specifically those related to problems and 
negative life changes experienced by older adults with epilepsy, can be used to provide 
such tailoring to self-management interventions. These findings can guide researchers 
regarding the areas for which older adults with epilepsy should be assessed for problems. 
The interventions those older adults receive would be tailored based on their current or 
potential areas of difficulty. 
In the chronic disease literature, there is evidence that self-efficacy theory-based 
interventions are most effective at improving outcomes, though they have not been 
shown to affect all outcomes, and their effects attenuate with time. Based on the findings 
from this study and those of Moore’s (2009), a self-efficacy and systems-based epilepsy 
self-management intervention should be developed for older adults with epilepsy. 
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The literature review in Chapter II supports the notion that self-management is 
problem-based (Lorig & Holman, 2003), and the findings from this study indicate that 
proactive self-management strategies are more effective at rendering positive outcomes. 
The participants in this study who used proactive strategies were engaging in  
problem-solving when they planned and implemented proactive strategies.  
Problem-solving ability is a component of self-efficacy that is amenable to intervention 
(Lorig & Holman, 2003), and thus self-management interventions developed for this 
population must have a problem-solving component that will prepare them to engage in 
proactive self-management strategies, even in the early stages of their diagnosis. Such an 
intervention would not provide older adults with epilepsy with straight education or a list 
of strategies to use. Rather, the focus of the intervention should be on preparing these 
older adults to manage, via the use of proactive strategies, their epilepsy/treatments and 
problems/life changes they experience. 
While problem-based interventions have been shown to affect self-management 
outcomes, and the findings of this study suggest that problem-solving ability is important 
in epilepsy self-management in older adults, prior self-management interventions (see 
Chapter II) based on self-efficacy theory have failed to affect outcomes over an extended 
period of time. Here, it is proposed that the addition of a systems component to a  
self-efficacy-based epilepsy self-management intervention would render that intervention 
more effective. Prior to the implementation of an epilepsy self-management intervention 
for an older adult with epilepsy, that person’s specific context should be assessed so that 
the intervention can be tailored to his or her available systems (Moore, 2009).  
Problem-solving also should be taught in the context of the system that the older adult 
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with epilepsy will be using to self-manage his or her epilepsy. Given that many of these 
older adults utilize systems with spouses, other family members, or friends, the 
intervention may need to be implemented with these significant others as well. It is also 
possible that the intervener would need to assist the older adult with epilepsy in 
identifying his or her available systems. The goal of the intervention would be to improve 
the problem-solving ability of the older adult with epilepsy so that he or she can 
implement proactive management strategies, within a system unique to him or her, and 
achieve his or her personal self-management outcomes. 
As mentioned previously, older adults in this study felt uncomfortable using the 
Internet and preferred to interact with another person when learning about their condition. 
The most recently developed epilepsy self-management intervention, WebEase, is only 
available online (DiIorio et al., 2009). While this intervention has demonstrated 
promising results in a small sample of those with epilepsy, it may not be applicable to 
older adults who lack the skills or equipment to use it. This is especially true for older 
adults living in rural areas. 
All of the participants in this study, however, had telephones. Interventions 
delivered via telephone have been shown to be effective. Bakas and colleagues (2009) 
implemented a telephone-based intervention aimed at improving the outcomes of 
caregivers of stroke survivors. The eight-week intervention involved telephone calls from 
a nurse who assessed caregiver needs and provided an intervention tailored to those 
caregivers’ specific needs. This intervention was effective—caregivers who received the 
intervention had better outcomes than those in the attention control group who received a 
brochure on caregiving and phone calls from nurses but no tailored intervention  
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(Bakas et al., 2009). A prime advantage of a telephone intervention is that it is low-cost 
and does not require participants to travel for the intervention, which would be a 
particular problem for older adults with epilepsy. In the case of older adults with 
epilepsy, because family members or friends are likely to be part of the system upon 
which the older adult will rely in self-managing his or her epilepsy, an initial home visit 
by the advanced practice nurse implementing the intervention may be necessary. The 
remainder of the intervention could be carried out via telephone. 
Recommendations for Future Research 
In this chapter, several recommendations for future research have been made. 
Researchers must now focus their efforts on conducting: 
 A quantitative research study aimed at describing the current delay in 
diagnosis in a larger, more diverse sample of older adults with epilepsy; 
 A needs assessment regarding primary care providers’ knowledge of 
symptom presentation in older adults with epilepsy, as well as their 
perceptions of the impact of the disease on patients’ lives; 
 A quantitative research study aimed at describing the relationships 
between types of self-management strategies used (proactive versus 
reactive) and self-management outcomes in a larger, more diverse sample 
of older adults with epilepsy; 
 A qualitative, quantitative, or mixed methods study testing of the 
conceptual framework presented in this study (see Figure 5); 
 The development of an instrument designed to measure changes in  
self-management outcomes important to older adults with epilepsy; and 
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 Based on the research in the current study, intervention development and 
testing studies aimed at improving older adults’ experiences being 
diagnosed with epilepsy and their epilepsy self-management outcomes. 
Summary 
In this chapter, the methods used in the study and the major findings have been 
discussed. Implications for practice have been identified and recommendations for future 
research have been made. 
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APPENDIX A 
SUMMARY OF STATE OF THE SCIENCE OF CHRONIC DISEASE AND 
EPILEPSY SELF-MANAGEMENT LITERATURES 
  
Literature Review 
Questions 
General Chronic 
Disease Literature 
Epilepsy Literature Comments 
How is self-
management 
conceptually 
defined? 
No single definition 
exists. 
Historically 
portrayed as a 
behavioral 
concept—what 
people do 
constitutes their 
self-management. 
Occurs in multiple 
domains. 
Not synonymous 
with compliance. 
More recently 
portrayed as a 
process that is 
context-dependent 
and often involves 
an entire family. 
Portrayed as a 
behavioral concept 
that occurs in the 
domains of 
medications, 
seizures, safety, 
physical and 
emotional comfort, 
and functional 
status. 
Most recent 
definitions portray 
it as context-
dependent. 
Portrayed as 
particularly 
complex. 
Epilepsy 
researchers are just 
beginning to 
acknowledge the 
context-dependent 
nature of epilepsy 
self-management. 
Epilepsy self-
management has 
not yet been 
conceptualized as 
including the entire 
family in which the 
person with 
epilepsy exists. 
Table continues 
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Literature Review 
Questions 
General Chronic 
Disease Literature 
Epilepsy Literature Comments 
How is self-
management 
operationally 
defined? 
Medication and 
treatment 
compliance. 
Engagement in 
behaviors. 
Medication and 
treatment 
compliance. 
Engagement in 
behaviors. 
Often measured via 
Epilepsy Self-
Management Scale. 
Because self-
management is a 
process, it does not 
lend itself to direct 
measurement. 
Measuring self-
management as 
compliance is at 
odds with the 
conceptual 
definition of self-
management. 
Measuring self-
management as 
engagement in 
behaviors does not 
recognize the fluid 
and context-bound 
nature of the 
concept and is too 
limiting. 
Researchers should 
strive to 
characterize self-
management rather 
than directly 
measure it. 
Table continues 
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Literature Review 
Questions 
General Chronic 
Disease Literature 
Epilepsy Literature Comments 
What are the 
outcomes of self-
management? 
Disease status and 
severity 
(progression of 
disease, number of 
exacerbations). 
Health status and 
quality of life. 
Healthcare resource 
utilization. 
Seizure frequency 
and severity. 
Health status and 
quality of life. 
Healthcare resource 
utilization (rarely). 
The disease status 
and severity 
outcomes are 
derived from the 
medical model, 
whereas health 
status and quality of 
life outcomes are 
congruent with the 
nursing model. 
Researchers must 
consider how 
developmental 
factors (age, for 
example) and length 
of time since 
diagnosis affect 
pertinent outcomes. 
Table continues 
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Literature Review 
Questions 
General Chronic 
Disease Literature 
Epilepsy Literature Comments 
What affects and 
influences self-
management? 
Contextual factors: 
age, gender, 
socioeconomic 
status, disease 
severity. 
Internal factors: 
knowledge and 
beliefs, self-
efficacy, self-
regulation. 
External factors: 
access to healthcare 
and social support 
Contextual factors: 
Age, gender, and 
socioeconomic 
status assumed to 
influence epilepsy 
self-management as 
in general chronic 
disease, but not 
tested in epilepsy; 
some evidence that 
seizure severity 
influences self-
management. 
Internal factors: 
knowledge, beliefs 
and self-efficacy. 
External factors: 
Social support has 
been shown to be 
related to self-
management in one 
study. 
In general chronic 
disease, the most 
evidence suggests 
that self-efficacy 
affects self-
management, 
including self-
management 
outcomes. 
The relationship 
between self-
efficacy and 
epilepsy self-
management has 
not been tested, 
though self-efficacy 
appears in most 
epilepsy self-
management 
models. 
Table continues 
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Literature Review 
Questions 
General Chronic 
Disease Literature 
Epilepsy Literature Comments 
How effective are 
self-management 
interventions? 
True self-
management 
interventions are 
superior to pure 
education. 
Theory-based self-
management 
interventions are 
superior. 
In the arthritis and 
asthma populations, 
evidence suggests 
that self-
management 
interventions affect 
outcomes, though 
these changes 
attenuate with time. 
Generic self-
management 
interventions can 
improve outcomes, 
though these 
changes attenuate 
with time. 
Too few high-
quality studies 
testing epilepsy 
self-management 
interventions have 
been implemented 
to allow for 
conclusions to be 
drawn about the 
effect of such 
interventions. 
A new intervention, 
WebEase, has been 
shown to slightly 
affect outcomes in a 
small sample of 
those with epilepsy. 
In general chronic 
disease, conclusions 
that can be made 
regarding the 
effectiveness of 
self-management-
enhancing 
interventions are 
limited by the small 
number of high-
quality studies that 
have been executed, 
measurement of 
outcomes only in 
the short-term, and 
use of varying 
measurements for 
outcomes. 
The literature 
regarding the 
effectiveness of 
epilepsy self-
management 
interventions is so 
underdeveloped that 
ways in which 
epilepsy self-
management 
outcomes can be 
improved via 
intervention cannot 
be described. 
Table continues 
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Literature Review 
Questions 
General Chronic 
Disease Literature 
Epilepsy Literature Comments 
What is known 
about self-
management in 
older adults? 
The presence of 
chronic disease 
negatively affects 
older adults’ lives 
and results in 
increased numbers 
of subjective 
unhealthy days. 
Older adults utilize 
some self-
management 
strategies more 
often than younger 
adults. 
Self-management 
interventions 
delivered to older 
adults with 
hypertension and 
diabetes have been 
shown to improve 
outcomes. 
Older adults with 
epilepsy experience 
decrements in 
quality of life. 
No research has 
been conducted 
regarding the 
epilepsy self-
management of 
older adults. 
Unique 
characteristics of 
older adults have 
the potential to 
complicate their 
epilepsy self-
management. 
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APPENDIX B 
IRB APPROVAL OF STUDY 
 
 
To: JANICE M BUELOW NURSING 
From: IU Human Subjects Office 
Office of Research Administration – Indiana University 
Date: April 08, 2011 
RE: NOTICE OF EXPEDITED APPROVAL 
Protocol Title: Epilepsy Self-Management in Older Adults: A Qualitative Study 
Protocol #: 1102004788 | 
Funding Agency/Sponsor: NATIONAL INSTITUTES OF HEALTH 
IRB: IRB-01, IRB00000220 
Expiration Date: April 07, 2012 
The above-referenced protocol was reviewed by the Institutional Review Board (IRB-
01). The protocol meets the requirements for expedited review pursuant to §46.110, 
Category (6) (7) . The protocol is approved for a period of April 08, 2011 through April 
07, 2012. This approval does not replace any departmental or other approvals that may be 
required. If you submitted and/or are required to provide participants with an informed 
consent document, study information sheet, or other documentation, a copy 
of the enclosed approved stamped document is enclosed and must be used. 
As the principal investigator (or faculty sponsor in the case of a student protocol) of this 
study, you assume the following responsibilities: 
1. CONTINUING REVIEW: Federal regulations require that all research be reviewed 
at least annually. You may receive a “Continuation Renewal Reminder” approximately 
two months prior to the expiration date; however, it is the Principal Investigator’s 
responsibility to obtain review and continued approval before the expiration date. If 
continued approval is not received by the expiration date, the study will automatically 
expire, requiring all research activities, including enrollment of new subjects, interaction 
and intervention with current participants, and analysis of identified 
data to cease. 
2. AMENDMENTS: Any proposed changes to the research study must be reported to the 
IRB prior to implementation. Only after approval has been granted by the IRB can these 
changes be implemented. An amendment form can be obtained at: 
http://researchadmin.iu.edu/HumanSubjects/hs_forms.html. 
3. UNANTICIPATED PROBLEMS AND NONCOMPLIANCE: Unanticipated 
problems and noncompliance must reported to the IRB according to the policy described 
in the Unanticipated Problems and Noncompliance SOP, which can be found at 
http://researchadmin.iu.edu/HumanSubjects/hs_policies.html. NOTE: If the study 
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involves gene therapy and an event occurs which requires prompt reporting to the IRB, it 
must also be reported to the Institutional Biosafety Committee (IBC). 
4. ADVERTISEMENTS: Only IRB-approved advertisements may be used to recruit 
participants for the study. If you submitted an advertisement with your study submission, 
an approved stamped copy is provided with the approval. To request approval of an 
advertisement in the future, please submit an amendment, explaining the mode of 
communication and information to be contained in the advertisement. 
5. COMPLETION: Prompt notification must be made to the IRB when the study is 
completed (i.e. there is no further subject enrollment, no further interaction or 
intervention with current participants, including follow-up, and no .further analysis of 
identified data). To notify the IRB of study closure, please obtain a close-out form at 
http://researchadmin.iu.edu/HumanSubjects/hs_forms.html. 
6. LEAVING THE INSTITUTION: The IRB must be notified of the disposition of the 
study when the principal investigator (or faculty sponsor in the case of a student project) 
leaves the institution. 
7. VULNERABLE POPULATION: Please note that there are special requirements for 
the inclusion of prisoners in research. You may not enroll or otherwise include an 
individual who is or becomes a prisoner while enrolled in the research. For additional 
information on the requirements for including prisoners in research, please refer to 
http://researchadmin.iu.edu/HumanSubjects/hs_policies.html. 
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APPENDIX C 
ADVERTISEMENT USED IN PILOT STUDY 
 
 
Are you age 60 or older? Have you been diagnosed with epilepsy (seizures)? If so, 
you may be eligible to take part in an 
Epilepsy Self-Management Study 
Researchers at the Indiana University School of Nursing will be conducting a study 
beginning in spring 2011 exploring the self-management experiences of older adults 
diagnosed with epilepsy (seizures).  
What is the study about? 
Managing epilepsy can be a complex and difficult process. 
The purpose of this study is to find out how older adults who have been diagnosed with 
epilepsy manage this disease on a daily basis. We hope to gain information that will 
allow us to help older adults with any problems they face in managing this disease. 
What does the study involve? 
About an hour of your time 
Answering questions about your experiences with having and self-managing epilepsy as 
an older adult 
You will receive a $20 Wal-Mart gift card as a token of appreciation for your time 
How do I participate? 
If you would like to be contacted by a researcher for more information about taking part 
in the study, please call Wendy Miller at 812-797-4646. 
Please contact Wendy Miller, MSN, RN, CCRN, PhD Student at  
(812) 797-4646 with any questions. 
Principal Investigator: Janice Buelow, PhD, RN 
Indiana University School of Nursing (IUPUI campus) 
1111 Middle Drive 
Indianapolis, IN 46202 
 
  
Study # 1102004788 
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APPENDIX D 
RECRUITMENT LETTER 
 
A Research Study: Epilepsy Self-Management in Older Adults 
Conducted by Janice Buelow, PhD, RN and Wendy R. Miller, MSN, RN, CCRN 
Indiana University School of Nursing 
 
Dear Patient, 
Managing your epilepsy can be a difficult and complex process. As your neurologist, I 
am writing to tell you about a study for older adults with epilepsy. 
The purpose of this study is to learn more about how older adults diagnosed with epilepsy 
late in life manage their disease on a daily basis and how having epilepsy affects their 
lives. The study involves a one-time, face-to-face interview with co-investigator Wendy 
Miller. You will be asked a series of questions about how you manage your epilepsy. As 
well, if you have a family member who assists you in managing your epilepsy, you may 
invite him or her to participate in a separate interview.  
What does the study involve? 
About an hour of your time 
Answering questions about your experiences with having and self-managing 
epilepsy as an older adult 
You will receive a $20 Wal-Mart gift card as a token of appreciation for your time 
In the next few weeks, a nurse from Indiana University will call you to see if you are 
interested and eligible to take part in the study. If you know you do not want to take 
part in the study, call Wendy Miller at 812-797-4646 and let her know and she will 
not contact you again. 
Taking part in this study is completely up to you. Your care will not be affected at all by 
your decision.  
Sincerely,  
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APPENDIX E 
INFORMED CONSENT 
INDIANA UNIVERSITY INFORMED CONSENT STATEMENT FOR 
Epilepsy Self-Management in Older Adults: A Qualitative Study 
You are invited to participate in a research study of self-management in epilepsy. You 
were selected as a possible subject because you are an adult aged 60 years or older who 
has been diagnosed with epilepsy. We ask that you read this form and ask any questions 
you may have before agreeing to be in the study.  
The study is being conducted by Janice Buelow, PhD, RN and Wendy Miller, MSN, RN, 
CCRN of Indiana University School of Nursing.  
STUDY PURPOSE: 
The purpose of this study is to find out how older adults with epilepsy manage this 
disease on a daily basis. We are interested in what kinds of experiences older adults with 
epilepsy have while managing their disease and how epilepsy affects their lives. Because 
older adults often have a family member or friend who helps them manage their disease, 
we are also interested in what kinds of experiences those family members or friends have 
in helping older adults manage their epilepsy. 
NUMBER OF PEOPLE TAKING PART IN THE STUDY: 
If you agree to participate, you will be one of 20 older adults who will be participating in 
this research. 
PROCEDURES FOR THE STUDY: 
If you agree to be in the study, you will do the following things: 
You will receive a phone call from or meet with an investigator (Wendy Miller) to 
arrange an interview. You will meet with the investigator for one audio-recorded 
interview that will last about 45 minutes. Before the interview begins, you will complete 
the Mini-Mental Status Exam. This exam involves answering simple questions and 
following simple commands. Those older adults who have a family member or friend 
(“significant other”) taking part in the study will also complete the Dyadic Relationship 
Scale. Completing this scale involves answering questions about your relationship with 
your family member or friend (“significant other”) who assists you with self-management 
of your epilepsy. These take about five minutes each to complete. During the interview, 
you will be asked questions about how you manage your epilepsy and how epilepsy has 
changed your life. Interviews will take place in a private location of your choice. All 
interviews will take place over approximately 5 months, and your interview will take 
place when it is most convenient for you following your agreement to be part of the 
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study. Once your interview has been completed, your participation in the study is 
complete.  
RISKS OF TAKING PART IN THE STUDY: 
While on the study, the risks are: 
-Feeling uncomfortable answering the interview questions.  
-Possible loss of confidentiality. The risk of loss of confidentiality is slight. 
-Feeling uncomfortable being audio-recorded.  
In order to prevent these above risks from happening, several steps will be taken. If at any 
time you feel uncomfortable answering a question on the questionnaire(s) or during the 
interview, you may tell the investigator that you feel uncomfortable with the question and 
do not care to answer it. Also, you can choose to stop the interview at any time or take a 
break from the interview if you begin to feel uncomfortable. Regarding the protection of 
your confidentiality, the following measures will be taken to make sure your 
confidentiality is protected: only two investigators (Wendy Miller and Janice Buelow) 
will have access to the audio-recorded interviews, audio recorded interviews will be 
destroyed as soon as the recordings are transcribed, transcriptions of interviews will not 
contain your name, all information we receive from you will be kept in a locked cabinet 
in a private location accessible only to investigators Wendy Miller and Janice Buelow, 
any private information that is stored on a computer will be stored on a single computer 
accessible only to these investigators and will be protected by a password, and the study 
results that are shared or published will be presented without your name or any other 
information that might make it possible for someone to identify you. 
BENEFITS OF TAKING PART IN THE STUDY: 
The benefits to participation that are reasonable to expect are that the knowledge gained 
from your participation will help the investigators gain a better understanding about how 
epilepsy affects the lives of older adults, how older adults manage epilepsy, and the 
specific problems faced by older adults managing epilepsy. Learning about how older 
adults self-manage epilepsy and the problems they face when doing so will allow 
investigators to create tools and programs to help other older adults managing epilepsy. 
Participating in the study will provide no direct, immediate benefits to you.  
ALTERNATIVES TO TAKING PART IN THE STUDY: 
Instead of being in the study, you have these options: Not taking part in the study. 
CONFIDENTIALITY: 
Efforts will be made to keep your personal information confidential. We cannot 
guarantee absolute confidentiality. Your personal information may be disclosed if 
required by law. Your identity will be held in confidence in reports in which the study 
may be published and in computer databases in which the results are stored. 
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Only two investigators will have access to the audio-taped interviews. The tapes will not 
be used for educational purposes, and will be destroyed once the interview is completely 
transcribed by the researcher—most likely within 1 month of the interview. 
Organizations that may inspect and/or copy your research records for quality assurance 
and data analysis include groups such as the study investigator and his/her research 
associates, the IU Institutional Review Board or its designees, the Bloomington Hospital 
Institutional Review Board or its designees, study sponsor, and (as allowed by law) state 
or federal agencies (specifically the Office for Human Research Protections (OHRP) may 
need to access your medical and/or research records. 
COSTS: 
There are no costs associated with participation in this study. 
PAYMENT: 
You will receive a $20 Wal-Mart gift card as a token of appreciation for your time. 
CONTACTS FOR QUESTIONS OR PROBLEMS: 
For questions about the study or a research-related injury, contact the researcher Janice 
Buelow at 317-274-9639 or 1-800-506-7796. After business hours, please call 317-274-
9639 or 1-800-506-7796.  
In the event of an emergency, you may contact Janice Buelow at 317-274-9639 or 1-800-
506-7796. 
For questions about your rights as a research participant or to discuss problems, 
complaints or concerns about a research study, or to obtain information, or offer input, 
contact the IU Human Subjects office at 812-856-4242 or 800-696-2949 or by email @ 
irb01@iupui.edu 
You may also call the Bloomington Hospital Institutional Review Board at 812-353-
2847. 
VOLUNTARY NATURE OF STUDY: 
Taking part in this study is voluntary. You may choose not to take part or may leave the 
study at any time. Leaving the study will not result in any penalty or loss of benefits to 
which you are entitled. Your decision whether or not to participate in this study will not 
affect your current or future relations with your neurologist or other health care providers. 
Your participation may be terminated by the investigator without regard to your consent 
in the following circumstances: If it is determined that you do not represent the 
population of interest in the study. For example, if you do not meet the inclusion criterion 
of being age 60 years or older. 
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SUBJECT’S CONSENT: 
In consideration of all of the above, I give my consent to participate in this research 
study.  
I will be given a copy of this informed consent document to keep for my records. I agree 
to take part in this study. 
Subject’s Printed Name:  ________________________________ 
Subject’s Signature: _______________________________ Date:________________  
 (must be dated by the subject) 
Printed Name of Person Obtaining Consent: ________________________________  
Signature of Person Obtaining Consent: ____________________ Date:__________  
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APPENDIX F 
MINI MENTAL STATUS EXAM 
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APPENDIX G 
DEMOGRAPHIC DATA COLLECTION FORM 
OLDER ADULTS 
Study ID Number:________  
Age:_____  
Gender:_____  
Type of epilepsy:___________________________  
Cause of epilepsy:___________________________  
Number of seizures per month:_____________  
Work Status: Unemployed Employed Full-Time Employed Part-Time Retired  
Living Situation: Alone With Another Person Alone but Visited Regularly  
Assistive Significant Other? Yes No  
Length of time person has known assistive significant other:_________  
Nature of relationship with significant other:____________________  
Level of education (number of years):_______  
Other co-morbidities:_______________________________________  
Number of medications taken (including AEDs):________________________ 
Length of time since epilepsy diagnosis:_____________  
Household income: less than $20,000 $21,000–$40,000 $41,000–$60,000
 $61,000–$100,000 greater than $100,000 
  
 250 
REFERENCES 
Alderson, M., Starr, L., Gow, S., & Moreland, J. (1999). The program for rheumatic 
independent self-management: A pilot evaluation. Clinical Rheumatology, 18(4), 
283–292. 
Anderson, R., Freedland, K., Clouse, R., & Lustman, P. (2001). The prevalence of 
comorbid depression in adults with diabetes: A meta-analysis. Diabetes Care, 
24(6), 1069–1078. 
Armbrister, K. (2008). Self-management: Improving heart failure outcomes. The Nurse 
Practitioner: The American Journal of Primary Health Care, 33(11), 20–28. 
Ayres, L., Kavanaugh, K., & Knafl, K. (2003). Within-case and across-case approaches 
to qualitative data analysis. Qualitative Health Research, 13(6), 871–883. 
Bailey, J. M. (2009). The top 10 rural issues for health care reform. Center for Rural 
Affairs, 2(1), 1–8. 
Bakas, T., Austin, J. K., Okonkwo, K. F., Lewis, R. R., & Chadwick, L. (2002). Needs, 
concerns, strategies, and advice of stroke caregivers the first six months after 
discharge. Journal of Neuroscience Nursing, 34(5), 242–251. 
Bakas, T., Champion, V., Perkins, S., Farran, C., & Williams, L. (2006). Psychometric 
testing of the revised 15-item Bakas Caregiving Outcomes Scale. Nursing 
Research, 55(5), 346–355. 
Bakas, T., Farran, C. J., Austin, J. K., Given, B. A., Johnson, E. A., & Williams, L. S. 
(2009). Stroke caregiver outcomes from the Telephone Assessment and  
Skill-Building Kit (TASK). Topics in Stroke Rehabilitation, 16(2), 105–121. 
  
 251 
Bandura, A. (1986). Social foundations of thought and action: A social cognitive theory. 
Englewood Cliffs, NJ: Prentice Hall. 
Bandura, A. (1997). Self-efficacy: The exercise of control. New York, NY:  
W. H. Freeman. 
Barlow, J., Sturt, J., & Hearnshaw, H. (2002). Self-management interventions for people 
with chronic conditions in primary care: Examples from arthritis, asthma and 
diabetes. Health Education Journal, 61(4), 365–378. 
Barlow, J., Turner, A., Swabyl, L., Gilchristl, M., Wright, C., & Doherty, M. (2008). An 
8-yr follow-up of Arthritis Self-Management Programme participants. 
Rheumatology, 48(2), 128–133. 
Barlow, J., Wright, C., Sheasby, J., Turner, A., & Hainsworth, J. (2002).  
Self-management approaches for people with chronic conditions: A review. Patient 
Education and Counseling, 48(2), 177–187. 
Begley, C. E., Shegog, R., Iyagba, B., Chen, V., Dubinsky, S., Newmark, M., . . . 
Friedman, D. (2010). Socioeconomic status and self-management in epilepsy: 
Comparison of diverse clinical populations in Houston, TX. Epilepsy & Behavior, 
19(3), 232–238. 
Berg, J., Dunbar-Jacob, J., & Sereika, S. (1997). An evaluation of a self-management 
program for adults with asthma. Clinical Nursing Research, 6(2), 225. 
Bodenheimer, T., Lorig, K., Holman, H., & Grumbach, K. (2002). Patient  
self-management of chronic disease in primary care. Journal of the American 
Medical Association, 288(19), 2469–2475. 
  
 252 
Boss, G., & Seegmiller, J. (1981). Age-related physiological changes and their clinical 
significance. Western Journal of Medicine, 135(6), 434–440. 
Boult, C., Altmann, M., & Gilbertson, D. (1996). Decreasing disability in the 21st 
century: The future effects of controlling six chronic conditions. American Journal 
of Public Health, 86(10), 1388–1393. 
Bourbeau, J., & van der Palen, J. (2009). Promoting effective self-management 
programmes to improve COPD [Editorial]. European Respiratory Journal, 33(3), 
461–463. 
Brodie, M. J., & Kwan, P. (2005). Epilepsy in elderly people. British Medical Journal, 
331(7528), 1317–1322. 
Brody, B., Williams, R., Thomas, R., Kaplan, R., Chu, M., & Brown, S. (1999).  
Age-related macular degeneration: A randomized clinical trial of a  
self-management intervention. Annals of Behavioral Medicine, 21(4), 322–329. 
Buelow, J., & Shore, C. (2006). Childhood epilepsy: Failures along the path to diagnosis 
and treatment. Epilepsy & Behavior, 9(3), 440–447. 
Buelow, J., & Smith, M. (2004). Medication management by the person with epilepsy: 
Perception versus reality. Epilepsy & Behavior, 5(3), 401–406. 
Buelow, J. M. (2001). Epilepsy management issues and techniques. Journal of 
Neuroscience Nursing, 33(5), 260–269. 
Buelow, J. M., & Johnson, J. (2000). Self-management of epilepsy: A review of the 
concept and its outcomes. Disease Management & Health Outcomes, 8(6),  
327–336. 
  
 253 
Buelow, J. M., McNelis, A., Shore, C. P., & Austin, J. K. (2006). Stressors of parents of 
children with epilepsy and intellectual disability. Journal of Neuroscience Nursing, 
38(3), 147–154. 
Buetow, S., Goodyear-Smith, F., & Coster, G. (2001). Coping strategies in the  
self-management of chronic heart failure. Family Practice, 18(2), 117–122. 
Buszewicz, M., Rait, G., Griffin, M., Nazareth, I., Patel, A., Atkinson, A., . . . Haines, A. 
(2006). Self management of arthritis in primary care: Randomised controlled trial. 
British Medical Journal, 333(7574), 879. 
Callahan, C., Unverzagt, F., Hui, S., Perkins, A., & Hendrie, H. (2002). Six-item screener 
to identify cognitive impairment among potential subjects for clinical research. 
Medical Care, 40(9), 771–781. 
Caplin, D., & Creer, T. (2001). A self-management program for adults with asthma: 
Maintenance and relapse of skills. Journal of Asthma, 38(4), 343–356. 
Center for Managing Chronic Disease. (2010). Key informants’ perspectives on 
managing epilepsy. Ann Arbor, MI: Author. 
Center for the Advancement of Health. (2002). Essential elements of self-management 
interventions. Washington, DC: Author. 
Centers for Disease Control and Prevention. (2000). Health-related quality of life among 
adults with arthritis. Morbidity and Mortality Weekly Report, 49(17), 366–269. 
Centers for Disease Control and Prevention. (2001). Key findings in chronic disease. 
Retrieved from http://www.cdc.gov 
Centers for Disease Control and Prevention. (2009). Chronic disease incidence, 
prevalence, and costs. Retrieved from http://www.cdc.gov 
 254 
Centers for Disease Control and Prevention. (2010a). Improving and extending quality of 
life in older Americans. Retrieved from http://www.cdc.gov 
Centers for Disease Control and Prevention. (2010b). Framework for epilepsy prevention 
and control. Retrieved from http://www.cdc.gov 
Centers for Disease Control and Prevention. (2010c). Intervention programs. Retrieved 
from http://www.cdc.gov 
Charron-Prochownik, D., Zgibor, J., & Peyrot, M. (2007). The diabetes self-management 
assessment report tool (D-SMART): Process evaluation and patient satisfaction. 
Diabetes Education, 33(5), 833–835. 
Chodosh, J., Morton, S. C., Mjoica, W., Maglione, M., Suttorp, M., Hilton, L., . . . 
Shekelle, P. (2005). Meta-analysis: Chronic disease self-management programs for 
older adults. Annals of Internal Medicine, 143(6), 427–438. 
Clark, N. (2003). Management of chronic disease by patients. Annual Review of Public 
Health, 24(1), 289–313. doi: 10.1146/annurev.publhealth.24.100901.141021 
Clark, N., Gong, M., & Kaciroti, N. (2001). A model of self-regulation for control of 
chronic disease. Health Education and Behavior, 28(6), 769–782. 
Clark, N. M., Janz, N. K., Dodge, J. A., Schork, M. A., Wheeler, J., Liang, J., . . . 
Santinga, J. (1997). Self-management of heart disease by older adults: Assessment 
of an intervention based on social cognitive theory. Research on Aging, 19(3),  
362–382. 
Clark, N. M., Stoll, S., Sweetman, M., Youatt, E. J., Derry, R., & Gorelick, A. (2010). 
Fostering epilepsy self-management: The perspectives of professionals. Epilepsy 
and Behavior, 19(3), 225–231. 
 255 
Collins, N. S., Shapiro, R. A., & Ramsay, R. E. (2006). Elders with epilepsy. The 
Medical Clinics of North America, 90(5), 945–966. 
Commission on Outcome Measurement in Epilepsy. (1998). Commission on Outcome 
Measurement in Epilepsy, 1994–1997: Final report. Epilepsia, 39(2), 213–231. 
Corbin, J., & Strauss, A. (1988). Unending work and care: Managing chronic illness at 
home. San Francisco, CA: Jossey-Bass. 
Corbin, J., & Strauss, A. (2008). Basics of qualitative research: Techniques and 
procedures for developing grounded theory (3rd ed.). London, UK: Sage. 
Coster, S., & Norman, I. (2009). Cochrane reviews of educational and self-management 
interventions to guide nursing practice: A review. International Journal of Nursing 
Studies, 46(4), 508–528. 
Cramer, J. A., Perrine, K., Devinsky, O., Bryant-Comstock, L., Meador, K., &  
Hermann, B. (1998). Development and cross-cultural translations of a 31-item 
quality of life in epilepsy inventory. Epilepsia, 39(1), 81–88. 
Crystal, S., Johnson, R. W., & Harman, J. (2000). Out of pocket health care costs among 
older Americans. Journal of Gerontology, 55(1), 51–62. 
Diaz, H., & Herring, P. (2006). Type 2 diabetes as a portal for older adult community and 
university collaboration: One county’s experience. Public Health Report, 121(4), 
479–482. 
DiIorio, C. (1997). Epilepsy self-management. In D. Gochman (Ed.), Handbook of health 
and behavioral research: Provider determinants (pp. 213–230). New York, NY: 
Plenum. 
  
 256 
DiIorio, C. (2009, December). Theoretical aspects of self-management. Poster presented 
at the American Epilepsy Society Annual Meeting, Boston, MA. 
DiIorio, C., Escoffery, C., McCarty, F., Yeager, K., Henry, T., Koganti, A., . . .  
Wexler, B. (2009). Evaluation of WebEase: An epilepsy self-management Web 
site. Health Education Research, 24(2), 185–197. 
DiIorio, C., Faherty, B., & Manteuffel, B. (1992). Self-efficacy and social support in  
self-management of epilepsy. Western Journal of Nursing Research, 14(3),  
292–303. 
DiIorio, C., Faherty, B., & Manteuffel, B. (1994). Epilepsy self-management: Partial 
replication and extension. Research in Nursing & Health 17(3), 167–174. 
DiIorio, C., Hennessy, M., & Manteuffel, B. (1996). Epilepsy self-management: A test of 
a theoretical model. Nursing Research, 45(4), 211–217. 
DiIorio, C., & Henry, M. (1995). Self-management in persons with epilepsy. Journal of 
Neuroscience Nursing, 27(6), 338–343. 
DiIorio, C., Shafer, P., Letz, R., Henry, T., Schomer, D., & Yeager, K. (2004). Project 
EASE: A study to test a psychosocial model of epilepsy medication management. 
Epilepsy & Behavior, 5(6), 926–936. 
Epilepsy Foundation. (2009). Facts and statistics. Retrieved from 
http://www.epilepsyfoundation.org 
Epilepsy Foundation. (2010). Epilepsy in the elderly. Retrieved from 
http://www.epilepsyfoundation.org/ 
Faught, E. (1999). Epidemiology and drug treatment of epilepsy in elderly people. Drugs 
and Aging, 15(4), 255–269.  
 257 
Faught, E., Duh, M. S., Weiner, J. R., Guerin, A., & Cunnington, M. C. (2008). 
Nonadherence to antiepileptic drugs and increased mortality: Findings from the 
RANSOM Study. Neurology, 71(120), 1572. 
Feely, M. (1999). Drug treatment of epilepsy. British Medical Journal, 318(7176), 106. 
Ferrans, C., & Cohen, F. (1996). Quality of life: Persons with epilepsy and the general 
population. Epilepsia, 34(6), 25. 
Ferrans, C., & Powers, M. (1985). Quality of Life Index: Development and psychometric 
properties. Advances in Nursing Science, 8(1), 15–24. 
Folstein, M., Folstein, S., & McHugh, P. (1975). Mini-mental state: A practical method 
for grading the cognitive state of patients for the clinician. Journal of Psychiatric 
Research, 12(3), 189–198. 
Fuller, G. (2000). Falls in the elderly. American Family Physician, 61(7), 2159–2168. 
Funnel, M. M., & Anderson, R. M. (2004). Empowerment and self-management of 
diabetes. Clinical Diabetes, 22(3), 123–127. 
Gallo, B. (2006). Epilepsy in the elderly. Epilepsy Foundation, 68(1), 83–86. 
Galvin, J. E., Duda, J. E., Kaufer, D. I., & Lippa, C. F. (2010). Lewy Body dementia: 
Caregiver burden and unmet needs. Alzheimer Disease and Associated Disorders, 
24(2), 177–181. 
George, M., Campbell, J., & Rand, C. (2009). Self-management of acute asthma among 
low-income urban adults. The Journal of Asthma, 46(6), 618–624.  
doi: 10.1080/02770900903029788 
  
 258 
 
Gibson, P. G., Coughlan, J., Wilson, A. J., Abramson, M., Bauman, A., Hensley, M., & 
Walters, E. (2002). Self-management education and regular practitioner review for 
adults with asthma. Cochrane Database of Systematic Reviews, 2.  
doi: 10.1002/14651858 
Gilliam, F., Kuzniecky, R., Faught, E., Black, L., Carpenter, G., & Schrodt, R. (1997). 
Patient-validated content of epilepsy specific quality-of-life measurement. 
Epilepsia, 38(6), 233. 
Gordon, C., & Galloway, T. (2008). Review of findings on Chronic Disease  
Self-Management Program (CDSMP) outcomes: Physical, emotional &  
health-related quality of life, health care utilization and costs. Retrieved from 
http://health.utah.gov/arthritis 
Gotham, A. M., Brown, R. G., & Marsden, C. D. (1986). Depression in Parkinson's 
disease: A quantitative and qualitative analysis. Journal of Neurology, 
Neurosurgery, and Psychiatry, 49(4), 381–389. 
Grey, M., Knafl, K., & McCorkle, R. (2006). A framework for the study of self- and 
family management of chronic conditions. Nursing Outlook, 54(5), 278–286. 
Healy, B. (1991). The Yentl Syndrome. New England Journal of Medicine, 325(4),  
274–276. 
Hesdorffer D. C., Logroscino G., Benn, E., Katri, N., Cascino, G., & Hauser, W. (2011). 
Estimating risk for developing epilepsy: A population-based study in Rochester, 
Minnesota. Neurology, 76(1), 23–27. 
  
 259 
Holman, H., & Lorig, K. (2004). Patient self-management: A key to effectiveness and 
efficiency in care of chronic disease. Public Health Reports, 119(3), 239–243. 
Hsieh, H., & Shannon, S. (2005). Three approaches to qualitative content analysis. 
Qualitative Health Research, 15(9), 1277–1288. 
Jaarsma, T., Stromberg, A., Martensson, J., & Dracup, K. (2003). Development and 
testing of the European Heart Failure Self-Care Behaviour Scale. The European 
Journal of Heart Failure, 5(3), 363–370. 
Jacoby, A. (1992). Epilepsy and the quality of everyday life: Findings from a study of 
people with well-controlled epilepsy. Social Science and Medicine, 34(6),  
657–666. 
Jacoby, A., Baker, G., Smith, D., Dewey, M., & Chadwick, D. (1993). Measuring the 
impact of epilepsy: The development of a novel scale. Epilepsy Research, 16(1), 
83–88. 
Janson, S. L., McGrath, K., Covington, J. K., Cheng, S., & Boushey, H. A. (2009). 
Individualized asthma self-management improves medication adherence and 
markers of asthma control. Journal of Allergy and Clinical Immunology, 123(4), 
840–846. 
Janz, N., Clark, N., Dodge, J. A., Schork, M., Mosca, L., & Fingerlin, T. (1999). The 
impact of a disease-management program on the symptom experience of older 
women with heart disease. Women’s Health, 30(2), 1–24. 
Joyce, G. F., Emmett, B., Keeler, B. S., & Goldman, D. P. (2005). The lifetime burden of 
chronic disease among the elderly [2005 Web-Exclusive Supplement 2]. Health 
Affairs, 10(24). doi: 10.1377/hlthaff.W5.R18 
 260 
Karceski, S. C. (2005). Advances in managing epilepsy. Patient Care, 39(2), 29–36. 
Katz, P., Yelin, E., Eisner, M., & Blanc, P. (2002). Perceived control of asthma and 
quality of life among adults with asthma. Annals of Allergy, Asthma and 
Immunology, 89(3), 251–258. 
Kobau, R., & DiIorio, C. (2003). Epilepsy self-management: A comparison of  
self-efficacy and outcome expectancy for medication adherence and lifestyle 
behaviors among people with epilepsy. Epilepsy & Behavior, 4(3), 217–225. 
Kovar, P., Allegrante, J., MacKenzie, C., Peterson, M., Gutin, B., & Charlson, M. (1992). 
Supervised fitness walking in patients with osteoarthritis of the knee: A 
randomized, controlled trial. Annals of Internal Medicine, 116(7), 529–534. 
Krauss, G., & Crone, N. (2001). Side-effects of anti-epileptic drugs. Epilepsia, 22(2), 13. 
Kruger, J., Helmick, C. G., Callahan, L., & Haddix, A. (1998). Cost-effectiveness of the 
arthritis self-help course. Archives of Internal Medicine, 158(11), 1245–1249. 
Krumholz, A. (2009). Driving issues in epilepsy: Past, present, and future. Epilepsy 
Currents, 9(2), 31–34. 
Krumholz, A., Fisher, R. S., Lesser, R. P., & Hauser, W. A. (1991). Driving and epilepsy: 
A review and reappraisal. Journal of the American Medical Association, 265(5), 
622–626. 
Laccheo, I., Ablah, E., Heinrichs, R., Sadler, T., Baade, L., & Liow, K. (2008). 
Assessment of quality of life among the elderly with epilepsy. Epilepsy and 
Behavior, 12(2), 257. 
  
 261 
Lawlor, D. A., Patel, R., & Ebrahim, S. (2003). Association between falls in elderly 
women and chronic diseases and drug use: Cross-sectional study. British Medical 
Journal, 327(7417), 712–717. 
Leppik, I. (1988). Compliance during treatment of epilepsy. Epilepsia, 29(2), S79–S84. 
Leppik, I. (2001). Treatment of epilepsy in the elderly. Epilepsy Currents, 1(2), 46–47. 
Leppik, I., Kelly, K., DeLorenzo, R., Mathern, G., White, H., Patrylo, P., &  
DeToledo-Morrell, L. (2006). Basic research in epilepsy and aging. Epilepsy 
Research, 68(S1), S21–S37. 
Lewis, L. (2007). Round-table: Promoting self-management of diabetes. American 
Journal of Nursing, 107(6), 65–69. 
Lincoln, Y., & Guba, E. (1985). Naturalistic inquiry. Newbury Park, CA: Sage. 
Locharernkul, C. Suwaroporn, S., Krongthong, W., Limarun, C., & Arnamwong, A. 
(2010). A study of knowledge and attitude improvement on epilepsy among Thai 
physicians and nurses. Journal of the Medical Association of Thailand, 93(8), 
875–884. 
Lorig, K. (2003). Self-management education: More than a nice extra. Medical Care, 
41(6), 699–701. 
Lorig, K., Feigenbaum, P., Regan, C., Ung, E., & Holman, H. (1986). A comparison of 
lay-taught arthritis self-management courses. Journal of Rheumatology, 13(4),  
763–767. 
Lorig, K., González, V., Laurent, D., Morgan, L., & Laris, B. (1998). Arthritis  
self-management program variations: 3 studies. Arthritis Care Research, 11(6), 
448–454. 
 262 
Lorig, K., & Holman, H. (2003). Self-management education: History, definition, 
outcomes, and mechanisms. Annals of Behavioral Medicine, 26(1), 1–7. 
Lorig, K., Laurin, J., & Holman, H. (1984). Arthritis self-management: A study of the 
effectiveness of patient education for the elderly. Gerontologist, 24(5), 455–457. 
Lorig, K., Lubeck, D., Kraines R. G., Seleznick, M., & Holman, H. R. (1985). Outcomes 
of self-help education for patients with arthritis. Arthritis and Rheumatology, 
28(6), 680–685. 
Lorig, K., Mazonson, P., & Holman, H. (1993). Evidence suggesting that health 
education for self-management in patients with chronic arthritis has sustained 
health benefits while reducing health care costs. Arthritis and Rheumatology, 
36(4), 439–446. 
Lorig, K., Ritter, P., & González, V. (2003). Hispanic chronic disease self-management. 
A randomized community-based outcome trial. Nursing Research, 52(6),  
361–369. 
Lorig, K., Ritter, P., Laurent, D., & Fries, J. (2004). Long-term randomized controlled 
trials of tailored-print and small-group arthritis self-management interventions. 
Medical Care, 43(4), 346–354. 
Lorig, K., Ritter, P., Stewart, A., Sobel, D., Brown, B., Bandura, A., . . . Holman, H. 
(2001). Chronic disease self-management program. 2-year health status and health 
care utilization outcomes. Medical Care, 39(11), 1217–1223. 
Lowry, K. P., Dudley, T., Oddone, E. Z., & Bosworth, H. B. (2005). Intentional and 
unintentional nonadherence to antihypertensive medication. The Annals of 
Pharmacotherapy, 39(7), 1998–1203. 
 263 
Lyon, B. (2005). Getting back on track: Nursing’s autonomous scope of practice. Clinical 
Nurse Specialist, 19(1), 28–33. 
Malow, B. (2004). Sleep deprivation and epilepsy. Epilepsy Currents, 4(5), 193–195. 
Managing Epilepsy Well Network. (n.d.). MEW Network at a glance. Retrieved from 
http://www.sph.emory.edu/ManagingEpilepsyWell 
Mancuso, C., Rincon, M., McCulloch, C., & Charlson, M. (2001). Self-efficacy, 
depressive symptoms, and patients’ expectations predict outcomes in asthma. 
Medical Care, 39(12), 1326–1338. 
Marks, R., Allegrante, J., & Lorig, K. (2005a). A review and synthesis of research 
evidence for self-efficacy-enhancing interventions for reducing disability: 
Implications for health education practice (Part I). Health Promotion Practice, 
6(37), 37–43. 
Marks, R., Allegrante, J., & Lorig, K. (2005b). A review and synthesis of research 
evidence for self-efficacy-enhancing interventions for reducing disability: 
Implications for health education practice (Part II). Health Promotion Practice, 
6(148), 148–156. 
Martin, M., Beebe, J., & Lopez, L. (2010). A qualitative exploration of asthma  
self-management beliefs and practices in Puerto Rican families. Journal of Health 
Care for the Poor and Underserved, 21(2), 464–474. 
  
 264 
Martin, M., Catrambone, C., Kee, R., Evans, A., Sharp, L., Lyttle, C., . . . The Chicago 
Initiative to Raise Asthma Health Equity Investigative Team. (2009). Improving 
asthma self-efficacy: Developing and testing a pilot community-based asthma 
intervention for African American adults. The Journal of Allergy and Clinical 
Immunology, 123(1), 153–159. 
Martin, R., Griffith, R., Faught, E., Gilliam, F., Mackey, M., & Vogtle, L. (2005). 
Cognitive functioning in community dwelling older adults with chronic partial 
epilepsy. Epilepsia, 46(2), 298–303. 
Martin, R., Vogtle, L., Gilliam, F., & Faught, E. (2003). Health-related quality of life in 
senior adults with epilepsy: What we know from randomized clinical trials and 
suggestions for future research. Epilepsy & Behavior, 6(4), 626–634. 
Martin, R., Vogtle, L., Gilliam, F., & Faught, E. (2005). What are the concerns of older 
adults living with epilepsy? Epilepsy & Behavior, 7(4), 297–300. 
Mason, J. (2002). Qualitative interviewing: Asking, listening and interpreting. In T. May 
(Ed.), Qualitative research in action (pp. 225–241). London, England: Sage. 
Maxwell, J. (1992). Understanding and validity in qualitative research. Harvard 
Educational Review, 62(3), 279–300. 
Mazzuca, S., Moorman, N., Wheeler, M., Norton, J., Finebert, N., Vinicor, F., . . .  
Clark, C. (1986). The diabetes education study: A controlled trial of the effects of 
diabetes patient education. Diabetes Care, 9(1), 1–10. 
McAuley, J., Elliott, J., Patankar, S., Hart, S., Long, L., Moore, J., & Shneker, B. (2010). 
Comparing patients’ and practitioners’ views on epilepsy concerns: A call to 
address memory concern. Epilepsy & Behavior, 19(4), 580–583. 
 265 
McAuley, J., McFadden, L., Elliott, J., & Shneker, B. (2008). An evaluation of  
self-management behaviors and medication adherence in patients with epilepsy. 
Epilepsy and Behavior, 13(4), 637–641.  
McGowan, P., & Green, L. (1995). Arthritis self-management in native populations of 
British Columbia: An application of health promotion and participatory research 
principles in chronic disease control. Canadian Journal of Aging, 14(Supp. 1),  
201–212. 
McSweeney. J., O’Sullivan, P., Cleves, M., Lefler, L., Cody, M., Moser, D., . . .  
Zaho, W. (2010). Racial differences in women’s prodromal and acute myocardial 
infarction symptoms. American Journal of Critical Care, 19(1), 63–73. 
Miles, M., & Huberman, A. (1994). Qualitative data analysis: A source book of new 
methods. Beverly Hills, CA: Sage. 
Miller, W. (2010). Qualitative research findings as evidence: Utility in nursing practice. 
Clinical Nurse Specialist, 24(4), 191–193. 
Miller, W., & Buelow, J. (2010, December). Epilepsy self-management in older adults: A 
pilot study. Poster presented at the American Epilepsy Society Annual Meeting, 
San Antonio, TX. 
Mitrushina, M., & Satz, P. (2006). Reliability and validity of the Mini-Mental State Exam 
in neurologically intact elderly. Journal of Clinical Psychology, 47(4), 537–543. 
Miura, T., Kojima, R., Mizutani, M., Shiga, Y., Takatsu, F., & Suzuki, Y. (2001). Effect 
of digoxin non-compliance on hospitalization and mortality in patients with heart 
failure in long-term therapy: A prospective cohort study. European Journal of 
Clinical Pharmacology, 57(1), 77–83. 
 266 
Moons, P., Budts, W., & DeGeest, S. (2006). Critique on the conceptualisation of quality 
of life: A review and evaluation of different conceptual approaches. International 
Journal of Nursing Studies, 43(7), 891–901. 
Moore, S. (2009, December). Self-management: A systems approach [Discussion of 
research project NINR P30 NR010676]. Presentation at the Indiana University 
School of Nursing Center for Enhancing Quality of Life, Indianapolis, IN. 
Morrow, A., Haidet, P., Skinner, J., & Naik, A. (2008). Integrating diabetes  
self-management with the health goals of older adults: A qualitative exploration. 
Patient Education and Counseling, 72(3), 418–423. 
Moskowitz, J. M., Henneman, T. A., & Young-Holt, B. (2002). California 2000 
HIV/AIDS knowledge, attitudes, beliefs and behaviors (KABB) survey: Methods 
and results [Pamphlet]. Berkeley, CA: University of California, Berkeley. 
Naughton, C., Bennet, K., & Feely, F. (2006). Prevalence of chronic disease in the 
elderly based on a national pharmacy database. Age and Ageing, 35(6), 633–636. 
Newman, M. (1986). Health as expanding consciousness. St. Louis, MO: Mosby. 
Nightingale, F. (1859/1969). Notes on nursing: What it is and what it is not. New York, 
NY: Dover. 
Osborne R., Wilson T., Lorig K., & McColl, G. (2007). Does self-management lead to 
sustainable health benefits in people with arthritis? A 2-year transition study of 452 
Australians. Journal of Rheumatology, 34(5), 1–6. 
Paradowski, B., & Zagrajek, M. (2005). Epilepsy in middle-aged and elderly people: A 
three-year observation. Epileptic Disorders, 7(2), 91–95. 
  
 267 
Partnership for Solutions. (2002). Chronic conditions: Making the case for ongoing care. 
Baltimore, MD: The Johns Hopkins University. 
Patton, M. (2001). Qualitative research and evaluation methods (3rd ed.). Thousand 
Oaks, CA: Sage. 
Perucca, E., Berlowitz, D., & Birnbaum, A. (2006). Pharmacological and clinical aspects 
of antiepileptic drug use in the elderly. Epilepsy Research, 68(1), 49–63. 
Powell, L. H., Calvin, J. E., Richardson, D., Janssen, I., Mendes de Leon, C., Flynn,  
K. J., . . . Avery, E. for the HART Investigators. (2010). Self-management 
counseling in patients with heart failure: The heart failure adherence and retention 
randomized behavioral trial. Journal of the American Medical Association, 304(12), 
1331–1338. 
Ramsay, R., Rowan, A. J., & Pryor, F. (2004). Special considerations in treating the 
elderly patient with epilepsy. Neurology, 62(2), S24–S29. 
Reimsma, R., Kirwan, J., Taal, E., & Rasker, J. J. (2002). Patient education for adults 
with rheumatoid arthritis. Cochrane Database of Systematic Reviews, 2003(2),  
doi: 10.1002/14651858.CD003688 
Rodgers, B., & Cowles, K. (1993). The qualitative research audit trail: A complex 
collection of documentation. Research in Nursing and Health, 16(3), 219–226. 
Rolfe, G. (2004). Validity, trustworthiness and rigour: Quality and the idea of qualitative 
research. Journal of Advanced Nursing, 53(3), 304–310. 
  
 268 
Rowan, A. J., Ramsay, R., Collins, J., Pryor, F., Boardman, K., Uthman, B., . . . The VA 
Cooperative Study 428 Group. (2005). New onset geriatric epilepsy: A randomized 
study of gabapentin, lamotrigine, and carbamazepine. Neurology, 4(11),  
1868–1873. 
Rowan, A. J., & Ramsay, R. E. (1997). Epilepsy in the elderly. New York, NY: 
Butterworth-Heinemann. 
Ruggiero, R., Glasgow, R., & Dryfoos, J. (1997). Diabetes self-management:  
Self-reported recommendations and patterns in a large population. Diabetes Care, 
20(4), 568–576. 
Ryan, P., & Sawin, K. (2009). The individual and family self-management theory: 
Background and perspectives on context, process, and outcomes. Nursing Outlook, 
57(4), 217–225. 
Sandelowski, M. (1993). Rigor or rigor mortis: The problem of rigor in qualitative 
research revisited. Advances in Nursing Science, 16(2), 1–8. 
Sandelowski, M. (1994). The use of quotes in qualitative research. Research in Nursing 
and Health, 17(6), 479–482. 
Sandelowski, M. (1995a). Qualitative analysis: What it is and how to begin. Research in 
Nursing and Health, 18(4), 371–375. 
Sandelowski, M. (1995b). Sample size in qualitative research. Research in Nursing and 
Health, 18(2), 179–183. 
Sandelowski, M. (1996). One is the liveliest number: The case orientation of qualitative 
research. Research in Nursing and Health, 19(6), 525–529. 
 269 
Sandelowski, M. (2000). Whatever happened to qualitative description? Research in 
Nursing and Health, 23(3), 334–340. 
Sandelowski, M. (2001). Real qualitative researchers do not count: The use of numbers in 
qualitative research. Research in Nursing and Health, 24(3), 230–240. 
Sandelowski, M. (2010a, June). Qualitative research. Workshop presented at the 
University of North Carolina Qualitative Analysis I Workshop. Chapel Hill, NC. 
Sandelowski, M. (2010b). What’s in a name? Qualitative description revisited. Research 
in Nursing and Health, 33(1), 77–84. 
Sawicki, P. T. (1999). A structured teaching and self-management program for patients 
receiving oral anticoagulation: A randomized controlled trial. Journal of the 
American Medical Association, 281(2), 145–150. 
Schneider, J., & Conrad, P. (1983). Having epilepsy: The experience and control of 
illness. Philadelphia, PA: Temple University Press. 
Shaw, E., Stokes, T., Camosso-Stefinovic, J., Baker, R., Baker, G., & Jacoby, A. (2009). 
Self-management education for adults with epilepsy. Cochrane Database of 
Systematic Reviews 2010(10), doi: 10.1002/14651858.CD004723.pub3 
Shegog, R., Bartholomew, L. K., Parcel, G. S., Sockrider, M. M., Masse, L., & 
Abramson, S. L. (2001). Impact of a computer-assisted education program on 
factors related to asthma self-management behavior. Journal of the American 
Medical Informatics Association, 8(1), 49–56. 
Shope, J. T. (1996). Educating patients and families to manage a seizure disorder 
successfully. In N. Santilli (Ed.), Managing Seizure Disorders (pp. 123–134). 
Philadelphia, PA: Lippincott-Raven. 
 270 
Shultz, J., Corbett, C., & Allen, C. (2009). Slavic women’s understanding of diabetes 
dietary self-management and reported dietary behaviors. Journal of Immigrant and 
Minority Health, 11(5), 400–405. 
Speer, E., Reddy, S., Lommel, T., Fischer, J., Heather, S., Park, S., & Johnson, M. 
(2008). Diabetes self-management behaviors and A1C improved following a 
community-based intervention in older adults in Georgia senior centers. Journal of 
Nutrition for the Elderly, 27(1–2), 179–200. 
Spiera, H. (1987). Osteoarthritis as a misdiagnosis in elderly patients. Geriatrics, 42(11), 
37–42. 
Stanley-Hermanns, M., & Engebretson, J. (2010). Sailing the stormy seas: The illness 
experience of persons with Parkinson’s disease. The Qualitative Report, 15(2), 
340–369. 
Sweeney, J., Rosano, C., Berman, R., & Luna, B. (2001). Inhibitory control of attention 
declines more than working memory during normal aging. Neurobiology of Aging, 
22(1), 39–47. 
Swendeman, D., Ingram, B., & Rotheram-Borus, M. J. (2009). Common elements in  
self-management of HIV and other chronic illnesses: An integrative framework. 
AIDS Care, 21(10), 1321–1334. 
Taylor, J., Rea, H., McNaughton, S., Smith, L., Muldar, J., Asher, M., . . . Stewart, A. 
(1991). A tool for measuring the asthma self-competency of families. Journal of 
Psychosomatic Research, 35(4–5), 483–491. 
  
 271 
Thomas, L. (1981). On the science and technology of medicine. In P. Lee, N. Brown, &  
I. Red (Eds.), The nation's health (pp. 485–492). San Francisco, CA: Boyd & 
Fraser. 
Thornhill, K., Lyons, A., Nouwen, A., & Lip, G. (2008). Experiences of living with 
congestive heart failure: A qualitative study. British Journal of Health Psychology, 
13(1), 155–175. 
Uitti, R. J. (2009). Parkinson's disease and issues related to driving. Parkinsonism 
Related Disorders, 15(S3), S122–S125. 
Unger, W., & Buelow, J. (2009). Hybrid concept analysis of adults newly diagnosed with 
epilepsy. Epilepsy & Behavior, 14(1), 89–95. 
United States Census Bureau. (2009). United States population statistics. Retrieved from 
http://www.census.gov 
United States Department of Health and Human Services. (2003). National healthcare 
disparities report. Retrieved from http://archive.ahrq.gov 
Unsworth, C. (1999). Living with epilepsy: Safety during home, leisure, and work 
activities. Australian Occupational Therapy Journal, 46(3), 89–98. 
van Genugten, L., van Empelen, P., Flink, I., & Oenema, A. (2010). Systematic 
development of a self-regulation weight-management intervention for overweight 
adults. BMC Public Health, 10(1), 649. 
Wagner, E., Austin, B., & von Korff, M. (1996). Organizing care for patients with 
chronic illness. Milbank Quarterly, 74(4), 511–544. 
Waterhouse, E., & Towne, A. (2005). Seizures in the elderly: Nuances in presentation 
and treatment. Cleveland Clinic Journal of Medicine, 72(3), S26. 
 272 
Webel, A., & Holzemer, W. (2009). Positive self-management program for women living 
with HIV: A descriptive analysis. Journal of the Association of Nurses in AIDS 
Care, 20(6), 458–467. 
White, L. (2011, April). Alzheimer’s disease may be easily misdiagnosed. Workshop 
presented at the American Academy of Neurology Meeting, Honolulu, HI. 
Whitley, H. P., Fermo, J. D., Ragucci, K., & Chumney, E. C. (2006). Assessment of 
patient knowledge of diabetic goals, self-reported medication adherence, and goal 
attainment. Pharmacy Practice, 4(4), 183–190. 
Yeager, K., DiIorio, C., Shafer, P., McCarty, F., Letz, R., Henry, T., & Schomer, D. 
(2005). The complexity of treatments for persons with epilepsy. Epilepsy and 
Behavior, 7(4), 679–686. 
Yohannes, A. M., Roomi, J., Baldwin, R. C., & Connolly, M. J. (1998). Depression in 
elderly outpatients with disabling chronic obstructive pulmonary disease. Journal 
of Clinical Nursing, 17(5), 34–42. 
Yusuff, K. B., Olubunmi, O., & Bonatson, Y. J. (2008). Adherence to anti-diabetic drug 
therapy and self-management practices among type-2 diabetics in Nigeria. 
Pharmacy World & Science, 30(6), 876–883. 
 
 
  
CURRICULUM VITAE 
Wendy Renee Miller 
EDUCATION 
 
Institution Major Degree Awarded Date 
Indiana 
University 
Nursing BSN 2003 
Indiana 
University 
Adult Health 
Clinical Nurse 
Specialist 
MSN  2007 
Indiana 
University 
Clinical Nursing 
Science 
PhD 2011 
 
LICENSURE 
 
License Expiration Date 
Registered Nurse 10/31/2013 
 
CERTIFICATIONS 
 
 Certified Critical Care Registered Nurse (CCRN) 
 Advanced Cardiac Life Support (ACLS) 
 
HONORS AND AWARDS 
 
Award Year 
National Research Service Award (F31)—
National Institutes of Health 
2010–2013 
American Epilepsy Society Nurse 
Researcher Award 
2010 
American Epilepsy Society Top 10% 
Abstract Award 
2010 
NIH T32 Pre-Doctoral Research 
Fellowship 
2008–2010 
Research Incentive Fellowship—Indiana 
University 
2008–2010 
Academic Achievement Award—Indiana 
University          
2008, 2009, 2010, 2011 
Region 8 Faculty Workforce Development 
Scholarship 
2006 
BSN Graduate with Highest Distinction 2003 
Elizabeth Grossman Award for highest 
graduation GPA in nursing on all Indiana 
University campuses 
2003 
  
Sigma Theta Tau Induction Scholarship 2003 
Jessie I. Cross Scholarship 2002 
 
PROFESSIONAL SOCIETIES 
 
American Association of Critical Care Nurses 
American Epilepsy Society 
American Psychiatric Nurses Association 
Gerontological Association of America 
Indiana State Nurses Association 
Midwestern Nursing Research Society 
National Association of Clinical Nurse Specialists (including local Indiana chapter) 
Sigma Theta Tau 
 
FUNDED GRANTS 
 
National Institutes of Health National Research Service Award (1F31NR012114-01). 
2010. 
National Institutes of Health National Research Service Award (1F31NR012114-02). 
2011. 
 
PUBLICATIONS 
 
Fulton, J., Otte, J., & Miller, W. (2011). Concept analysis of quality of life: A  
meta-analysis. Manuscript submitted for publication. 
 
Miller, W., & Buelow, J. (2011). Psychometric Testing of Self-Efficacy for Partnership 
Scale: An example of instrument development. Clinical Nurse Specialist, 25(1), 
11–14. 
 
Buelow, J., Dean, P., Gilbert, K., Miller, W., and Pleuger, M. (2010). Epilepsy. In 
American Association of Neuroscience Nursing Core Curriculum (5th ed.).  
 
Habermann, B., Miller, W., McLennon, S., Chen, H., Rafail, L., & Wojcieszek, J. (2010). 
Couples living with Parkinson's disease: Needs and concerns at advanced to end 
stage. Movement Disorders, 25(Supp. 3), S694. 
 
Miller, W. (2010). Qualitative Research findings as evidence: Utility in nursing practice. 
Clinical Nurse Specialist, 24(4), 191–193. 
 
Unger*, W., & Buelow, J. (2009). Hybrid concept analysis of self-management in adults 
newly diagnosed with epilepsy. Epilepsy & Behavior, 14(1), 89–95. 
 
Unger*, W. (2008, May). Findings from a hybrid concept analysis of patients  
newly-diagnosed with epilepsy [Abstract]. Clinical Nurse Specialist, 22(2), 107.  
 
  
Unger*, W. (2008). Use of the clinical reasoning model for the development of 
interventions for mechanical tissue tension-induced pain [Abstract]. National 
Association of Clinical Nurse Specialists Journal, 21(2), 109. 
 
*Maiden name 
 
PRESENTATIONS 
 
Miller, W. (2011, October). Epilepsy self-management in older adults: A qualitative 
study. Poster presented at the Sigma Theta Tau International Conference, 
Grapevine, TX. 
 
Habermann, B., Chen, H., Miller, W., & McLennon, S. (2011, August). Couples living 
with advanced Parkinson's disease (PD) or multiple sclerosis (MS): Needs, 
concerns and decision making at end of life. Poster presented at the NINR Science 
of Compassion Conference, Bethesda, MD. 
 
Miller, W. (2010, December). Epilepsy self-management in older adults: A pilot study. 
Poster presented at the American Epilepsy Society Annual Meeting, San Antonio, 
TX. 
 
Miller, W. (2010, April). Psychometric testing of a Self-Efficacy for Care Partnership 
Scale and a Family Care Needs Scale for parents of children with epilepsy and 
intellectual disabilities. Poster presented at the Midwestern Research Nursing 
Society Annual Meeting, Kansas City, MO. 
 
Unger*, W. (2008, May). Findings from a hybrid concept analysis of patients  
newly-diagnosed with epilepsy. Student abstract presented at the National 
Association of Clinical Nurse Specialists Annual Meeting, Atlanta, GA. 
 
Unger*, W. (2007, May). Use of the clinical reasoning model for the development of 
interventions for mechanical tissue tension-induced pain. Poster presented at the 
National Association of Clinical Nurse Specialists Annual Meeting, Phoenix, AZ. 
 
*Maiden name 
 
SPEAKING ENGAGEMENTS 
 
Year Organization Engagement 
2011 Indiana University Health 
System 
Delivered presentation at the Iowa 
Advanced Practice Institute regarding 
appraisal of the evidence. 
2010 Indiana University 
Bloomington 
Delivered critical care content to 
undergraduate nursing students in a 
Health Alterations course. 
  
  
2010 Indiana University–Purdue 
University Indianapolis 
Served as a content expert for the 
concept of self-management and 
delivered lecture to Master’s nursing 
students in a Scientific Basis for 
Nursing Practice course. 
 
 
EMPLOYMENT 
 
Year(s) Institution Job Description 
2006–Present Indiana University 
School of Nursing 
Adjunct faculty, with the 
following teaching 
assignments: 
 H361 (didactic) 
 H362 (clinical) 
 S470 (didactic) 
 S471 (clinical) 
 H354 (clinical) 
 H365 (didactic) 
2004–2007 Bloomington Hospital 
Bloomington, IN 
Staff/Charge Nurse/Primary 
Preceptor in the following 
units: 
 Cardiovascular ICU 
 Medical-Surgical ICU 
 Cath Lab recovery 
2003–2004 Methodist Hospital 
Indianapolis, IN 
Staff Nurse in a level one 
neurological trauma center 
 
SERVICE 
 
Year(s) Organization Activities 
2010–Present Neuroscience Nursing 
Foundation 
Grant Reviewer 
2010–Present Clinical Nurse Specialist—
The Journal of Advanced 
Nursing Practice 
Manuscript Reviewer 
2010–Present Journal of Neuroscience 
Nursing 
Manuscript Reviewer 
2008–Present American Epilepsy Society Committee 
Member/Abstract Reviewer 
 
